Patent Application
20210054362
The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Oct. 28, 2020, is named 53470_701_831_SL.txt and is 719,493 bytes in size.
Genome editing tools such as CRISPR/Cas systems can aid development of human therapeutics and breeding for agriculturally desirable traits. Double-stranded breaks generated by genome editing enzymes are repaired by cellular repair mechanisms such as non-homologous end joining (NHEJ) pathway and homology-dependent recombination mechanism. Of the NHEJ processes, error-free repair rather than error-prone repair pathways can dominate, which results in low efficiency of mutagenesis by the genome editing enzymes. Thus, there is a need for tools to increase error-prone repair processes in order to increase mutagenesis efficiency of genome editing enzymes.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a DNA modifying enzyme comprising a RecE domain. In some embodiments, the RecE domain exhibits at least 70% identity over at least 70% of its sequence to RecE. In some embodiments, the RecE domain exhibits at least 90% identity to RecE. In some embodiments, the RecE domain comprises a RecE sequence.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a DNA modifying enzyme comprising a RecJ domain. In some embodiments, the RecJ domain exhibits at least 70% identity over at least 70% of its sequence to RecJ. In some embodiments, the RecJ domain exhibits at least 90% identity to RecJ. In some embodiments, the RecJ domain comprises a RecJ sequence.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a DNA modifying enzyme comprising a RecBCD domain. In some embodiments, the RecBCD domain exhibits at least 70% identity over at least 70% of its sequence to RecBCD. In some embodiments, the RecBCD domain exhibits at least 90% identity to RecBCD. In some embodiments, the RecBCD domain comprises a RecBCD sequence.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a DNA modifying enzyme comprising a Mungbean nuclease domain. In some embodiments, the Mungbean nuclease domain exhibits at least 70% identity over at least 70% of its sequence to Mungbean nuclease. In some embodiments, the Mungbean nuclease domain exhibits at least 90% identity to Mungbean nuclease. In some embodiments, the Mungbean nuclease domain comprises a Mungbean nuclease sequence.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a DNA modifying enzyme comprising an ExoI domain. In some embodiments, the ExoI domain exhibits at least 70% identity over at least 70% of its sequence to ExoI. In some embodiments, the ExoI domain exhibits at least 90% identity to ExoI. In some embodiments, the ExoI domain comprises an ExoI sequence.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a DNA modifying enzyme comprising an ExoIII domain. In some embodiments, the ExoIII domain exhibits at least 70% identity over at least 70% of its sequence to ExoIII. In some embodiments, the ExoIII domain exhibits at least 90% identity to ExoIII. In some embodiments, the ExoIII domain comprises an ExoIII sequence.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a DNA modifying enzyme comprising an ExoVII domain. In some embodiments, the ExoVII domain exhibits at least 70% identity over at least 70% of its sequence to ExoVII. In some embodiments, the ExoVII domain exhibits at least 90% identity to ExoVII. In some embodiments, the ExoVII domain comprises an ExoVII sequence.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a DNA binding protein (DBP). In some embodiments, the DBP binds single-stranded DNA. In some embodiments, the DBP binds double-stranded DNA.
Described herein are polypeptides comprising a sequence-specific endonuclease fused in frame to a terminal deoxyribonucleotidyl transferase (TdT). In some embodiments, the sequence-specific endonuclease comprises a region exhibiting 70% identity over at least 70% of its residues to a Cas9 domain. In some embodiments, the polypeptide or region exhibits at least 90% identity to a Cas9 domain. In some embodiments, the region is a Cas9 domain. In some embodiments, the Cas9 is SpCas9. In some embodiments, the Cas9 is SpyCas9. In some embodiments, the sequence-specific endonuclease comprises a region exhibiting 70% identity over at least 70% of its residues to a Cpf1 domain. In some embodiments, the polypeptide or region exhibits at least 90% identity to a Cpf1 domain. In some embodiments, the region is a Cpf1 domain. In some embodiments, the Cpf1 is FnCpf1. In some embodiments, the sequence-specific endonuclease comprises a TALEN nucleic acid recognition site. In some embodiments, the sequence-specific endonuclease comprises a zinc finger nucleic acid recognition site. In some embodiments, the polypeptide comprises a nuclear localization signal. In some embodiments, the polypeptide comprises an affinity tag.
In some embodiments, the DNA modifying enzyme generates a 3′ OH overhang. In some embodiments, the DNA modifying enzyme exposes a recessed 3′ OH. In some embodiments, the DNA modifying enzyme comprises cleaved end resection activity. In some embodiments, the polypeptide concurrently exhibits increased mutation efficiency and increased homologous recombination efficiency relative to wild type Cas9. In some embodiments, the increased activity is measured in at least one human cell genome or plant cell genome. In some embodiments, measured activity is assessed following a 2 hour incubation. In some embodiments, the measured activity is assessed following a 24 hour incubation. In some embodiments, the increased activity comprises an increased deletion rate. In some embodiments, the increased activity comprises an increased insertion rate. In some embodiments, the increased activity comprises an increased homologous recombination rate.
In some embodiments, the polypeptide is substantially free of bacterial cellular contaminant. In some embodiments, the polypeptide does not have an animal glycosylation pattern. In some embodiments, the polypeptide does not have a bacterial glycosylation pattern. In some embodiments, the polypeptide does not have a fungal glycosylation pattern. In some embodiments, the polypeptide is incubated in contact with a genome at a pH of at least 6. In some embodiments, the polypeptide is incubated in contact with a genome at a pH of at least 10.
Described herein are nucleic acids encoding a chimeric polypeptide. The chimeric polypeptide can be any of the polypeptides described herein. In some embodiments, the nucleic acid comprises an open reading frame that is at least partially codon optimized for expression in a plant target organism. In some embodiments, the nucleic acid comprises an open reading frame that is at least partially codon optimized for expression in a bacterial target organism. In some embodiments, the nucleic acid comprises an open reading frame that is at least partially codon optimized for expression in an animal target organism. In some embodiments, the nucleic acid comprises an open reading frame that is at least partially codon optimized for expression in a mammalian target organism. In some embodiments, the nucleic acid comprises an open reading frame that is at least partially codon optimized for expression in a human cell. In some embodiments, the nucleic acid comprises a 5′ UTR at least partially optimized for expression in a plant target organism. In some embodiments, the nucleic acid comprises a 3′ UTR at least partially optimized for expression in a plant target organism. In some embodiments, the nucleic acid comprises a 5′ UTR at least partially optimized for expression in a bacterial target organism. In some embodiments, the nucleic acid comprises a 3′ UTR at least partially optimized for expression in a bacterial target organism. In some embodiments, the nucleic acid comprises a 5′ UTR at least partially optimized for expression in an animal target organism. In some embodiments, the nucleic acid comprises a 3′ UTR at least partially optimized for expression in an animal target organism. In some embodiments, the nucleic acid comprises a 5′ UTR at least partially optimized for expression in a mammalian target organism. In some embodiments, the nucleic acid comprises a 3′ UTR at least partially optimized for expression in a mammalian target organism.
In some embodiments, the nucleic acid is configured for transient expression in a plant cell.
In some embodiments, the nucleic acid is coated on at least one gold particle. In some embodiments, the nucleic acid is coated on at least one tungsten particle. In some embodiments, the nucleic acid is packaged into a viral expression vector. In some embodiments, the nucleic acid is configured for stable expression in a plant cell. In some embodiments, the nucleic acid is configured for agrobacterium expression. In some embodiments, the nucleic acid is packaged into a bacterial transformation vector. In some embodiments, the nucleic acid is packaged into a viral transformation vector. In some embodiments, the nucleic acid is packaged into a transformation vector for nuclear transformation. In some embodiments, the nucleic acid is packaged into a transformation vector for organellar transformation. In some embodiments, the nucleic acid comprises plant viral promoter. In some embodiments, the nucleic acid comprises a 35S promoter. In some embodiments, the nucleic acid comprises an rbcS promoter. In some embodiments, the nucleic acid comprises a psbA promoter. In some embodiments, the nucleic acid comprises an ubiquitin promoter.
Described herein are methods of tagging a repaired chromosome, comprising contacting the chromosome to a composition comprising a polypeptide described herein, wherein the polypeptide comprises a terminal deoxyribonucleotidyl transferase (TdT) activity, and a labeled nucleic acid. In some embodiments, the labeled nucleic acid comprises a non-canonical base. In some embodiments, the non-canonical base comprises BrdU. In some embodiments, the method comprises isolating nucleic acids comprising the labeled nucleic acid.
Described herein are methods of concurrently increasing a CRISPR-directed mutation rate and homologous recombination rate, comprising contacting a chromosome to a composition comprising a polypeptide described herein, wherein the polypeptide yields an exposed 3′ OH overhang at a cleavage site of the chromosome. In some embodiments, the method comprises contacting the chromosome to a 5′-3′ exonuclease activity. In some embodiments, the method exhibits at least a 20% genome modification rate. In some embodiments, the contacting occurs at a pH of at least 6. In some embodiments, the contacting occurs at a pH of at least 10.
Described herein are methods, of modifying a plant genome, comprising transfecting a cell harboring the plant genome using a polypeptide described herein, culturing the cell, and recovering plant tissue comprising a modified plant genome. In some embodiments, the modified plant genome does not encode a protein glycosyl transferase.
Described herein are methods of modifying a plant genome, comprising transfecting a cell harboring the plant genome using a nucleic acid described herein, culturing the cell, and recovering plant tissue comprising a modified plant genome. In some embodiments, the modified plant genome does not encode a protein glycosyl transferase.
Described herein are compositions comprising a polypeptide having endonuclease activity, a mung bean nuclease domain and a DNA sequence specificity domain.
The present disclosure provides methods of targeting a single locus for mutagenesis, said methods comprising selecting a locus for mutagenesis, contacting a genomic sample comprising the locus to an enzyme comprising an exonuclease domain and a programmable endonuclease domain that binds to the locus, sequencing across the locus, and sequencing a substantial portion of the genomic sample aside from the locus. In some embodiments, said selecting comprises identifying a unique segment of at least 10 bases in the genomic sample. In some embodiments, said contacting occurs in vivo. In some embodiments, said contacting comprises transfecting a cell using a vector encoding the enzyme. In some embodiments, said contacting comprises bombarding a cell using a nucleic acid encoding the enzyme. In some embodiments, bombarding comprises contacting to at least one gold particle. In some embodiments, bombarding comprises contacting to at least one tungsten particle. In some embodiments, said contacting comprises vacuum infiltration. In some embodiments, said contacting comprises agrobacterium-mediated transformation. In some embodiments, said contacting comprises stable transformation. In some embodiments, said contacting comprises transient expression. In some embodiments, said exonuclease domain comprises an ExoI exonuclease activity. In some embodiments, said exonuclease domain comprises 5′-3′ overhang exonuclease activity. In some embodiments, said exonuclease domain comprises double-stranded nucleic acid exonuclease activity. In some embodiments, said exonuclease domain does not exhibit single stranded nucleic acid exonuclease activity. In some embodiments, sequencing across the locus comprises observing a mutation relative to the locus prior to contacting. In some embodiments, sequencing across the locus comprises observing a deletion relative to the locus prior to contacting. In some embodiments, sequencing a substantial portion of the genomic sample aside from the locus comprises sequencing at least 1% of a genome copy of the genomic sample. In some embodiments, sequencing a substantial portion of the genomic sample aside from the locus comprises sequencing at least 5% of a genome copy of the genomic sample. In some embodiments, sequencing a substantial portion of the genomic sample aside from the locus comprises sequencing at least 10% of a genome copy of the genomic sample. In some embodiments, sequencing a substantial portion of the genomic sample aside from the locus comprises sequencing at least 50% of a genome copy of the genomic sample. In some embodiments, said contacting occurs in vivo, and wherein said sequencing a substantial portion of the genomic sample aside from the locus is performed subsequent to at least one cell division subsequent to said contacting. In some embodiments, the method further comprises contacting the sample to a Zinc ion. In some embodiments, the method further comprises contacting the sample to a composition comprising Zinc sulfate. In some embodiments, the exonuclease domain and the programmable endonuclease domain are fused in frame as a chimeric polypeptide, wherein the chimeric polypeptide exhibits enhanced on target mutagenesis compared to the sequence specific endonuclease and wherein the peptide exhibits the same or lower off target mutagenesis compared to the sequence specific endonuclease when unfused.
All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.
The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
Some understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments.
The present data disclosed in the figures below describe particular enzymes, which are explicitly recited. However, one of skill understands that these results may be generalized to a number of Cas protein fusions, both recited and not recited, but understood, to those of skill.
CRISPR/Cas9-based genome editing (GE) tools promise unprecedentedly bright future in biotechnology in that it accelerates development of human disease therapeutics, agricultural traits, and industrial microorganisms. Capability of CRISPR/Cas9-based GE depends on site-specific cleavage of the double stranded DNA by RNA-guided endonucleases such as Cas9 and Cpf1, and subsequent repair mechanisms. Action of CRISPR GE enzymes results in three major outcomes: 1) error-free non-homologous end joining (NHEJ), error-prone NHEJ, and homology-dependent recombination (HR) in the presence of repair templates. Homology-depended recombination can be referred in several ways, which are commonly accepted. For example, homology-dependent recombination can be referred to as “homology-directed repair” or may be abbreviated as “HR” or “HDR.” Due to outperformance of error-free repair mechanisms, the apparent rates of mutations and HR after the action of CRISPR GE tools are relatively low in vivo.
To enhance both the rate of indel mutation and HR recombination, presented herein are variants of CRISPR genome editing (GE) tools, also referred to as “chimeric polypeptides”, “variants”, “fusions”, or “fusion constructs” comprising translational fusion of DNA modifying enzymes (DME), DNA binding protein (DBP), or terminal deoxyribonucleotidyl transferase (TdT) at either upstream or downstream of CRISPR GE enzymes. In one embodiment, a variant irreversibly deleted the DNA at the CRISPR enzyme-dependent double strand break sites in 5′ to 3′ direction, and the resulting modified ends with 3′-OH overhang can better serve HR repairs in presence of repair template. The current inventions includes functional enhancement of the CRISPR-Cas enzymes. Disclosed herein are possible variants and their intended improvements.
The editing efficiency of CRISPR/Cas9 genome editing systems exhibit varying degrees depending on the biological systems under examined (Liu et al., 2017; Bortesi et al., 2015). The parameters most affecting the efficiency can includes detection method of the mutations, expression of the effector proteins and guide RNA, methods of delivery into the cells, forms of GE enzymes like DNA plasmid, RNAs, or pre-assembled ribonucleoproteins, and so on. Overall, the efficiency of DNA-based CRISPR-Cas9 NHEJ ranges 10 to 20% in transient expression system of plants.
Using the chimeric polypeptides of the present disclosure, also referred herein as “fusions” or “genome editing constructs” or “polypeptides”, when stably transformed, the efficiency of CRISPR/Cas9 mediated NHEJ increased up to 30-40%. This may be due to prolonged exposure of the genome to continuously translated Cas9 ribonucleoproteins.
In some embodiments, any Cas9 enzymes are used in the chimeric polypeptides of the present disclosure. For example, the Cas9 may be a Streptococcus pyogenes Cas9, referred to herein as “SpyCas9” or “SpCas9”. Alternatively, variants or homologs of any Cas9 protein or Cas9 proteins from other species are also consistent with the present disclosure. Alternatively, any Cas protein, such as a Cas12 or a Cas14, or any other RNA guided endonuclease can be used in the chimeric polypeptides of the present disclosure and is consistent with the methods disclosed herein.
Exceptionally, when pre-assembled CRISPR/Cas9 RNPs were administered to lettuce protoplasts, the efficiency reached as high as 46% (Woo et al., 2015). However, in the protoplast experiments with grape and apple, RNP delivery to protoplasts scored only 0.1% and 6.9%, respectively (Malony et al., 2016). Also, administration with Cas9 mRNA showed the efficiency only 1.1% (Zhang et al., 2016).
Overall, relatively low efficiency of error-prone mutation in CRISPR/Cas9-mediated NHEJ process awaits breakthrough technology to overcome the genome editing hurdles.
Here, we propose a genus of compositions comprising at least 32 representative molecules (also referred to as “variants”, “chimeric polypeptides”, “polypeptides”, “fusions”, or “fusion constructs”) including Cas9-MBN, that Mungbean nuclease (MBN) from Vigna radiata is translationally fused to C-terminus of Cas9 protein. We designed the MBN fusion to harness its irreversible DNA resection activity at the single-strand DNAs that are generated after the Cas9 action. Once a portion of DNA is deleted before onset of NHEJ process, it inevitably causes deletion mutations at the target site. In some embodiments the polypeptides disclosed herein, including a wide range of DNA modifying enzymes coupled to CRIPSR/Cas enzymes, can improve the efficiency of NHEJ from 1% to 5%, 5% to 10%, 10% to 15%, 15% to 20%, 20% to 25%, 25% to 30%, 30% to 35%, 35% to 40%, 40% to 45%, 45% to 50%, 50% to 55%, 55% to 60%, 60% to 65%, 65% to 70%, 70% to 75%, 75% to 80%, 80% to 85%, 85% to 90%, 90% to 95%, 95% to 100%, 1% to 20%, 10% to 40%, 30% to 50%, 20% to 60%, 30% to 90%, 1% to 100%, or 50% to 90%.
In addition to MBN, we aimed to fuse many different DME as summarized in Tables 1 and 2. The DME includes many types of 5′ to 3′ exonuclease, 3′ to 5′ exonuclease, enzymes removing single-stranded DNA extensions, terminal deoxyribonucleotidyl transferase, single stranded DNA binding proteins (SSB), and double stranded DNA binding proteins (DSB). The DMEs harness the single-/double-stranded DNA resection and nucleotide insertion activity at the DSB sites to enhance the efficiency of error-prone mutation in CRISPR/Cas9-mediated NHEJ process. The SSB and DSB increase the efficiency of HR repair processes by stimulating the delivery of template DNA for HR.
In particular, fusions of SSB, or related domains, to a CRISPR/Cas enzyme (e.g., CRISPR/Cas9), can increase the efficiency of HDR after in vivo transfection. For example, in vivo transfection can be analyzed for HDR by EcoRI restriction digestion. Any cells can be cultured and evaluated for transfection. For example, primary cells can be used as well as immortalized cell lines, As an example, HEK293T cells are cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, penicillin, and streptomycin.
RNP preparation and electroporation may be carried out as follows. Before transfection to the cells, purified SpyCas9, SSB-SpyCas9, and SSB-SpyCas9-RecJ protein (33 pmol) and DHCR7 sgRNA (66 pmol) are incubated at RT for 20 minutes for RNP complex. 2 or 20 pmols of 56 mer ssODN (CCTCGCAGGGAGGTGGACTGGTTTTGAATTCCACTGGCGAGCGTCATCTTCCTACT (SEQ ID NO: 63)) are then added to RNP complex. In some embodiments, SSB in the above described fusions can be any variant of SSB, a homolog, or any domain functionally equivalent to SSB may be used. Nucleofection of HEK293T cells is performed using Lonza. Each nucleofection reaction consists of approximately 2×105 cells in 20 μl of nucleofection reagent and is mixed with 10 μl of RNP:DNA. Various concentration of cells in various volumes may be used and mixed with various volumes of RNP:DNA. For example, if being performed in cell, culture 1×104 cells, 5×105 cells, 1×106 cells, 5×106 cells, 1×107 cells, 5×107 cells, 1×108 cells, 5×108 cells, or 1×109 cells can be used. Genomic DNA extraction may be performed using PureLink Genomic DNA kits following the manufacture's instruction. PCR amplification of target region may be carried out as follows. A 1633 nt region of DHCR7 loci, containing the target site, is PCR amplified using the following primer set. Then, 2nd PCR is performed using 1st PCR product as a template. Primers are listed below. The resulting amplicons are purified using QIAquick PCR Purification kit. The PCR products are analyzed on 1% agarose gel. EcoRI may directly cleave PCR DNA containing the newly integrated EcoRI restriction sequence to detect successful HDR. The reaction may contain 10 ug of PCR products and 10 units of EcoRI in CutSmart buffer. After 2 hours of enzyme digestion at 37° C., the product is resolved on 2% agarose gel. The percentage of HDR can be calculated using ImageJ.
In vivo transfection and analysis of HDR by EcoRI restriction digestion can reveal more efficient HDR. HDR can be enhanced through the single stranded DNA binding (SSB) protein fusion to SpyCas9 at its N-terminus (SSB-SpyCas9). The SSB-SpyCas9 binds to the repair template ssODN. Ternary complex can consist of the ssODN, SSB-SpyCas9, and sgRNA can result in “Deliver to Repair” even with relatively tiny amount of the ssODN DNA. In some cases, HDR occur more efficiently than that of control group due to local availability of the ssODN, since SSB protein will bring ssODN at the place where double stand break occurs. HDR can be enhanced by at least 1%, at least 2%, at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or at least 100% as compared to HDR upon transfection of a CRISPR/Cas9 moiety alone.
Depending on the accessary proteins attached to the Cas9 or Cpf1, functions of the CRISPR-Cas GE enzymes were augmented. Overall, the novel enzymes were designed to increase the efficiency of indel mutations and HR repair processes in conventional CRISPR-Cas9 mediated GE. In some embodiments, the efficiency of indel mutations resulting from the novel chimeric polypeptides disclosed herein may be increased by 1% to 5%, 5% to 10%, 10% to 15%, 15% to 20%, 20% to 25%, 25% to 30%, 30% to 35%, 35% to 40%, 40% to 45%, 45% to 50%, 50% to 55%, 55% to 60%, 60% to 65%, 65% to 70%, 70% to 75%, 75% to 80%, 80% to 85%, 85% to 90%, 90% to 95%, 95% to 100%, 1% to 20%, 10% to 40%, 30% to 50%, 20% to 60%, 30% to 90%, 1% to 100%, or 50% to 90% as compared to conventional CRISPR-Cas9 mediated GE. Additionally, in some cases, the efficiency of the HR repair process resulting from the novel chimeric polypeptides disclosed herein may be increased by 1% to 5%, 5% to 10%, 10% to 15%, 15% to 20%, 20% to 25%, 25% to 30%, 30% to 35%, 35% to 40%, 40% to 45%, 45% to 50%, 50% to 55%, 55% to 60%, 60% to 65%, 65% to 70%, 70% to 75%, 75% to 80%, 80% to 85%, 85% to 90%, 90% to 95%, 95% to 100%, 1% to 20%, 10% to 40%, 30% to 50%, 20% to 60%, 30% to 90%, 1% to 100%, or 50% to 90% as compared to conventional CRISPR-Cas9 mediated GE.
Genome editing enzymes including meganucleases, Zinc-Finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs) are all composed of two functional components: protein domains addressing the GE enzymes to specific sequences and DNA-cleaving enzyme like Fok I (Gaj et al., 2013). These chimeric nucleases facilitate genome engineering by inducing DNA double strand breaks (DSBs) with sequence-specific manner.
DNA-binding domains of ZFNs come from Zinc-finger type transcription factor proteins. The DNA binding domains are engineered to bind specifically the DNA sequence flanking the intended site of DSB. The Fok I nuclease domain cleave the target DNA sequence when dimerized with another Fok I domain bound in tandem. A pair of ZFNs recognizes 18 to 36 bp DNA sequences, which contributes to high specificities of this enzyme (Modares et a., 2017).
TALENs, the second-generation programmable nucleases, consist of a nuclease domain derived from FokI, and employs DNA binding domains derived from transcription activator-like (TAL) effectors of the plant pathogen Xanthomonas sp. Like ZFN, TALENs cleave the target DNA sequences using artificially fused DNA-cleaving enzyme Fok I. TALENs recognize 30 to 40 bp DNA sequences, and they can be programmed to target almost any DNA sequence, which represents a significant benefit over ZFNs (Kanchiswamy et al., 2016).
The latest SSN is CRISPR-Cas GE enzymes dubbed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)—CRISPR Associated System (Cas). Of the two CRISPR-Cas classes, class II includes the single-polypeptide effector proteins such as Cas9, Cpf1, C2C2, and Cas13 (Makarova et al., 2015; Shmakov et al., 2017). Of these, CRISPR/Cas9 belonging to Class 2 Type II, was discovered as part of bacterial adaptive immune system against infecting foreign genetic elements like bacteriophage. The CRISPR/Cas9 effector proteins are placed on and cleave the target foreign DNAs. Recognition of the target sequences is possible because the pieces of the previously infected viral DNA are saved in the bacterial genome as CRISPR array, which transcribes into crRNA and this associates with the Cas9 effector protein to form functional DNA cleaving enzymes. When bound to their target sequences, the ribonucleoprotein (RNP) complex of Cas9 and single guide RNA (sgRNA, physically fused form of the two separate RNAs of crRNA and tracrRNA) cleave the target DNA to result in a blunt-ended, double-stranded break upstream of the 5′-NGG-3′ protospacer-adjacent motif (PAM) sequence (Jinek et al., 2012).
Another example of class 2 CRISPR system assigned to type V, Cpf1, originates from Prevotella and Francisella. Different from Cas9, Cpf1 requires just one piece of RNA for addressing the RNP complex to specific locus, and the RNP cuts the target DNA with staggered ends rather than blunt ends
Site-specific cleavage of target DNA in a cell by genome editing proteins triggers DNA repair pathways such as non-homologous end-joining (NHEJ) and homology-directed repair. There can be three major outcomes of the repair process: 1) error-free NHEJ, 2) error-prone NHEJ, and 3) homology-dependent recombination (HR) in the presence of repair templates. Error-free NHEJ repairs the target DNA and results in restoration of the original DNA sequence without producing any mutagenesis in the target DNA. On the other hand, error-prone NHEJ results in the target DNA having mutations such as frameshift mutations, relative to the original DNA sequence.
Disclosed herein are compositions and methods comprising engineered chimeric polypeptides to improve efficiency of genome editing. Practice of some parts of the disclosure herein achieves increased error-prone NHEJ efficiency. Practice of some parts of the disclosure herein achieves increased mutation efficiency. Practice of some parts of the disclosure herein achieves increased homologous recombination efficiency. Practice of some parts of the disclosure herein achieves lower rate of off-target mutations. Practice of some parts of the disclosure facilitates detection of off-target cleavage sites.
An exemplary chimeric polypeptide of the disclosure comprises a nuclease such as a site-specific endonuclease or a domain thereof. Non-limiting exemplary site-specific endonucleases that are suitable with the present disclosure include but are not limited to CRISPR-associated (Cas) polypeptides or Cas nucleases including Class 1 Cas polypeptides, Class 2 Cas polypeptides, type I Cas polypeptides, type II Cas polypeptides, type III Cas polypeptides, type IV Cas polypeptides, type V Cas polypeptides, and type VI CRISPR-associated (Cas) polypeptides; zinc finger nucleases (ZFN); transcription activator-like effector nucleases (TALEN); meganucleases; RNA-binding proteins (RBP); CRISPR-associated RNA binding proteins; recombinases; flippases; transposases; Argonaute (Ago) proteins (e.g., prokaryotic Argonaute (pAgo), archaeal Argonaute (aAgo), and eukaryotic Argonaute (eAgo)); any derivative thereof any variant thereof and any fragment thereof.
Some chimeric polypeptides of the disclosure comprise one or more domains of a site-specific endonuclease. Non-limiting examples of domains suitable for use with the disclosure include guide nucleic acid recognition or binding domain; nuclease domains such as DNase domain, RNase domain, RuvC domain, and HNH domain; DNA binding domain; RNA binding domain; helicase domains; protein-protein interaction domains; and dimerization domains. A guide nucleic acid recognition or binding domain interacts with a guide nucleic acid. A nuclease domain comprises catalytic activity for nucleic acid cleavage. Alternatively, a nuclease domain is a mutated nuclease domain that lacks or has reduced catalytic activity. A site-specific endonuclease can be a chimera of various site-specific endonuclease proteins, for example, comprising domains from different Cas proteins.
A site-specific endonuclease consistent with the disclosure is a wild-type form of the protein, such as a form encoded in an unaltered genome. Alternatively, some site-specific endonucleases are a modified versions of the wildtype form, for example, comprising an amino acid change such as a deletion, insertion, substitution, variant, mutation, fusion, chimera, or any combination thereof, relative to a wild-type version of the protein.
A modified site-specific endonuclease of the disclosure may comprise a polypeptide having at least about 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to a wild type exemplary site-specific endonuclease.
Similarly, a modified site-specific endonuclease of the disclosure may comprise an amino acid sequence having at least about 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to a nuclease domain, for example, a RuvC domain or an HNH domain, of a wild-type site-specific endonuclease.
Some site-specific endonucleases of the disclosure comprise a Cas polypeptide or a recognizable domain thereof. Non-limiting exemplary Cas polypeptides suitable for use with the present disclosure include Cas9, Cpf1, c2c1, C2c2, Cas13, c2c3, Cas1, Cas1B, Cas2, Cas3, Cas4, Cas5, Cas5e (CasD), Cas6, Cas6e, Cas6f, Cas7, Cas8a, Cas8a1, Cas8a2, Cas8b, Cas8c, Csn1, Csx12, Cas10, Cas1Od, Cas1O, Cas1Od, CasF, CasG, CasH, Csy1, Csy2, Csy3, Cse1 (CasA), Cse2 (CasB), Cse3 (CasE), Cse4 (CasC), Csc1, Csc2, Csa5, Csn2, Csm2, Csm3, Csm4, Csm5, Csm6, Cmr1, Cmr3, Cmr4, Cmr5, Cmr6, Csb1, Csb2, Csb3, Csx17, Csx14, Csx1O, Csx16, CsaX, Csx3, Csx1, Csx15, Csf1, Csf2, Csf3, Csf4, and Cul966; any derivative thereof; any variant thereof; and any fragment thereof that is recognizable by one of skill in the art as arising from or comprising a recognizable portion of or activity of a protein listed above or elsewhere herein.
CRISPR/Cas9 from Streptococcus pyogenes (SpCas9) is relatively large-sized protein with 1,368 amino acids, and is characterized to have two endonuclease domains, HNH and RuvC, and a recognition lobe (REC) domain (Nishimasu et al. 2014). The HNH domain cleaves the DNA strand complementary to the guide RNA sequence, while the RuvC-like domain cuts the other non-complementary DNA strand through Watson-Crick base pairing by a gRNA/Cas9 complex (Jinek et al., 2012). As a result of the double stranded breaks (DSBs) by the CRISPR/Cas9 non-homologous end joining (NHEJ) process is triggered to result in error-free or error-prone insertions or deletions (indels) of DNA. Error-prone mutations lead to frameshift mutations when placed in the coding region of eukaryotic genes (Cho et al., 2013; DiCarlo et al., 2013; Belhaj et al., 2013). Cas9 has derived a series of functional alterations by introducing substitution mutations. Substitution of aspartic acid (D) at the 10th amino acid in the RuvC domain to alanine (A) removes the RuvC-dependent nuclease function leaving only HNH-dependent endonuclease function (Jinek et al., 2012; Mali et al., 2013). The D10A variant of Cas9 is used to generate a single strand nick at the target site. Additional substitution mutation, a change from histidine (H) to alanine (A) at the 840th amino acid in HNH domain of Cas9 H840A, got rid of even the nickase activity of Cas9D10A. The deactivated Cas9 (D10A and H840A) possessing only sequence-specific binding function can as a functional transcription factor when fused in frame with either an activator or a repressor domain.
Cas9 polypeptides are examples of site-specific endonuclease, as are any derivative thereof; any variant thereof; and any fragment thereof that is recognizable by one of skill in the art as arising from or comprising a recognizable portion of or activity of a protein listed above or elsewhere herein. Cas9 is classified as a class II, Type II CRISPR/Cas effector protein. An exemplary Cas9 polypeptide is Cas9 from Streptococcus pyogenes, referred to herein as SpCas9, which is composed of 1,368 amino acids. Cas9 is characterized to have two endonuclease domains, HNH and RuvC, and a recognition lobe (REC) domain. The HNH domain cleaves the DNA strand complementary to the guide RNA sequence. The RuvC-like domain cuts the other non-complementary DNA strand through Watson-Crick base pairing formed by a guide RNA/Cas9 complex. In some cases, a Cas9 protein comprises mutations. For example, substitution of aspartic acid (D) at the 10th amino acid in the RuvC domain to alanine (A) removes the RuvC-dependent nuclease function leaving only HNH-dependent endonuclease function. The D10A variant of Cas9, known as a nickase, can be used to generate a single strand nick at the target site. An additional substitution mutation, a change from histidine (H) to alanine (A) at the 840th amino acid in HNH domain of Cas9 H840A, produces a deactivated Cas9 protein lacking all nuclease activity. The deactivated Cas9, comprising mutations D10A and H840A, retains sequence-specific binding function and can serve as a functional transcription factor, for example, when fused in frame with either an activator or a repressor domain.
In some embodiments, any Cas9 enzymes are used in the chimeric polypeptides of the present disclosure. For example, the Cas9 may be a Streptococcus pyogenes Cas9, referred to herein as “SpyCas9” or “SpCas9”. Alternatively, variants or homologs of any Cas9 protein or Cas9 proteins from other species are also consistent with the present disclosure. Alternatively, any Cas protein, such as a Cas12 (e.g., Cpf1) or a Cas14, or any other RNA guided endonuclease can be used in the chimeric polypeptides of the present disclosure and is consistent with the methods disclosed herein.
Cpf1 is classified as a class II, Type V CRISPR/Cas system containing having about 1,300 amino acids, and is a smaller and simpler endonuclease than Cas9. Cpf1 was identified later than Cas9 by metagenomic data analysis, and composed of two major domains such as REC and RuvC domains. Cpf1 does not have a HNH endonuclease domain, which is the other essential domain of Cas9 (Fagerlund et al., 2015; Zetsche et al., 2015). CRISPR/Cpf1 cleaves a double stranded DNA (dsDNA) immediate downstream from T-rich (5′-TTTN-3′) PAM (Zetsche et al., 2015). CRISPR/Cpf1 generates 4-5 nt-long 5-overhang in 20 nt away from T-rich PAM, and the sticky ends enhance the efficiency of DNA replacement during HR distinct from Cas9 (Fagerlund et al., 2015; Zetsche et al., 2015).
Similarly, Cpf1 is an example of a site-specific endonuclease is Cpf1, as are any derivatives thereof, any variant thereof, and any fragment thereof that is recognizable by one of skill in the art as arising from or comprising a recognizable portion of or activity of a protein listed above or elsewhere herein. Cpf1 is classified as a class II, Type V CRISPR/Cas effector protein having about 1,300 amino acids. Cpf1 is smaller than Cas9. Cpf1 comprises two major domains such as REC and RuvC domains. Cpf1 lacks the HNH endonuclease domain. Cpf1 cleaves a double stranded DNA (dsDNA) immediately downstream from T-rich (5′-TTTN-3′) PAM. Cpf1 generates a 4-5 nt-long 5′-overhang 20 nucleotides away from T-rich PAM. In some cases, the sticky ends produced by Cpf1 enhance the efficiency of DNA replacement during HR.
Exemplary site-specific endonucleases such as a Cas polypeptide are optionally derived or obtained from the organism Streptococcus pyogenes (S. pyogenes). Alternatively any of the following non-limiting examples are suitable for use as a source of the site-specific endonuclease: Streptococcus thermophilus, Streptococcus sp., Staphylococcus aureus, Nocardiopsis dassonvillei, Streptomyces pristinae spiralis, Streptomyces viridochromo genes, Streptomyces viridochromo genes, Streptosporangium roseum, Streptosporangium roseum, Alicyclobacillus acidocaldarius, Bacillus pseudomycoides, Bacillus selenitireducens, Exiguobacterium sibiricum, Lactobacillus delbrueckii, Lactobacillus salivarius, Microscilla marina, Burkholderiales bacterium, Polaromonas naphthalenivorans, Polaromonas sp., Crocosphaera watsonii, Cyanothece sp., Microcystis aeruginosa, Pseudomonas aeruginosa, Synechococcus sp., Acetohalobium arabaticum, Ammonifex degensii, Caldicelulosiruptor becscii, Candidatus Desulforudis, Clostridium botulinum, Clostridium difficile, Finegoldia magna, Natranaerobius thermophilus, Pelotomaculum thermopropionicum, Acidithiobacillus caldus, Acidithiobacillus ferrooxidans, Allochromatium vinosum, Marinobacter sp., Nitrosococcus halophilus, Nitrosococcus watsoni, Pseudoalteromonas haloplanktis, Ktedonobacter racemifer, Methanohalobium evestigatum, Anabaena variabilis, Nodularia spumigena, Nostoc sp., Arthrospira maxima, Arthrospira platensis, Arthrospira sp., Lyngbya sp., Microcoleus chthonoplastes, Oscillatoria sp., Petrotoga mobilis, Thermosipho africanus, Acaryochloris marina, Leptotrichia shahii, Prevotella, or Francisella novicida.
The disclosure provides a guide nucleic acid for use in a CRISPR/Cas system. A guide nucleic acid such as a guide RNA binds to a Cas protein and targets the Cas protein to a specific location within a target nucleic acid. A guide nucleic acid comprises a nucleic acid-targeting segment and a Cas protein binding segment. In some cases, a guide nucleic acid comprises a single nucleic acid molecule, referred to as a single guide nucleic acid (sgRNA). Alternatively, a guide nucleic acid comprises two separate nucleic acid molecules, referred to as a double guide nucleic acid.
Some site-specific endonucleases of the disclosure comprise a zinc finger nuclease or ZFN. ZFNs are engineered cleavage inducing agents comprised of a zinc finger DNA binding domain and a double-strand-break-inducing agent domain. Recognition site specificity is conferred by the zinc finger domain, which can comprise two, three, or four zinc fingers, for example having a C2H2 structure. Zinc finger domains are amenable for designing polypeptides which specifically bind a selected polynucleotide recognition sequence. Exemplary ZFNs comprise an engineered DNA-binding zinc finger domain linked to a non-specific endonuclease domain, for example, a nuclease domain from a Type IIS endonuclease such as FokI.
Alternately or on combination, some site-specific endonucleases of the disclosure comprises a transcription activator-like effector nucleases (TALEN). TALENs are created by fusing a native or engineered transcription activator-like (TAL) effector, or functional part thereof, to the catalytic domain of an endonuclease, such as, for example, FokI. The modular TAL effector DNA binding domain allows for the design of proteins with potentially any given DNA recognition specificity.
Similarly, a site-specific endonuclease of the disclosure optionally comprises a meganuclease. A meganuclease binds and cuts specific recognition site, for example, which are about 18 bp or more.
Additional functionalities are fused to the site-specific endonuclease in some cases, such as transcriptional activator domains and transcription repressor domains.
A chimeric polypeptide of the disclosure comprises a site-specific endonuclease fused in frame to one or more accessory polypeptides. Depending on the accessory polypeptide fused to the site-specific endonuclease, the chimeric polypeptide exhibits, for example, increased mutation efficiency, increased homologous recombination efficiency, or concurrently both, relative to a wild-type version of the site-specific endonuclease.
Table 1 shows exemplary accessory polypeptides suitable for fusion with a site-specific endonuclease to generate a chimeric polypeptide of the disclosure.
The present disclosure provides various chimeric polypeptides or “fusions”, which function to enhance mutagenesis by enhancing repair processes, such as NHEJ and HDR. An exemplary chimeric polypeptide of the disclosure comprises a site-specific endonuclease fused to a DNA modifying enzyme (DME) or a catalytic domain thereof. A DME enhances efficiency of error-prone NHEJ process at the double-stranded nucleic acid break sites produced by a site-specific endonuclease by, for example, harnessing DNA resection activity, nucleotide insertion activity, or a combination thereof. A DME generates a 3′ OH overhang at the cleavage site generated by a site-specific endonuclease. Alternatively or in combination, a DME exposes a recessed 3′ OH at a cleavage site generated by a site-specific endonuclease. Alternatively or in combination, a DME comprises an enzyme or domain comprising cleaved end resection activity.
In some cases, a DME comprises a nucleic acid end-processing enzyme or a catalytic domain thereof. Alternatively, a DME comprises a region exhibiting, for example, about 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identity over at least 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% of its residues to an end-processing enzyme or catalytic domain thereof. Non-limiting examples of end-processing enzymes suitable for use with the disclosure include exonucleases such as 5′-3′ exonucleases, 3′-5′ exonucleases, 5′-3′ alkaline exonucleases; endonucleases such as 5′ flap endonucleases; helicases; phosphatases; hydrolases; template-independent DNA polymerases; and enzymes removing single-stranded nucleic acid extensions. Exemplary exonucleases of the Cas9 series and exemplary endonucleases of the Cpf1 series are shown in Table 2. A person skilled in the art recognizes that other exonucleases and endonucleases are suitable for use with the disclosure. In some cases, DMEs of the present disclosure comprise any DME, which when fused to a CRISPR/Cas9 results in the enhancement of mutagenesis, specifically NHEJ or HDR repair.
Several exonuclease DMEs are consistent with the present disclosure. The DME fused to a site-specific endonuclease comprises a 5′-3′ exonuclease or a catalytic domain thereof in some cases. Non-limiting examples of 5′-3′ exonucleases suitable for use with the disclosure include those from prokaryotes such as RecE, RecJ, RexB, and the exonuclease domain of DNA Polymerase I; bacteriophages such as T2, T3, T4, T5, T7, or lambda bacteriophage; and eukaryotes such as Xrn1 or ExoI 5′-exonuclease. In some cases, the mutation efficiency achieved with a chimeric polypeptide comprising 5′-3′ exonuclease activity is greater than that achieved with a chimeric polypeptide comprising 3′-5′ exonuclease activity.
One example of a 5′ to 3′ exonuclease is RecJ. RecJ was identified in Escherichia coli. RecJ is a processive monomeric exonuclease of 60 kD, and it degrades ssDNA in a 5′ to 3′ polarity in a reaction that requires Mg′, resulting in degradation of DNA to mononucleotides (Lovett, 2011). RecJ nuclease can produce ssDNA with 3′ overhang tails which may be bound by SSB (Ralph, 1990). RecJ does not require a terminal 5′ phosphate and will digest equally well DNA terminating in 5′ OH. RecJ has no activity on blunt dsDNA and requires at least 6 unpaired bases to bind and to initiate degradation (Kowalczykowski et al., 1994). Once bound to a ssDNA-tailed molecule, RecJ can digest into a dsDNA region to a limited extent but most often terminates digestion at the ds/ssDNA boundary (Lovett, 2011; Kowalczykowski et al., 1994). RecJ is specialized for degradation from a single-strand gap, then leads to produce 3′ ssDNA tailed recombinogenic molecules from double-strand ends. RecJ can remove 5′ overhanging ss DNA produced by 3′ to 5′ exonuclease activity to increase the indel mutation rate. Also, RecJ is suited to link to C-terminus of Cpf1, because RecJ chews 5-nt overhang produced by Cpf1.
Alternately, the DME fused to a site-specific endonuclease comprises RecJ or a catalytic domain thereof. RecJ is a processive monomeric exonuclease of about 60 kD. RecJ degrades ssDNA in a 5′ to 3′ polarity in a reaction that requires Mg′, resulting in degradation of DNA to mononucleotides. RecJ nuclease can produce ssDNA with 3′ overhang tails which may be bound by a single-stranded DNA binding protein. In some cases, RecJ does not require a terminal 5′ phosphate and will digest equally well DNA terminating in 5′ OH. In some cases, RecJ has no activity on blunt dsDNA. In some cases, RecJ requires at least 6 unpaired bases to bind and to initiate degradation. Once bound to a ssDNA-tailed molecule, RecJ can digest into a dsDNA region to a limited extent but most often terminates digestion at the ds/ssDNA boundary. RecJ is specialized for degradation from a single-strand gap, then leads to produce 3′ ssDNA tailed recombinogenic molecules from double-strand ends. RecJ can remove 5′ overhanging ssDNA produced by 3′ to 5′ exonuclease activity to increase the indel mutation rate. In some cases, RecJ is suited to link to C-terminus of a site-specific endonuclease such as Cpf1, for example, because RecJ is capable of chewing 5-nt overhang produced by Cpf1.
One example of a 5′ to 3′ exonuclease is RecE. Exonuclease VIII (RecE) possesses processive Mg2+-dependent 5′ to 3′ exonuclease activity on dsDNA ends (Lovett, 2011) and is the functional equivalent to the lambda exonuclease. RecE is an 866 amino acid protein. RecE resects double stranded DNA from 5′ to 3′ direction, whereas 5′ ends of single strand breaks or gaps are preferred. RecE was identified within a cryptic prophage named Rac (for recombination activation), present in E. coli K-12 strain. RecE requires a 5′ phosphate for its exonuclease activity, and is not able to function on the ends of dsDNA without a 5′ phosphate. We liked the RecE activity only the DSB generated by the action of Cas9 leaving some nicks opportunistically occurred in the genome untouched. This is important consideration to minimize the off-target effects nascent to Cas9 or Cas9-RecE enzymes. We expect that RecE can enhance both the indel mutation rate and HR by producing 3′ overhangs from Cas9-produced blunt end, still leaving the nicks opportunistically occurred in off-target sites
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises RecE or a domain thereof. RecE (also known as Exonuclease VIII or ExoVIII) possesses processive Mg2+-dependent 5′ to 3′ exonuclease activity. RecE is the functional equivalent to the lambda exonuclease. An exemplary source of RecE is E. coli. RecE is composed of about 866 amino acids. RecE resects double stranded DNA from 5′ to 3′ direction. RecE requires a 5′ phosphate for its exonuclease activity. In some cases, RecE preferentially acts on dsDNA blunt ends, which are produced by site-specific endonucleases such as Cas9. In some cases, the RecE activity is preferable, for example, because RecE acts only on the DSB generated by the action of Cas9, leaving some nicks and single-stranded breaks occurring randomly in the genome untouched. This can be an important consideration to minimize the off-target effects nascent to Cas9 or Cas9-RecE enzymes. RecE can enhance both the indel mutation rate and HR by producing 3′ overhangs from Cas9-produced blunt end, still leaving the nicks opportunistically occurred in off-target sites. Accordingly, some exonuclease activities are specific to or preferentially or differentially act upon Cas9, Cpf1 or other CRISPR-related double strand cleavage or single strand nick introduction, to the exclusion of DNA cleavage or nick events occurring elsewhere in a nucleic acid molecule.
One example of a 5′ to 3′ exonuclease is T5 exonuclease. Bacteriophage T5 exonuclease (T5-exo) was originally purified from phage-infected cells. T5-exo is a 276 amino acid protein. Phage T5 exonuclease has a 5′→3′ exodeoxyribonuclease activity, which also possesses endonucleolytic activity a free single-stranded 5′-end. T5-exo degrades ssDNA or dsDNA in the 5′ to 3′ direction (Garforth and Sayers, 1997). T5-exo is able to initiate nucleotide removal from the 5′ termini or at gaps and nicks of linear or circular dsDNA (Ceska et al., 1996). However, T5-exo does not degrade supercoiled circular dsDNA. T5-exo can enhance both the indel mutation and HR by producing 3′-overhangings from double strand breaks generated by Cas9.
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises T5 exonuclease or a catalytic domain thereof. T5 exonuclease (T5-exo) is a 276 amino acid protein. T5 exonuclease has a 5′→3′ exodeoxyribonuclease activity. T5 exonuclease degrades ssDNA or dsDNA in the 5′ to 3′ direction. T5 exonuclease is able to initiate nucleotide removal from the 5′ termini or at gaps and nicks of linear or circular dsDNA. Some T5 exonuclease moieties do not degrade supercoiled circular dsDNA. T5 exonuclease can enhance indel mutation and HR by producing 3′-overhangs from double strand breaks generated by a site-specific endonuclease such as Cas9.
One example of a 5′ to 3′ exonuclease is lambda exonuclease. Lambda exonuclease belongs to exonuclease IV, which has exonucleolytic cleavage in the 5′- to 3′-direction to yield nucleoside 5′-phosphates. This enzyme has preference for blunt-ended, 5′-phosphorylated dsDNA. Lambda Exonuclease is unable to initiate DNA digestion at nicks or gaps (Shevelev and Hubscher, 2002). We propose that Lambda Exonuclease can enhance both the indel mutation rate and HR by producing 3′ overhangs from Cas9-produced blunt end, still leaving the nicks occurred in off-target sites.
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises Lambda exonuclease or a catalytic domain thereof. Lambda exonuclease belongs to exonuclease IV, which has exonucleolytic cleavage in the 5′- to 3′-direction to yield nucleoside 5′-phosphates. Lambda exonuclease has a preference for blunt-ended, 5′-phosphorylated dsDNA. Lambda Exonuclease is unable to initiate DNA digestion at nicks or gaps. Lambda Exonuclease can enhance both the indel mutation rate and HR by producing 3′ overhangs from Cas9-produced blunt ends.
One example of a 5′ to 3′ exonuclease is small fragment of DNA pol I. The smaller fragment formed when DNA polymerase I from E. coli is cleaved by subtilisin retains the 5′→3′ exonuclease and 5′ flap (5′ overhang extending from duplex strands) endonuclease activity but does not have the other two activities exhibited by the Klenow fragment (i.e. 5′→3′ polymerase activity, and 3′→5′ exonuclease activity) which is a large protein fragment produced when DNA polymerase I from E. coli is enzymatically cleaved by the protease subtilisin (Zhao et al., 2014).
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises an exonuclease domain of DNA polymerase I. Cleavage of DNA polymerase I, for example, by the protease subtilisin, produces a small fragment and a large fragment (also known as the Klenow fragment). The small fragment, referred to herein as small fragment of DNA pol I, comprises 5′→3′ exonuclease and 5′ flap (5′ overhang extending from duplex strands) endonuclease activity, and is suitable for use as a DME comprising 5′→3′ exonuclease activity. The larger fragment comprises 5′→3′ polymerase activity, and 3′→5′ exonuclease activity.
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises a 3′-5′ exonuclease or a catalytic domain thereof. Non-limiting examples of 3′-5′ exonucleases suitable for use with the disclosure include TREX such as TREX2, Mungbean nuclease, Exonuclease I, Exonuclease III, Exonuclease VII, and RecBCD exonuclease.
One example of a 3′ to 5′ exonuclease is TREX2. TREX2 is one of autonomous eukaryotic exonucleases, and is a 279 amino acid protein. The TREX1 and TREX2 proteins constituted homodimers, which function robust 3′ excision activities. TREX1 and TREX2 employ single-stranded oligonucleotides, and most closely relate structurally with the bacterial epsilon subunit of DNA pol III, ExoI, and ExoX (Shevelev and Hubscher, 2002).
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises TREX or a catalytic domain thereof. The TREX enzyme can be TREX1 or TREX2. TREX2 is an autonomous eukaryotic exonuclease, which is a 279 amino acid protein. The TREX1 and TREX2 proteins form homodimers with 3′ excision activities. TREX1 and TREX2 employ single-stranded oligonucleotides, and most closely relate structurally with the bacterial epsilon subunit of DNA pol III, ExoI, and ExoX.
One example of a 3′ to 5′ exonuclease is mungbean nuclease. Mungbean nuclease is a 355 amino acid protein, isolated from sprouts of the mung bean, Vigna radiata, and cut-out nucleotides in a step-wise manner from ssDNA from a mixture also containing dsDNA, or a flap structure of dsDNA with a free single-stranded 5′-end, however, Mungbean exonuclease does not digest double-stranded DNA, double-stranded RNA, DNA/RNA hybrids, or the intact strand of nicked duplex DNA (McCutchan et al., 1984). Mungbean nuclease catalyzes the specific degradation of single-stranded DNA or RNA, and produces mono and oligonucleotides carrying a 5′-P terminus (Kroeker et al., 1976; Kowalski et al., 1976). Mungbean can increase indel mutation by removing both 5′ and 3′ single stranded overhangings produced in Cas9-producing break ends.
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises Mungbean nuclease or a catalytic domain thereof. Mungbean nuclease is a 355 amino acid protein, isolated from the sprouts of the mung bean, Vigna radiata. Mungbean nuclease cleaves nucleotides in a step-wise manner from ssDNA or a flap structure of dsDNA with a free single-stranded 5′-end. In some cases, Mungbean exonuclease does not digest double-stranded DNA, double-stranded RNA, DNA/RNA hybrids, or the intact strand of nicked duplex DNA. Mungbean nuclease catalyzes the specific degradation of single-stranded DNA or RNA, and produces mono and oligonucleotides carrying a 5′-P terminus. In some cases, Mungbean exonuclease increases indel mutation by removing 5′ and 3′ single-stranded overhangs produced by site-specific endonucleases such as Cas9.
Another example of a 3′ to 5′ exonuclease is exonuclease I. Exonuclease 1 is an 846 amino acid protein with a Mg2+-dependent 3′ to 5′ single strand exonuclease activity. Exonuclease I was the first exonuclease to be purified and characterized from E. coli and digests dsDNA to mononucleotides. ExoI is a member of the DnaQ superfamily and its structure is highly similar to the 3′ to 5′ exonucleases active site of the Klenow fragment of DNA polymerase I (Lovett, 2011; Kowalczykowski et al., 1994). ExoI can increase the indel mutation by removing ss overhangings in double strand break ends produced by Cas9
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises exonuclease I or a catalytic domain thereof. Exonuclease 1 (ExoI) is an 846 amino acid protein with a Mg2+-dependent 3′ to 5′ single strand exonuclease activity. Exonuclease I digests dsDNA to mononucleotides. Exonuclease I is a member of the DnaQ superfamily and its structure is similar to the 3′ to 5′ exonucleases active site of the Klenow fragment of DNA polymerase I. In some cases, Exonuclease I increases the indel mutation by removing single stranded overhang in double strand break ends produced by site-specific endonucleases such as Cas9.
Another example of a 3′ to 5′ exonuclease is exonuclease III (Exo III working on dsDNA). Exonuclease III catalyzes the stepwise removal of mononucleotides from 3′-hydroxyl termini of double-stranded DNA (Shevelev and Hubscher, 2002). The preferred substrates are blunt or recessed 3′-terminus. Exo III also acts at nicks in duplex DNA to produce single-strand gaps, which are resistant to cleavage because Exo III is not active on 3′-overhang termini with extensions 4 bases or longer being essentially resistant to cleavage (Lovett, 2011; Kowalczykowski et al., 1994). Exo III produces unidirectional deletions from a linear molecule with one 3′-overhang resistant and one 5′-overhang or blunt susceptible terminus. Exo III activity depends partially on the DNA helical structure and displays sequence dependence (C>A=T>G). ExoIII has also been reported to have RNase H, 3′-phosphatase and AP-endonuclease activities (Lovett, 2011; Kowalczykowski et al., 1994). Exo III increase the indel mutation by accelerating the 3′ to 5′ exonuclease activity of Cas9.
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises exonuclease III (ExoIII) or a catalytic domain thereof. Exonuclease III catalyzes the stepwise removal of mononucleotides from 3′-hydroxyl termini of double-stranded DNA. Exemplary substrates of exonuclease III are blunt or recessed 3′-termini. In some cases, Exonuclease III also acts at nicks in duplex DNA to produce single-strand gaps, which can be resistant to cleavage, because often Exonuclease III may not be active on 3′-overhang termini with extensions 4 bases or longer being frequently resistant to cleavage. Exonuclease III produces unidirectional deletions from a linear molecule with one 3′-overhang resistant and one 5′-overhang or blunt susceptible terminus. Exonuclease III activity depends partially on the DNA helical structure and displays sequence dependence (C>A=T>G). Exonuclease III can also comprise RNase H, 3′-phosphatase and AP-endonuclease activities. In some cases, Exonuclease III increases indel mutations by accelerating the 3′ to 5′ exonuclease activity of Cas9.
Another example of a 3′ to 5′ exonuclease is exonuclease VII. Exonuclease VII is an Escherichia coli exonuclease enzyme, which is composed of two nonidentical subunits; one large subunit and four small ones. Exonuclease VII cleaved ssDNA from either 5′-3′ or 3′-5′ direction to yield 5′-phosphomononucleotides. The large subunit also contains an N-terminal DNA binding domain (Shevelev and Hubscher, 2002). Exo VII increase the indel mutation by removing ss overhangs generated in Cas9-producing break ends.
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises exonuclease VII or a catalytic domain thereof. Exonuclease VII (ExoVII) cleaves single-stranded DNA from either 5′-3′ or 3′-5′ direction to yield 5′-phosphomononucleotides. Exonuclease VII also comprises an N-terminal DNA binding domain. In some cases, Exonuclease VII increases indel mutations by removing single stranded overhangs generated by Cas9-producing break ends.
Another example of a 3′ to 5′ exonuclease is RecBCD exonuclease. RecBCD exonuclease was isolated from E. coli, and composed of Mg2+-dependent RecB domain, RecC domain, and RecD domain, which unwind dsDNA and degrade ssDNA and dsDNA. RecBCD cleaved ssDNA from either 5′-3′ or 3′-5′ direction to yield 5′-phosphomononucleotides (Lovett, 2011; Kowalczykowski et al., 1994; Shevelev and Hubscher, 2002). RecBCD increase the indel mutation by removing ss overhangings generated in Cas9-producing double strand breaks.
In an exemplary chimeric polypeptide, the DME fused to a site-specific endonuclease comprises RecBCD exonuclease or a catalytic domain thereof. RecBCD exonuclease comprises a Mg2+-dependent RecB domain, RecC domain, and RecD domain, which unwind dsDNA and degrade single-stranded DNA and double-stranded DNA. RecBCD cleaves ssDNA from either 5′-3′ or 3′-5′ direction to yield 5′-phosphomononucleotides. In some cases, RecBCD increases indel mutation by removing single-stranded overhangs generated in Cas9-based double strand breaks.
One example of a terminal DNA transferase is DNTT (DNA nucleotidylexotransferase). Human terminal deoxynucleotidyl transferase (TdT), a template-independent DNA polymerase with 509 amino acids, catalyzes the random polymerization of deoxynucleoside 5′-triphosphates to the 3′-OH of a DNA initiator (Yang et al., 1994). We thought that Cas9-TdT can label DSB with BrdU, which results in easy-detection off-target sites produced by unintended Cas9 side effect as well as insertional mutation in Cas9-producing double strand breaks.
In an exemplary chimeric polypeptide, a site-specific endonuclease is fused to a terminal DNA transferase (DNTT) or a catalytic domain thereof. DNTT from Homo sapiens, Pan troglodytes, Macaca mulatta, Canis lupus familiaris, Bos taurus, Mus musculus, Rattus norvegicus, Gallus gallus, Xenopus tropicalis, and Danio rerio can be used, for example. Any DNTT isoform can be used. An exemplary terminal DNA transferase suitable for use with the disclosure is terminal deoxynucleotidyl transferase (TdT). TdT is a template-independent DNA polymerase. TdT catalyzes the random polymerization of deoxynucleoside 5′-triphosphates to the 3′-OH of a DNA initiator. In some cases, the TdT is from a human source. Human TdT is a 509 amino acid protein.
In an exemplary chimeric polypeptide, a site-specific endonuclease is fused to a DNA binding protein (DBP) or a domain thereof. DBPs suitable for use with the disclosure include those that bind to single-stranded DNA, double-stranded DNA, or a combination thereof.
Another example of a terminal DNA transferase is a single strand binding domain (SSB). SSB could be isolated from E. coli, and it binds to ssDNA. The SSB protein stimulates RecA protein-promoted pairing, traps ssDNA produced by DNA helicase activity, and protects ssDNA from nucleolytic degradation in the process of genetic recombination (Kowalczykowski et al., 1994). SSB can increase indel mutation by promoting the insertion of oligo DNA fragments and enhance the HR by enhancing the delivery and stability of single strand DNAs that are used for HR process.
In an exemplary chimeric polypeptide, a site-specific endonuclease is fused to a DBP that binds to single-stranded DNA, also referred to herein as a single-stranded DNA binding (SSB) protein. An exemplary source of SSB proteins is E. coli. SSB proteins stimulate RecA protein-promoted pairing, trap ssDNA produced by DNA helicase activity, and protects ssDNA from nucleolytic degradation in the process of genetic recombination. SSB proteins increase indel mutation, for example, by promoting the insertion of oligo DNA fragments. Alternatively, or in combination, SSB proteins enhance HR by enhancing the delivery and stability of single-strand DNAs that are used for the HR process.
Another example of a terminal DNA transferase is a double strand binding domain (DSB). A DSB binds double-stranded DNA, and interacts preferentially with T4 late promoter regions (Gansz et al., 1991). DSB can increase indel mutation by providing ds DNA fragments at Cas9-dependent cleavage site and enhance the HR by enhancing the delivery and stability of ds repair DNAs that are essential for HR process at cleavage sites.
In an exemplary chimeric polypeptide, a site-specific endonuclease is fused to a DBP that binds to double-stranded DNA, also referred to herein as a double-stranded DNA binding (DSB) protein. DSB proteins interact preferentially with T4 late promoter regions. DSB increases indel mutation, for example, by providing dsDNA fragments at site-specific endonuclease-dependent cleavage sites. Alternatively or in combination, DSB enhances HR, for example, by enhancing the delivery and stability of repair or template nucleic acids required for HR process at cleavage sites.
The chimeric polypeptide variants described herein do not exhibit off-target mutagenesis at any higher rates than standard CRIPSR Cas9 enzymes. In some cases, chimeric polypeptide variants described herein exhibit the same or lower off target effects than standard CRISPR Cas9 enzymes. This, the chimeric polypeptides described herein exhibit higher, or increased, on-target mutagenesis, either via NHEJ repair processes and increased percent indels or increased HR, without increasing off-target mutagenesis as compared to standard CRIPSR Cas9 enzymes. Based on whole genome sequencing, there were no significant values of off-target effect detected between Cas9 and Cas9-RecJ treatment. Cas9-RecJ had lower off-targeting efficiency for three regions, KCNJ6, CNTPNA2, and Ch.5 except ADCY5 in amplicon deep sequencing. Thus, the present disclosure provides, for example, an elevated rate of target specific frameshift mutation, without exhibiting an off-target mutagenesis rate that differs significantly from Cas9 or exhibits an off-target mutagenesis rate that is significantly lower from Cas9. In some embodiments, the off-target mutations that are introduced are point mutations, such as transitions or transversions.
The exemplary chimeric polypeptide variants disclosed herein were tested for genome wide off target variants, and, as seen in the below table, said chimeric polypeptides did not significantly vary in the number of insertions and deletions.
None of the above tested chimeric polypeptides had off-site mutations any more than controls in any category of mutations at any types of loci.
As shown in the table below, different categories of genomic regions such as downstream, exon, intergenic, intron, splice site acceptor, splice site donor, splice site region, transcript, upstream, and UTRs were evaluated for off-target mutagenesis using chimeric polypeptides of the present disclosure as compared to a relative control, and no bias was observed.
Table 4 lists exemplary chimeric polypeptide variants generated for use with the compositions and methods of the disclosure. The column headings indicate as follows: Name refers to the name of the chimeric polypeptide; Added moiety refers to abbreviated name of the accessory polypeptide fused at either N- or C-terminus of the site specific endonuclease; Origin of added moiety refers to origin of accessory polypeptide; Function of added moiety refers to illustrative biochemical function of the accessory polypeptide; Substrate DNA refers to the form of the DNA that the accessory polypeptide prefers to act on; Product refers to the DNA structure resulting from the action of chimeric polypeptide comprising the accessory polypeptide fused to the site-specific endonuclease; Intended enhancement refers to functional improvement derived from the chimeric polypeptide.
Streptococcus
pyogenes
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
blunt or
Escherichia coli
Vigna radiata
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Escherichia coli
Francisella novicida
Francisella novicida
Escherichia coli
Escherichia coli
Vigna radiata
Escherichia coli
Escherichia coli
Escherichia coli
As used herein, in some cases, a polypeptide domain corresponds to a named domain when consecutive residues comprising at least 70% of the named domain align to the claimed polypeptide so as to exhibit at least 70% identity. Alternatively, in some cases, a polypeptide domain corresponds to a named domain when consecutive residues comprising at least 70%, 75%, 80%, 85%, 90%, 95%, or 99% of the named domain align to the claimed polypeptide so as to exhibit at least 70%, 75%, 80%, 85%, 90%, 95%, or 99% identity. Alternately or in combination, a polypeptide domain corresponds to a named domain when at least 20 consecutive residues comprising of the named domain align to the claimed polypeptide so as to exhibit 100% identity across the at least 20 consecutive residues. Alternately, in some cases, a polypeptide domain corresponds to a named domain when at least 20, 25, 30, 35, 40, 50, 60, 70, 80, 90, or 100 consecutive residues comprising of the named domain align to the claimed polypeptide so as to exhibit 100% identity across the at least 20, 25, 30, 35, 40, 50, 60, 70, 80, 90, or 100 consecutive residues.
Sequence identity, such as for the purpose of assessing percent identity between one or more sequences, is measured by any suitable alignment algorithm, including but not limited to the Needleman-Wunsch algorithm, the BLAST algorithm, or the Smith-Waterman algorithm. Optimal alignment can be assessed using any suitable parameters of a chosen algorithm, including default parameters.
In some cases, a chimeric polypeptide does not have an animal glycosylation pattern. Alternatively or in combination, a chimeric polypeptide does not have a bacterial glycosylation pattern. Alternatively or in combination, a chimeric polypeptide does not have a fungal glycosylation pattern.
In some cases, a chimeric polypeptide is substantially free of bacterial cellular contaminant. For example, a chimeric polypeptide expressed, isolated and purified from a bacterial cell.
The chimeric polypeptides of the present disclosure include chimeric genes wherein any DME disclosed herein is translated in frame with Cas9. Importantly, the chimeric polypeptides disclosed herein can enhance the HR repair rate. In some embodiments, a 3′ to 5′ exonuclease can be fused to CRISPR Cas enzymes. In other cases a 5′ to 3′ exonuclease can be fused to CRISPR Cas enzymes. In some embodiments, the present disclose fusions of all of the above described exonucleases to a CRISPR Cas enzyme. In particular embodiments, exonuclease VIII (RecE) of E. coli was active preferentially on dsDNA blunt ends, which were usually produced by CRISPR/Cas9 enzyme. RecE is highly processive, degrading the 5′ strand dsDNA to mononucleotides. We expect that Cas9-RecE will trigger changing a main route from error-free to error-prone in NHEJ repair process, then all DSBs by CRISPR/Cas9 result in indel mutations, which cause frameshift in the coding region of a gene. All of the fusion constructs, or chimeric polypeptides, shown in
The apparent rates of mutations after the action of CRISPR genome editing tools are relatively low in vivo due to outperformance of error-free repair mechanisms. To enhance both the rate of indel mutation and HR recombination, genome editing tools were constructed by translational fusion of DNA modifying enzymes (DME), DNA binding protein (DBP), or terminal deoxyribonucleotidyl transferase (TdT) at either upstream or downstream of CRISPR genome editing enzymes. In one embodiment, a variant irreversibly deleted the DNA at the CRISPR enzyme-dependent double strand break sites in 5′->3′ direction, and the resulting modified ends with 3′-OH overhang can better serve HR repairs in presence of repair template. Disclosed herein are constructs that display functional enhancement of the CRISPR-Cas enzymes. Among Cas9-DME series, Cas9-RecJ showed the best performance in knock-out (KO) and knock-in (KI) performance efficiency in HEK293 cells and plant protoplasts. Second, Cas9-GFP exhibited high performance not only tracing the Cas9 protein due to GFP fluorescence but only genome editing for KO and KI. Third, unexpectedly, most exonuclease-fused Cas9 or Cpf1 exhibited superior performance in KO and KI as compared to Cas9 or Cpf1 unfused. Fourth, DSB-SpyCas9 bound to double stranded DNA, the binding between DSB-SpCas9 and dsDNA increased KO and KI efficiencies much more than employing SpCa9 and dsDNA. Fifth, off-target effects in Cas9-RecJ embodied the similar efficiency to Cas9 off-targeting in whole genome sequencing and targeted deep sequencing. Last, zinc sulfate effectively quenched Cas9 activity in vitro and in vivo HEK293 cells.
In some embodiments, sequences of exemplary chimeric polypeptides, also referred to herein as “CRISPR PLUS”, are shown in TABLE 7. In some embodiments, sequences of exemplary chimeric polypeptide have at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or at least 100% sequence identity to any one of SEQ ID NO: 1-SEQ ID NO: 56.
Compositions and systems herein are often used in various methods relating to increased targeted mutagenesis. Through use of compositions disclosed herein, a locus selected for mutagenesis is targeted by a programmable endonuclease such as a guide-RNA directed endonuclease so as to introduce a double-stranded break at a target locus. A broad range of endonucleases are consistent with the methods herein, such as Cas9, Cas12 or other programmable DNA endonuclease enzymes. Exonuclease activity is conveyed by an exonuclease domain fused to the endonuclease domain according to any of the examples provided herein or otherwise as understood in the art. Fusion polypeptides are administered, often in combination with targeting nucleic acids such as guide RNA so as to provide a programmable targeting mechanism to a locus of interest. A target locus is observed to have an increased rate of mutagenesis relative to a rate observed upon administration to a comparable sample of an endonuclease lacking a fusion to an exonuclease domain as disclosed herein. Often, upon sequencing of some, a substantial portion, a majority or all of non-target regions of a sample, one sees an off-target mutagenesis rate that is comparable to that of a rate observed upon administration to a comparable sample of an endonuclease lacking a fusion to an exonuclease domain as disclosed herein. Off-target sequencing variously comprises sequencing less than 1%, up to 1%, up to 5%, up to 10%, up to 15%, up to 20%, up to 25%, up to 30%, up to 35%, up to 40%, up to 45%, up to 50%, up to 55%, up to 60%, up to 65%, up to 70%, up to 75%, up to 80%, up to 85%, up to 90%, up to 95%, up to 99%, or at least 99% of a sample genome. That is, through practice of methods or use of compositions as disclosed herein, one achieves increased targeted mutagenesis of a selected locus such as a locus bound by a guide RNA, while maintaining an off-target mutagenesis rate comparable to or in some cases less than that observed using unfused endonuclease compositions.
Some methods further comprise targeted termination of an endonuclease/exonuclease reaction, such as by changing an ion concentration of a reaction, for example through addition of a Zinc ion such as that found in Zinc sulfate, ZnSO4. Often, targeted termination of a reaction is used to decrease off-target mutagenesis events that may arise after sufficient cleavage of a target locus has been achieved.
Disclosed herein are methods for increasing mutation rate, homologous recombination rate, or concurrently both, by contacting a target nucleic acid such as a chromosome to a chimeric polypeptide of the disclosure. In some cases, the chimeric polypeptide comprises a site-specific endonuclease that generates a cleavage site in the chromosome, and an accessory polypeptide such as a DME, DBP, TdT, or a combination thereof. In some cases, the chimeric polypeptide yields an exposed 3′ OH overhang at the cleavage site of the chromosome.
In some cases, a chimeric polypeptide increases mutation rate by increasing the efficiency of error-prone NHEJ.
The disclosure provides methods to decrease off-target cleavage and modification by site-specific endonucleases, for example, by treating the site-specific endonuclease with a metal ion such as Zn. In an exemplary method, a target nucleic acid is contacted with a chimeric polypeptide comprising a site-specific endonuclease such as Cas9. Once target modification is achieved, ZnSO4 is added to abolish activity of Cas9, thereby preventing or reducing off-target effects of the site-specific endonuclease.
The disclosure provides methods for detecting off-target cleavage sites, for example, by tagging a cleavage site of a site-specific endonuclease. In an exemplary method, a target nucleic acid such as a chromosome is contacted with a labeled nucleic acid and a chimeric polypeptide comprising site-specific endonuclease activity and TdT activity. The TdT labels the cleavage sites of the site-specific endonuclease with the labeled nucleic acid. A labeled nucleic acid can comprise a non-canonical base such as BrdU. Non-limiting examples of non-canonical bases suitable for use with the disclosure include fluorescently labeled dNTP. The TdT adds the labeled nucleic acid at double-strand breaks generated by the site-specific endonuclease. The labeled nucleic acids are isolated and sequenced to determine off-target sites of the site-specific endonuclease.
The disclosure provides methods for increasing mutation efficiency of a site-specific endonuclease. In some cases, the mutation comprises one or more deletions. Alternatively, or in combination, the mutation comprises one or more insertions. In some cases, the mutation efficiency of a site-specific endonuclease is increased by at least about 1.1 fold, at least about 1.2 fold, at least about 1.3 fold, at least about 1.4 fold, at least about 1.5 fold, at least about 1.6 fold, at least about 1.7 fold, at least about 1.8 fold, at least about 1.9 fold, at least about 2 fold, at least about 2.5 fold, at least about 3 fold, at least about 3.5 fold, at least about 4 fold, at least about 4.5 fold, at least about 5 fold, at least about 6 fold, at least about 7 fold, at least about 8 fold, at least about 9 fold, at least about 10 fold, at least about 12 fold, at least about 15 fold, at least about 20-fold, at least about 50-fold, at least about 70-fold, or at least about 100-fold compared with that achieved with a wild-type site-specific endonuclease lacking the accessory polypeptide.
The disclosure provides methods for increasing homologous recombination efficiency of a site-specific endonuclease. In some cases, the homologous recombination efficiency of a site-specific endonuclease is increased by at least about 1.1 fold, at least about 1.2 fold, at least about 1.3 fold, at least about 1.4 fold, at least about 1.5 fold, at least about 1.6 fold, at least about 1.7 fold, at least about 1.8 fold, at least about 1.9 fold, at least about 2 fold, at least about 2.5 fold, at least about 3 fold, at least about 3.5 fold, at least about 4 fold, at least about 4.5 fold, at least about 5 fold, at least about 6 fold, at least about 7 fold, at least about 8 fold, at least about 9 fold, at least about 10 fold, at least about 12 fold, at least about 15 fold, at least about 20-fold, at least about 50-fold, at least about 70-fold, or at least about 100-fold compared with that achieved with a wild-type site-specific endonuclease lacking the accessory polypeptide.
The disclosure provides methods for increasing error-prone NHEJ in cells. In some cases, the error-prone NHEJ is increased by at least about: 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 99% compared with that achieved with a wild-type site-specific endonuclease lacking an accessory polypeptide.
The disclosure provides methods for decreasing error-free NHEJ in cells. In some cases, the error-free NHEJ is decreased by at least about: 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 99% compared with that achieved with a wild-type site-specific endonuclease lacking an accessory polypeptide.
Disclosed herein are chimeric polypeptides of CRISPR Cas enzymes and DMEs (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME), wherein the knock-in efficiency, as measured by % HDR, is 1 to 10%, 10 to 20%, 20 to 30%, 30 to 40%, 40 to 50%, 50 to 60%, 60 to 70%, 70 to 80%, 80 to 90%, 90 to 100%, 1 to 20%, 20 to 40%, 40 to 60%, 60 to 80%, 80 to 100%, 5 to 15%, 15 to 25%, 25 to 35%, 35 to 45%, 45 to 55%, 55 to 65%, 65 to 75%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 30%, 40%, 50%, 60%, or 70%.
Some chimeric polypeptides of the present disclosure (e.g., any CRIPSR Cas enzyme fused to a DME (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME)) displays a knock-in efficiency that is 1 to 10%, 10 to 20%, 20 to 30%, 30 to 40%, 40 to 50%, 50 to 60%, 60 to 70%, 70 to 80%, 80 to 90%, 90 to 100%, 1 to 20%, 20 to 40%, 40 to 60%, 60 to 80%, 80 to 100%, 5 to 15%, 15 to 25%, 25 to 35%, 35 to 45%, 45 to 55%, 55 to 65%, 65 to 75%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 30%, 40%, 50%, 60%, or 70% higher than a standard CRISPR Cas enzyme.
Some chimeric polypeptides of the present disclosure (e.g., any CRIPSR Cas enzyme fused to a DME (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME)) displays a knock-in efficiency that is 2 to 10 fold, 10 to 20 fold, 20 to 30 fold, 30 to 40 fold, 40 to 50 fold, 50 to 60 fold, 60 to 70 fold, 70 to 80 fold, 80 to 90 fold, 90 to 100 fold, 2 to 20 fold, 20 to 40 fold, 40 to 60 fold, 60 to 80 fold, 80 to 100 fold, 5 to 15 fold, 15 to 25 fold, 25 to 35 fold, 35 to 45 fold, 45 to 55 fold, 55 to 65 fold, 65 to 75 fold, 2 fold, 3 fold, 4 fold, 5 fold, 6 fold, 7 fold, 8 fold, 9 fold, 10 fold, 15 fold, 20 fold, 30 fold, 40 fold, 50 fold, 60 fold, or 70 fold higher than a standard CRISPR Cas enzyme.
Also disclosed herein are chimeric polypeptides of CRISPR Cas enzymes and DMEs (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME), wherein the knock-out efficiency, as measured by % indels, is 1 to 10%, 10 to 20%, 20 to 30%, 30 to 40%, 40 to 50%, 50 to 60%, 60 to 70%, 70 to 80%, 80 to 90%, 90 to 100%, 1 to 20%, 20 to 40%, 40 to 60%, 60 to 80%, 80 to 100%, 5 to 15%, 15 to 25%, 25 to 35%, 35 to 45%, 45 to 55%, 55 to 65%, 65 to 75%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 30%, 40%, 50%, 60%, or 70%.
Some chimeric polypeptides of the present disclosure (e.g., any CRIPSR Cas enzyme fused to a DME (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME)) displays a knock-out efficiency that is 1 to 10%, 10 to 20%, 20 to 30%, 30 to 40%, 40 to 50%, 50 to 60%, 60 to 70%, 70 to 80%, 80 to 90%, 90 to 100%, 1 to 20%, 20 to 40%, 40 to 60%, 60 to 80%, 80 to 100%, 5 to 15%, 15 to 25%, 25 to 35%, 35 to 45%, 45 to 55%, 55 to 65%, 65 to 75%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, 30%, 40%, 50%, 60%, or 70% higher than a standard CRISPR Cas enzyme.
The chimeric polypeptides of the present disclosure (e.g., any CRIPSR Cas enzyme fused to a DME (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME)) displays a knock-out efficiency that is 2 to 10 fold, 10 to 20 fold, 20 to 30 fold, 30 to 40 fold, 40 to 50 fold, 50 to 60 fold, 60 to 70 fold, 70 to 80 fold, 80 to 90 fold, 90 to 100 fold, 2 to 20 fold, 20 to 40 fold, 40 to 60 fold, 60 to 80 fold, 80 to 100 fold, 5 to 15 fold, 15 to 25 fold, 25 to 35 fold, 35 to 45 fold, 45 to 55 fold, 55 to 65 fold, 65 to 75 fold, 2 fold, 3 fold, 4 fold, 5 fold, 6 fold, 7 fold, 8 fold, 9 fold, 10 fold, 15 fold, 20 fold, 30 fold, 40 fold, 50 fold, 60 fold, or 70 fold higher than a standard CRISPR Cas enzyme.
The above described improvements in on-target mutagenesis for the chimeric polypeptides of the present disclosure (e.g., any CRIPSR Cas enzyme fused to a DME (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME)) are further coupled to decreased or dissimilar rates of mutagenesis at off-target sites as compared to a standard CRISPR Cas enzyme.
Activity of any of the chimeric polypeptides described herein (e.g., any CRIPSR Cas enzyme fused to a DME (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME)) can be abolished or halted by addition of zinc sulfate. Zinc sulfate can be added in vitro or in vivo to halt genome editing. Zinc sulfate (ZnSO4) can be added to halt activity of a chimeric polypeptide of the present disclosure at a concentration of up to 1 mM, up to 0.5 mM, up to 0.25 mM, up to 0.125 mM, up to 0.0625 mM, up to 31.3 nM, up to 15.6 nM, up to 7.8 nM, up to 3.9 nM, up to 2.0 nM, up to 1.0 nM, up to 0.5 nM, up to 0.2 nM, or up to 0.1 nM. Addition of zinc sulfate rapidly halts or decreases activity of the chimeric polypeptides disclosed herein (e.g., any CRIPSR Cas enzyme fused to a DME (e.g., any one of RecE, RecJ, lambda, mungbean nuclease, T5, TdT, SSB, DSB, GFP, or any other DME)). For example, zinc sulfate can inactivate said chimeric polypeptides in under 30 min, under 25 min, under 20 min, under 15 min, under 10 min, under 5 min, under 0 min, under 5 min, under 4 min, under 3 min, under 2 min, under 1 min, under 30 sec, under 25 sec, under 20 sec, under 15 sec, under 10 sec, or under 5 sec.
The disclosure provides methods to increase genome modification rate of a target nucleic acid by a site-specific endonuclease. In some cases, the genome modification rate exhibited by a chimeric polypeptide of the disclosure for a target nucleic acid is at least about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 99%.
The disclosure provides methods to decrease off-target effects of site-specific endonucleases. In some cases, the off-target effects are reduced by at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 99% using the methods of the disclosure.
In some cases, a chimeric polypeptide of the disclosure is introduced into a cell as a nucleic acid encoding the chimeric polypeptide of the disclosure. Alternatively, a chimeric polypeptide is introduced into a cell as an mRNA transcript. Alternatively, a chimeric polypeptide is introduced into a cell as a polypeptide. Alternatively, a chimeric polypeptide is introduced into a cell or a protoplast as a ribonucleoprotein complex comprising the chimeric polypeptide and a guide nucleic acid.
In some cases, a chimeric polypeptide is introduced into a cell as a nucleic acid, for example, as a delivery vector, that encodes the chimeric polypeptide. Optionally, the nucleic acid comprises a promoter sequence for regulating expression of the chimeric polypeptide in the cell. Non-limiting examples of promoter sequences suitable for use with the disclosure include plant viral promoters, 35S promoter, rbcS promoter, psbA promoter, and ubiquitin promoter.
The open reading frame of nucleic acids encoding chimeric polypeptides of the disclosure are in some cases at least partially codon-optimized for expression in a target organism or cell. Alternatively, the open reading frame of nucleic acids encoding chimeric polypeptides of the disclosure are in some cases fully codon-optimized for expression in a target organism or cell.
A nucleic acid encoding a chimeric polypeptide comprises a 5′ UTR in some cases. Alternatively, or in combination, a nucleic acid encoding a chimeric polypeptide comprises a 3′ UTR. The 5′ UTR, 3′ UTR, or both are in some cases are at least partially codon-optimized for expression in a target organism or cell. Alternatively, the 5′ UTR, 3′ UTR, or both are in some cases fully codon-optimized for expression in a target organism or cell.
In some cases, a nucleic acid encoding a chimeric polypeptide of the disclosure is configured for transient expression in a target cell such as a plant cell. Alternatively, a nucleic acid encoding a chimeric polypeptide is configured for stable expression in a target cell. Alternatively, or in combination, a nucleic acid encoding a chimeric polypeptide is configured for agrobacterium expression.
In some cases, delivery of a nucleic acid encoding a chimeric polypeptide into a cell is facilitated by coating the nucleic acid on a particle such as a gold particle or a tungsten particle. Non-limiting examples of delivery or transformation methods suitable for use with the disclosure include, for example, viral or bacteriophage infection, transfection, conjugation, protoplast fusion, lipofection, electroporation, calcium phosphate precipitation, polyethyleneimine (PEI)-mediated transfection, DEAE-dextran mediated transfection, liposome-mediated transfection, particle gun technology, calcium phosphate precipitation, direct micro injection, and nanoparticle-mediated nucleic acid delivery.
In some cases, a nucleic acid encoding a chimeric polypeptide is packaged into a vector for delivery into a target cell. Non-limiting examples of vectors suitable for use with the disclosure include expression vectors such as viral and non-viral expression vectors, and transformation vectors such as bacterial transformation vectors, viral transformation vectors, transformation vectors for nuclear transformation, and transformation vectors for organellar transformation.
In some cases, a nucleic acid encoding a chimeric polypeptide additionally comprises a sequence encoding a guide nucleic acid such as guide RNA. In some cases, a nucleic acid encoding a chimeric polypeptide additionally comprises a sequence encoding a donor nucleic acid suitable for use a template for HR.
In some cases, the target organism or cell is a plant. Alternatively, a target organism or cell is a bacterium. Alternatively, a target organism or cell is an animal. Alternatively, a target organism or cell is a mammal. Alternatively, a target organism or cell is a human. Non-limiting examples of target organisms or cells suitable for use with the disclosure include a prokaryotic cell; a eukaryotic cell; a bacterial cell; an archaeal cell; a cell of a single-cell eukaryotic organism; a protozoa cell; a cell from a plant; an algal cell; seaweeds such as kelp; a fungal cell such as a yeast cell or a cell from a mushroom; an animal cell; a cell from an invertebrate animal such as fruit fly, cnidarian, echinoderm, and nematode; a cell from a vertebrate animal such as fish, amphibian, reptile, bird, and mammal; and a cell from a mammal such as a pig, a cow, a goat, a sheep, a rodent, a rat, a mouse, a non-human primate, and a human.
Non-limiting examples of plant cell types suitable for use with the disclosure include seeds, suspension cultures, embryos, meristematic regions, callus tissue, leaves, roots, shoots, gametophytes, sporophytes, pollen, and microspores. Non-limiting examples of plants suitable for use with the disclosure include monocots, dicots, crop plants, ornamental plants, non-domesticated plants, and wild plants.
Methods of the disclosure are performed at any suitable pH. A chimeric polypeptide of the disclosure is active and suitable for use at various pHs, including for example, pH 6, 7, 8, 9, and 10. As shown in
Methods of the disclosure are performed for any suitable length of time needed to achieve the desired degree of nucleic acid modification. For example, a chimeric polypeptide of the disclosure can be contacted or incubated with a target nucleic acid for at least 1 hour, 2 hours, 5 hours, 10 hours, 20 hours or 50 hours. In some cases, a chimeric polypeptide is incubated with a target nucleic acid for 2 hours. Alternatively, a chimeric polypeptide is incubated with a target nucleic acid for 20 hours.
Shown in
As shown in
Shown in
As shown in the schematic of
Genome editing results in regeneration of plantlets in lettuce, as shown in
In some cases, for CCR5: GFLAS05 exhibited non-zero percentages of off-target effects that ranged up to 9.10%, GFLAS06 exhibited non-zero percentages of off-target effects that ranged up to 9.09%, and GLFAS07 exhibited non-zero percentages of off-target effects that ranged up to 6.67%. In some cases, for DHCR7: GFLAS02 exhibited non-zero percentages of off-target effects that ranged up to 8.33%, GFLAS03 exhibited non-zero percentages of off-target effects that ranged up to 9.09%, GFLAS04 exhibited non-zero percentages of off-target effects that ranged up to 6.78%, GFLAS05 exhibited non-zero percentages of off-target effects that ranged up to 15.10%, GFLAS06 exhibited non-zero percentages of off-target effects that ranged up to 7.14%, and GLFAS07 exhibited non-zero percentages of off-target effects that ranged up to 4.65%.
The following embodiments recite non-limiting permutations of combinations of features disclosed herein. Other permutations of combinations of features are also contemplated. In particular, each of these numbered embodiments is contemplated as depending from or relating to every previous or subsequent numbered embodiment, independent of their order as listed. 1. A polypeptide comprising a sequence specific endonuclease fused in frame to a DNA modifying enzyme (DME), wherein the polypeptide exhibits enhanced on target mutagenesis compared to the sequence specific endonuclease and wherein the peptide exhibits the same or lower off target mutagenesis compared to the sequence specific endonuclease when unfused. 2. The polypeptide of embodiment 1, wherein the DNA modifying enzyme comprises a RecE domain. 3. The polypeptide of embodiment 2, wherein the RecE domain exhibits at least 70% identity over at least 70% of its sequence to RecE. 4. The polypeptide of embodiment 3, wherein the RecE domain exhibits at least 90% identity to RecE. 5. The polypeptide of embodiment 2, wherein the RecE domain comprises a RecE sequence. 6. The polypeptide of embodiment 1, wherein the DNA modifying enzyme comprises a RecJ domain. 7. The polypeptide of embodiment 6, wherein the RecJ domain exhibits at least 70% identity over at least 70% of its sequence to RecJ. 8. The polypeptide of embodiment 7, wherein the RecJ domain exhibits at least 90% identity to RecJ. 9. The polypeptide of embodiment 6, wherein the RecJ domain comprises a RecJ sequence. 10. The polypeptide of embodiment 1, wherein the DNA modifying enzyme comprises a RecBCD domain. 11. The polypeptide of embodiment 10, wherein the RecBCD domain exhibits at least 70% identity over at least 70% of its sequence to RecBCD. 12. The polypeptide of embodiment 11, wherein the RecBCD domain exhibits at least 90% identity to RecBCD. 13. The polypeptide of embodiment 10, wherein the RecBCD domain comprises a RecBCD sequence. 14. The polypeptide of embodiment 1, wherein the DNA modifying enzyme comprises a Mungbean nuclease domain. 15. The polypeptide of embodiment 6, wherein the Mungbean nuclease domain exhibits at least 70% identity over at least 70% of its sequence to Mungbean nuclease. 16. The polypeptide of embodiment 7, wherein the Mungbean nuclease domain exhibits at least 90% identity to Mungbean nuclease. 17. The polypeptide of embodiment 7, wherein the Mungbean nuclease domain comprises a Mungbean nuclease sequence. 18. The polypeptide of embodiment 1, wherein the DNA modifying enzyme comprises an ExoI domain. 19. The polypeptide of embodiment 18, wherein the ExoI domain exhibits at least 70% identity over at least 70% of its sequence to ExoI. 20. The polypeptide of embodiment 19, wherein the ExoI domain exhibits at least 90% identity to ExoI. 21. The polypeptide of embodiment 18, wherein the ExoI domain comprises an ExoI sequence. 22. The polypeptide of embodiment 1, wherein the DNA modifying enzyme comprises an ExoIII domain. 23. The polypeptide of embodiment 22, wherein the ExoIII domain exhibits at least 70% identity over at least 70% of its sequence to ExoIII. 24. The polypeptide of embodiment 23, wherein the ExoIII domain exhibits at least 90% identity to ExoIII. 25. The polypeptide of embodiment 22, wherein the ExoIII domain comprises an ExoIII sequence. 26. The polypeptide of embodiment 1, wherein the DNA modifying enzyme comprises an ExoVII domain. 27. The polypeptide of embodiment 26, wherein the ExoVII domain exhibits at least 70% identity over at least 70% of its sequence to ExoVII. 28. The polypeptide of embodiment 27, wherein the ExoVII domain exhibits at least 90% identity to ExoVII. 29. The polypeptide of embodiment 26, wherein the ExoVII domain comprises an ExoVII sequence. 30. A polypeptide comprising a sequence-specific endonuclease fused in frame to a DNA binding protein (DBP). 31. The polypeptide of embodiment 30, wherein the DBP binds single-stranded DNA. 32. The polypeptide of embodiment 30, wherein the DBP binds double-stranded DNA. 33. A polypeptide comprising a sequence-specific endonuclease fused in frame to a terminal deoxyribonucleotidyl transferase (TdT). 34. The polypeptide of any one of embodiments 1-33, wherein the sequence-specific endonuclease comprises a region exhibiting 70% identity over at least 70% of its residues to a Cas9 domain. 35. The polypeptide of embodiment 34, exhibiting at least 90% identity to a Cas9 domain. 36. The polypeptide of embodiment 34, wherein the region is a Cas9 domain. 37. The polypeptide of embodiment 34, wherein the Cas9 is SpCas9. 38. The polypeptide of any one of embodiments 1-33, wherein the sequence-specific endonuclease comprises a region exhibiting 70% identity over at least 70% of its residues to a Cpf1 domain. 39. The polypeptide of embodiment 37, exhibiting at least 90% identity to a Cpf1 domain. 40. The polypeptide of embodiment 37, wherein the region is a Cpf1 domain. 41. The polypeptide of any one of embodiments 1-33, wherein the sequence-specific endonuclease comprises a TALEN nucleic acid recognition site. 42. The polypeptide of any one of embodiments 1-33, wherein the sequence-specific endonuclease comprises a zinc finger nucleic acid recognition site. 43. The polypeptide of any one of embodiments 1-42, comprising a nuclear localization signal. 44. The polypeptide of any one of embodiments 1-42, comprising an affinity tag. 45. The polypeptide of any one of embodiments 1-29, wherein the DNA modifying enzyme generates a 3′ OH overhang. 46. The polypeptide of any one of embodiments 1-29, wherein the DNA modifying enzyme exposes a recessed 3′ OH. 47. The polypeptide of any one of embodiments 1-29, wherein the DNA modifying enzyme comprises cleaved end resection activity. 48. The polypeptide of any one of embodiments 1-29, wherein the polypeptide concurrently exhibits increased mutation efficiency and increased homologous recombination efficiency relative to wild type Cas9. 49. The polypeptide of embodiment 48, wherein the increased activity is measured in at least one human cell genome or plant cell genome. 50. The polypeptide of embodiment 49, wherein the measured activity is assessed following a 2 hour incubation. 51. The polypeptide of embodiment 49, wherein the measured activity is assessed following a 24 hour incubation. 52. The polypeptide of embodiment 48, wherein the increased activity comprises an increased deletion rate. 53. The polypeptide of embodiment 48, wherein the increased activity comprises an increased insertion rate. 54. The polypeptide of embodiment 48, wherein the increased activity comprises an increased homologous recombination rate. 55. The polypeptide of any one of embodiments 1-54, wherein the polypeptide is substantially free of bacterial cellular contaminant. 56. The polypeptide of any one of embodiments 1-54, wherein the polypeptide does not have an animal glycosylation pattern. 57. The polypeptide of any one of embodiments 1-54, wherein the polypeptide does not have a bacterial glycosylation pattern. 58. The polypeptide of any one of embodiments 1-54, wherein the polypeptide does not have a fungal glycosylation pattern. 59. The polypeptide of any one of embodiments 1-54, wherein the polypeptide is incubated in contact with a genome at a pH of at least 6. 60. The polypeptide of any one of embodiments 1-54, wherein the polypeptide is incubated in contact with a genome at a pH of at least 10. 61. The polypeptide of any one of embodiments 1-60, wherein the enhanced on target mutagenesis is 1% greater, 2% greater, 3% greater, 4% greater, 5% greater, 10% greater, 15%, greater, 20% greater, 25% greater, 30% greater, 35% greater, 40% greater, 45% greater, 50% greater, 55% greater, 60% greater, 65% greater, 70% greater, 75% greater, 80% greater, 85% greater, or 90% greater compared to on target mutagenesis of the sequence specific endonuclease. 62. A nucleic acid encoding a chimeric polypeptide of any one of embodiments 1-60. 63. The nucleic acid of embodiment 61, comprising an open reading frame that is at least partially codon optimized for expression in a plant target organism. 64. The nucleic acid of embodiment 61, comprising an open reading frame that is at least partially codon optimized for expression in a bacterial target organism. 65. The nucleic acid of embodiment 61, comprising an open reading frame that is at least partially codon optimized for expression in an animal target organism. 66. The nucleic acid of embodiment 61, comprising an open reading frame that is at least partially codon optimized for expression in a mammalian target organism. 67. The nucleic acid of embodiment 61, comprising an open reading frame that is at least partially codon optimized for expression in a human cell. 68. The nucleic acid of embodiment 61, comprising a 5′ UTR at least partially optimized for expression in a plant target organism. 69. The nucleic acid of embodiment 61, comprising a 3′ UTR at least partially optimized for expression in a plant target organism. 70. The nucleic acid of embodiment 61, comprising a 5′ UTR at least partially optimized for expression in a bacterial target organism. 71. The nucleic acid of embodiment 61, comprising a 3′ UTR at least partially optimized for expression in a bacterial target organism. 72. The nucleic acid of embodiment 61, comprising a 5′ UTR at least partially optimized for expression in an animal target organism. 73. The nucleic acid of embodiment 61, comprising a 3′ UTR at least partially optimized for expression in an animal target organism. 74. The nucleic acid of embodiment 61, comprising a 5′ UTR at least partially optimized for expression in a mammalian target organism. 75. The nucleic acid of embodiment 61, comprising a 3′ UTR at least partially optimized for expression in a mammalian target organism. 76. The nucleic acid of embodiment 61, configured for transient expression in a plant cell. 77. The nucleic acid of embodiment 61, coated on at least one gold particle. 78. The nucleic acid of embodiment 61, coated on at least one tungsten particle. 79. The nucleic acid of embodiment 61, packaged into a viral expression vector. 80. The nucleic acid of embodiment 61, configured for stable expression in a plant cell. 81. The nucleic acid of embodiment 61, configured for agrobacterium expression. 82. The nucleic acid of embodiment 80, packaged into a bacterial transformation vector. 83. The nucleic acid of embodiment 80, packaged into a viral transformation vector. 84. The nucleic acid of embodiment 80, packaged into a transformation vector for nuclear transformation. 85. The nucleic acid of embodiment 80, packaged into a transformation vector for organellar transformation. 86. The nucleic acid of embodiment 61, comprising a plant viral promoter. 87. The nucleic acid of embodiment 61, comprising a 35S promoter. 88. The nucleic acid of embodiment 61, comprising an rbcS promoter. 89. The nucleic acid of embodiment 61, comprising a psbA promoter. 90. The nucleic acid of embodiment 61, comprising an ubiquitin promoter. 91. A method of tagging a repaired chromosome, comprising contacting the chromosome to a composition comprising a polypeptide of any one of embodiments 1-60, wherein the polypeptide comprises a terminal deoxyribonucleotidyl transferase (TdT) activity, and a labeled nucleic acid. 92. The method of embodiment 91, wherein the labeled nucleic acid comprises a non-canonical base. 93. The method of embodiment 92, wherein the non-canonical base comprises BrdU. 94. The method of embodiment 93, comprising isolating nucleic acids comprising the labeled nucleic acid. 95. A method of concurrently increasing a CRISPR-directed mutation rate and homologous recombination rate, comprising contacting a chromosome to a composition comprising a polypeptide of any one of embodiments 1-60, wherein the polypeptide yields an exposed 3′ OH overhang at a cleavage site of the chromosome. 96. The method of embodiment 95, comprising contacting the chromosome to a 5′-3′ exonuclease activity. 97. The method of embodiment 95, wherein the method exhibits at least a 20% genome modification rate. 98. The method of embodiment 95, wherein the contacting occurs at a pH of at least 6. 99. The method of embodiment 95, wherein the contacting occurs at a pH of at least 10. 100. A method of modifying a plant genome, comprising transfecting a cell harboring the plant genome using a polypeptide of any one of embodiments 1-60, culturing the cell, and recovering plant tissue comprising a modified plant genome. 101. The method of embodiment 100, wherein the modified plant genome does not encode a protein glycosyl transferase. 102. A method of modifying a plant genome, comprising transfecting a cell harboring the plant genome using a nucleic acid of any one of embodiments 61-90, culturing the cell, and recovering plant tissue comprising a modified plant genome. 103. The method of embodiment 102, wherein the modified plant genome does not encode a protein glycosyl transferase. 104. A composition comprising a polypeptide having endonuclease activity, a mung bean nuclease domain and a DNA sequence specificity domain. 105. A method of targeting a single locus for mutagenesis, said method comprising selecting a locus for mutagenesis, contacting a genomic sample comprising the locus to an enzyme comprising an exonuclease domain and a programmable endonuclease domain that binds to the locus, sequencing across the locus, and sequencing a substantial portion of the genomic sample aside from the locus. 106. The method of embodiment 105, wherein said selecting comprises identifying a unique segment of at least 10 bases in the genomic sample. 107. The method of embodiment 105, wherein said contacting occurs in vivo. 108. The method of embodiment 107, wherein said contacting comprises transfecting a cell using a vector encoding the enzyme. 109. The method of embodiment 107, wherein said contacting comprises bombarding a cell using a nucleic acid encoding the enzyme. 110. The method of embodiment 109, wherein bombarding comprises contacting to at least one gold particle. 111. The method of embodiment 109, wherein bombarding comprises contacting to at least one tungsten particle. 112. The method of embodiment 107, wherein said contacting comprises vacuum infiltration. 113. The method of embodiment 107, wherein said contacting comprises agrobacterium-mediated transformation. 114. The method of embodiment 107, wherein said contacting comprises stable transformation. 115. The method of embodiment 107, wherein said contacting comprises transient expression. 116. The method of embodiment 105, wherein said exonuclease domain comprises an ExoI exonuclease activity. 117. The method of embodiment 105, wherein said exonuclease domain comprises 5′-3′ overhang exonuclease activity. 118. The method of embodiment 105, wherein said exonuclease domain comprises double-stranded nucleic acid exonuclease activity. 119. The method of embodiment 105, wherein said exonuclease domain does not exhibit single stranded nucleic acid exonuclease activity. 120. The method of embodiment 105, wherein sequencing across the locus comprises observing a mutation relative to the locus prior to contacting. 121. The method of embodiment 105, wherein sequencing across the locus comprises observing a deletion relative to the locus prior to contacting. 122. The method of embodiment 105, wherein sequencing a substantial portion of the genomic sample aside from the locus comprises sequencing at least 1% of a genome copy of the genomic sample. 123. The method of embodiment 105, wherein sequencing a substantial portion of the genomic sample aside from the locus comprises sequencing at least 5% of a genome copy of the genomic sample. 124. The method of embodiment 105, wherein sequencing a substantial portion of the genomic sample aside from the locus comprises sequencing at least 10% of a genome copy of the genomic sample. 125. The method of embodiment 105, wherein sequencing a substantial portion of the genomic sample aside from the locus comprises sequencing at least 50% of a genome copy of the genomic sample. 126. The method of any one of embodiments 122-125, wherein said contacting occurs in vivo, and wherein said sequencing a substantial portion of the genomic sample aside from the locus is performed subsequent to at least one cell division subsequent to said contacting. 127. The method of embodiment 105, comprising contacting the sample to a Zinc ion. 128. The method of embodiment 105, comprising contacting the sample to a composition comprising Zinc sulfate. 129. A method of targeting a single locus for mutagenesis, said method comprising selecting a locus for mutagenesis, contacting a genomic sample comprising the locus to DNA binding protein (DBP) and a programmable endonuclease domain that binds to the locus, sequencing across the locus, and sequencing a substantial portion of the genomic sample aside from the locus. 130. The method of embodiment 129, wherein the DBP binds single-stranded DNA. 131. The method of embodiment 129, wherein the DBP binds double-stranded DNA. 132, The method of embodiment 129, wherein the DBP comprises a single stranded DNA binding protein (SSB). 133. The method of embodiment 129, wherein the DBP and the programmable endonuclease are fused in frame and transfected in cells in vivo. 134. The method of embodiment 129, wherein the mutagenesis comprises homology directed repair (HDR). 135. The method of embodiment 129, wherein the mutagenesis increases the efficiency of HDR.
Further understanding of the disclosure herein is gained through reference to the following embodiments.
Linear dsDNA A (514 bp) and linear dsDNA B (317 bp) were cleaved with SpCas9 and SpCas9-RecE.
Circular dsDNA was cleaved with SpCas9 and SpCas9-RecE.
DNA was treated with SpCas9 or SpCas9-RecE for 1 hour. After 1 hour, the resulting cleaved DNA was treated with mungbean exonuclease and subjected to DNA electrophoresis for 40 mins. Next, the single linear DNA was eluted, cleaned-up, and ligated. Cleavage sites of 32 colonies were determined and aligned as shown in
Thus, this example illustrated that a chimeric polypeptide of the disclosure resulted in an increase in the mutagenic efficiency of a site-specific endonuclease in a chimeric polypeptide of the disclosure relative to the wild-type version.
DNA was treated with SpCas9 or SpCas9-RecE for 3 hours. After 3 hours, the resulting cleaved DNA was treated with mungbean exonuclease and subjected to DNA electrophoresis for 40 mins. Next, the single linear DNA was eluted, cleaned-up, and ligated. Cleavage sites of 80 colonies were determined and aligned as shown in
Thus, this example also illustrated that a chimeric polypeptide of the disclosure resulted in an increase in the mutagenic efficiency of a site-specific endonuclease in a chimeric polypeptide of the disclosure relative to the wild-type version.
DNA was treated with SpCas9 or SpCas9-RecE for 2 hours. After 2 hours, the resulting cleaved DNA was treated with T4 DNA polymerase treatment, which filled up the single-stranded DNA ends, and subjected to DNA electrophoresis for 40 mins. Next, the single linear DNA was eluted, cleaned-up, and ligated. Cleavage sites of 32 colonies were determined and aligned as shown in
Thus, this example also illustrated that a chimeric polypeptide of the disclosure resulted in an increase in the mutagenic efficiency of a site-specific endonuclease in a chimeric polypeptide of the disclosure relative to the wild-type version.
Thus, this example also illustrated that a chimeric polypeptide of the disclosure resulted in an increase in the mutagenic efficiency of a site-specific endonuclease in a chimeric polypeptide of the disclosure relative to the wild-type version.
Circular dsDNA was cleaved with SpCas9 and SpCas9-RecJ.
Three Cas9 variants: from Toolgen lacking RecJ, in house source lacking RecJ; Cas9 fused to RecJ, and a guide RNA against loci of human DHCR7 were transfected into HEK293 cells using lipid mediated transfection method. Cells were harvested at different time points, from 0 hours, as a control, to 72 hours, for genomic DNA extraction.
Circular dsDNA was cleaved with SpCas9 and SpCas9-T5 Exonuclease.
DNA was treated with SpCas9 or SpCas9-T5 Exo for 3 hours. After 3 hours, the resulting cleaved DNA was treated with Q5 DNA polymerase treatment, which filled up the single-stranded DNA ends, and subjected to DNA electrophoresis for 40 mins. Next, the single linear DNA was eluted, cleaned-up, and ligated. Cleavage sites of 19 colonies were determined and aligned as shown in
Thus, this example illustrated that a chimeric polypeptide of the disclosure resulted in an increase in the mutagenic efficiency of a site-specific endonuclease in a chimeric polypeptide of the disclosure relative to the wild-type version.
Activity of SpCas9 was determined at various pHs as shown in
Activity of SpCas9 and SpCas9-mungbean nuclease chimeric polypeptide was tested in the presence of 1 mM ZnSO4 at a range of pHs.
A cell harboring a plant genome is transfected with a chimeric polypeptide of the disclosure. The cell is cultured. The chimeric polypeptide modifies the plant genome. The cell harboring the modified plant genome is recovered.
A cell harboring a plant genome is transfected with a chimeric polypeptide of the disclosure. The cell is cultured. The chimeric polypeptide modifies the plant genome. The cell harboring the modified plant genome is recovered.
Under Mg2+ deficiency, SpCas9 lost its activity, as shown in
Cas9 and Cas9-RecJ apoproteins directed against the same loci of human PD-1 and CCR5 were transfected to HEK293 cells using lipid-mediated transfection. Cells were harvested at different time points, from 0 hours, as a control, to 48 hours, followed genomic DNA extraction. PCR was performed to generate 544 bp for CCR5 and 524 bp for PD-1. T7E1 endonuclease assay allowed for the generation of two 274 and 271 bps small fragments of CCR5, and PD-1 produced two 319 and 205 bps small fragments, which were used to measure indel efficiency, as shown in
SpyCas9. For RNP complex, each SpyCas9 and its fusion proteins (25 nM) at 5′ or 3′-terminus were mixed with sgRNA (30 nM) targeting for human CCR5 for 20 minutes. NEB3.1 buffer was used. 200 ng of CCR5 template was then added to RNP complex. The mixture was incubated for 1 hour at 37° C. DNA was analyzed by agarose gel electrophoresis and analyzed by ImageJ program. Cleavage efficiency was calculated based on ‘Control A’.
FnCpf1. For RNP complex, each FnCpf1 and its fusion proteins (50 nM) at 5′ or 3′-terminus were mixed with crRNA (60 nM) targeting for human CCR5 for 20 minutes. NEB1.1 buffer was used. 200 ng of CCR5 template was then added to RNP complex. The mixture was incubated for 2 hours at 37° C. DNA was analyzed by agarose gel electrophoresis and analyzed by ImageJ program. Cleavage efficiency is calculated based on ‘Control A’.
Cell culture. HEK293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, penicillin, and streptomycin.
Cell cycle synchronization. For CRISPR PLUS-mediated knockout, no nocodazole treatment cells were used. For improving efficiency of knock-in, HEK293T cells were seeded at 3×106 cell density in 10-cm culture dish. The cells were treated with nocodazole (200 ng/ml) for 16 hours before electroporation. ssODN templates for knock-in (table) are listed below.
RNP preparation and electroporation. Before transfection of CRISPR PLUS proteins to the cells, purified each SpyCas9 or FnCpf1 variant protein (33 pmol) and sgRNA or crRNA (66 pmol) were incubated at RT for 20 minutes for RNP complex. HDR template (20 pmol ssODN or 2 pmol dsDNA) was then added to RNP complex. Nucleofection of HEK293T cells was performed using Lonza. Each nucleofection reaction consisted of approximately 2×105 cells in 20 μl of nucleofection reagent and mixed with 10 μl of RNP:DNA.
Genomic DNA extraction. Genomic DNA extraction was performed using PureLink Genomic DNA kits following the manufacture's instruction.
Deep sequencing analysis of on-target sites. The genomic region flanking the target site for each gene was amplified by two step PCR method. First, the genomic DNA from the edited and control samples was isolated and PCR amplified 35 cycles using Q5 High-fidelity DNA polymerase with adapter primers. The resulting amplicons were QIAquick PCR Purification kit. These samples were subjected to eight cycles of PCR using KAPA HotStart DNA Polymerase for indexing, followed by AMPure bead purification. Purified DNA samples were quantified by Qubit 2.0 Fluorometer, size analyzed by BioAnalyzer, and pooled in an equimolar ratio. Sequencing libraries were sequenced with the Illumina MiniSeq. Data was analyzed using Cas-Analyzer program.
This example shows editing efficiency of fusion SpyCas9 and FnCpf1 constructs of the present disclosure. The sequences of said constructs are shown in the table below.
The apparent rates of mutations after the action of CRISPR genome editing tools are relatively low in vivo due to outperformance of error-free repair mechanisms. To enhance both the rate of indel mutation and HR recombination, genome editing tools were constructed by translational fusion of DNA modifying enzymes (DME), DNA binding protein (DBP), or terminal deoxyribonucleotidyl transferase (TdT) at either upstream or downstream of CRISPR genome editing enzymes. In one embodiment, a variant irreversibly deleted the DNA at the CRISPR enzyme-dependent double strand break sites in 5′->3′ direction, and the resulting modified ends with 3′-OH overhang can better serve HR repairs in presence of repair template. Disclosed herein are constructs that display functional enhancement of the CRISPR-Cas enzymes. Among Cas9-DME series, Cas9-RecJ showed the best performance in knock-out (KO) and knock-in (KI) performance efficiency in HEK293 cells and plant protoplasts. Second, Cas9-GFP exhibited high performance not only tracing the Cas9 protein due to GFP fluorescence but only genome editing for KO and KI. Third, unexpectedly, most exonuclease-fused Cas9 or Cpf1 did not show good performance in KO and KI as well as Cas9 or Cpf1. Fourth, off-target effects in Cas9-RecJ embodied the similar efficiency to Cas9 off-targeting in whole genome sequencing and targeted deep sequencing. Last, zinc sulfate effectively quenched Cas9 activity in vitro and in vivo HEK293 cells.
TGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAGTAC
AAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCACAG
CATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGACCG
CCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGCCGC
AAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCCAAG
GTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGAGGA
GGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACGAGG
TGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGCTGG
TGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTGGCC
CACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAACCCC
GACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAAC
CAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGC
CATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGATCG
CCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATCGCC
CTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAA
CCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGCCAA
GAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACACCG
AGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACGAG
CACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTGCC
CGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCCG
GCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAAG
CCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGAA
CCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATCC
CCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGAG
GACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCTG
ACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCGC
TTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTTC
GAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCAT
GACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTCGAGAAAAGGCCGGCGGCCACGAAAA
DIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATR
LKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFIIRLEESFLVEEDKKHERH
PIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLI
EGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLEN
LIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNL
LAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT
LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTE
ELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERM
TNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAI
VDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIK
DKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRR
YTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQ
KAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIE
MARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY
YLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKS
DNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKR
QLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFY
KVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSE
QEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF
ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGG
FDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGY
KEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLAS
HYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADANLDKVLSAY
NKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIH
QSITGLYETRIDLSQLGGDAAALDLEKRPAATKKAGQAKKKEHHHHHH
TGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAGTAC
AAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCACAG
CATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGACCG
CCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGCCGC
AAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCCAAG
GTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGAGGA
GGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACGAGG
TGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGCTGG
TGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTGGCC
CACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAACCCC
GACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAAC
CAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGC
CATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGATCG
CCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATCGCC
CTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAA
CCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGCCAA
GAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACACCG
AGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACGAG
CACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTGCC
CGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCCG
GCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAAG
CCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGAA
CCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATCC
CCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGAG
GACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCTG
ACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCGC
TTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTTC
GAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCAT
GACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTCGAGATGAGTAAAGGAGAAGAACTTTT
CACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAA
ATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCT
TAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACT
ACTTTCTCTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATATGAAGCGGC
ACGACTTCTTCAAGAGCGCCATGCCTGAGGGATACGTGCAGGAGAGGACCATCT
CTTTCAAGGACGACGGGAACTACAAGACACGTGCTGAAGTCAAGTTTGAGGGA
GACACCCTCGTCAACAGGATCGAGCTTAAGGGAATCGATTTCAAGGAGGACGG
AAACATCCTCGGCCACAAGTTGGAATACAACTACAACTCCCACAACGTATACAT
CACGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAATTAGACACA
ACATTGAAGATGGAAGCGTTCAACTAGCAGACCATTATCAACAAAATACTCCAA
TTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTCCACACAATCTGC
CCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTTCTTGAGTTTGT
AACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAACTCGAGAAAA
DIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATR
LKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERH
PIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLI
EGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLEN
LIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNL
LAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT
LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTE
ELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERM
TNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAI
VDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIK
DKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRR
YTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQ
KAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIE
MARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY
YLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKS
DNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKR
QLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKINSDFRKDFQFY
KVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSE
QEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF
ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGG
FDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGY
KEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLAS
HYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADANLDKVLSAY
NKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIH
QSITGLYETRIDLSQLGGDAAALDLEMSKGEELFTGVVPILVELDGDVNGHKFSVS
GEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFSRYPDHMKRHDFFKS
AMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLE
YNYNSHNVYITADKQKNGIKANFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDN
HYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYKLEKRPAATKKAGQAK
TGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAGTAC
AAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCACAG
CATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGACCG
CCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGCCGC
AAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCCAAG
GTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGAGGA
GGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACGAGG
TGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGCTGG
TGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTGGCC
CACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAACCCC
GACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAAC
CAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGC
CATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGATCG
CCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATCGCC
CTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAA
CCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGCCAA
GAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACACCG
AGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACGAG
CACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTGCC
CGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCCG
GCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAAG
CCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGAA
CCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATCC
CCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGAG
GACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCTG
ACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCGC
TTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTTC
GAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCAT
GACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTGCAGATGGATCCACCACGAGCGTCCCA
CTTGAGCCCTCGGAAGAAGAGACCCCGGCAGACGGGTGCCTTGATGGCCTCCTC
TCCTCAAGACATCAAATTTCAAGATTTGGTCGTCTTCATTTTGGAGAAGAAAAT
GGGAACCACCCGCAGAGCGTTCCTCATGGAGCTGGCCCGCAGGAAAGGGTTCA
GGGTTGAAAATGAGCTCAGTGATTCTGTCACCCACATTGTAGCAGAGAACAACT
CGGGTTCGGATGTTCTGGAGTGGCTTCAAGCACAGAAAGTACAAGTCAGCTCAC
AACCAGAGCTCCTCGATGTCTCCTGGCTGATCGAATGCATAGGAGCAGGGAAAC
CGGTGGAAATGACAGGAAAACACCAGCTTGTTGTGAGAAGAGACTATTCAGAT
AGCACCAACCCAGGCCCCCCGAAGACTCCACCAATTGCTGTACAAAAGATCTCC
CAGTATGCGTGTCAGAGAAGAACCACTTTAAACAACTGTAACCAGATATTCACG
GATGCCTTTGATATACTGGCTGAAAACTGTGAGTTTAGAGAAAATGAAGACTCC
TGTGTGACATTTATGAGAGCAGCTTCTGTATTGAAATCTCTGCCATTCACAATCA
TCAGTATGAAGGACACAGAAGGAATTCCCTGCCTGGGGTCCAAGGTGAAGGGT
ATCATAGAGGAGATTATTGAAGATGGAGAAAGTTCTGAAGTTAAAGCTGTGTTA
AATGATGAACGATATCAATCCTTCAAACTCTTTACTTCTGTATTTGGAGTGGGGC
TGAAGACTTCTGAGAAGTGGTTCAGGATGGGTTTCAGAACTCTGAGTAAAGTAA
GGTCGGACAAAAGCCTGAAATTTACACGAATGCAGAAAGCAGGATTTCTGTATT
ATGAAGACCTTGTCAGCTGTGTGACCAGGGCAGAAGCAGAGGCCGTCAGTGTG
CTGGTTAAAGAGGCTGTCTGGGCATTTCTTCCGGATGCTTTCGTCACCATGACAG
GAGGGTTCCGGAGGGGTAAGAAGATGGGGCATGATGTAGATTTTTTAATTACCA
GCCCAGGATCAACAGAGGATGAAGAGCAACTTTTACAGAAAGTGATGAACTTA
TGGGAAAAGAAGGGATTACTTTTATATTATGACCTTGTGGAGTCAACATTTGAA
AAGCTCAGGTTGCCTAGCAGGAAGGTTGATGCTTTGGATCATTTTCAAAAGTGC
TTTCTGATTTTCAAATTGCCTCGTCAAAGAGTGGACAGTGACCAGTCCAGCTGG
CAGGAAGGAAAGACCTGGAAGGCCATCCGTGTGGATTTAGTTCTGTGCCCCTAC
GAGCGTCGTGCCTTTGCCCTGTTGGGATGGACTGGCTCCCGGCAGTTTGAGAGA
GACCTCCGGCGCTATGCCACACATGAGCGGAAGATGATTCTGGATAACCATGCT
TTATATGACAAGACCAAGAGGATATTCCTCAAAGCAGAAAGTGAAGAAGAAAT
TTTTGCGCATCTGGGATTGGATTATATTGAACCGTGGGAAAGAAATGCCCTGCA
DIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATR
LKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFIIRLEESFLVEEDKKHERH
PIFGNIVDEVAYHEKYPTIYHIRKKLVDSTDKADLRLIYLALAHMIKFRGHFLI
EGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLEN
LIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNL
LAQIGDQYADLFLAAKNISDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT
LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTE
ELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERM
TNFDKNITNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAI
VDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIK
DKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRR
YTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQ
KAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIE
MARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY
YLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKS
DNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKR
QLVETRQITKIIVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFY
KVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSE
QEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF
ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGG
FDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGY
KEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLAS
HYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADANLDKVLSAY
NKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIH
QSITGLYETRIDLSQLGGDAAALDLQMDPPRASHLSPRKKRPRQTGALMASSPQDI
KFQDLVVFILEKKMGTTRRAFLMELARRKGFRVENELSDSVTHIVAENNSGSDVLE
WLQAQKVQVSSQPELLDVSWLIECIGAGKPVEMTGKHQLVVRRDYSDSTNPGPPK
TPPIAVQKISQYACQRRTTLNNCNQIFTDAHNLAENCEFRENEDSCVTFMRAASVL
KSLPFTIISMKDTEGIPCLGSKVKGIIEEIIEDGESSEVKAVLNDERYQSFKLFTSVFGV
GLKTSEKWFRMGFRTLSKVRSDKSLKFTRMQKAGFLYYEDLVSCVTRAEAEAVSV
LVKEAVWAFLPDAFVTMTGGFRRGKKMGHDVDFLITSPGSTEDEEQLLQKVMNL
WEKKGLLLYYDLVESTFEKLRLPSRKVDALDHFQKCFLIFKLPRQRVDSDQSSWQE
GKTWKAIRVDLVLCPYERRAFALLGWTGSRQFERDLRRYATHERKMILDNHALYD
KTKRIFLKAESEEEIFAHLGLDYIEPWERNALQKRPAATKKAGQAKKKKHHHHHH
TGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAGTAC
AAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCACAG
CATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGACCG
CCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGCCGC
AAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCCAAG
GTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGAGGA
GGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACGAGG
TGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGCTGG
TGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTGGCC
CACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAACCCC
GACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAAC
CAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGC
CATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGATCG
CCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATCGCC
CTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAA
CCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGCCAA
GAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACACCG
AGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACGAG
CACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTGCC
CGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCCG
GCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAAG
CCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGAA
CCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATCC
CCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGAG
GACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCTG
ACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCGC
TTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTTC
GAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCAT
GACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTGCAGGTGAAACAACAGATACAACTTCG
TCGCCGTGAAGTCGATGAAACGGCAGACTTGCCCGCTGAATTGCCTCCCTTGCT
GCGCCGTTTATACGCCAGCCGGGGCGTGCGCAGTGCGCAAGAACTGGAACGCA
GTGTTAAAGGTATGTTGCCCTGGCAGCAACTGAGCGGCGTCGAAAAGGCCGTTG
AGATCCTTTACAACGCTTTTCGCGAAGGAACGCGGATTATTGTGGTCGGCGATT
TTGACGCCGACGGCGCGACCAGCACGGCTCTAAGCGTGCTGGCGATGCGCTCGC
TTGGTTGCAGCAATATCGACTATCTGGTACCAAACCGTTTCGAAGACGGTTACG
GCTTAAGCCCGGAAGTAGTCGATCAGGCCCATGCCCGTGGCGCGCAGTTAATTG
TCACGGTGGATAACGGTATTTCCTCCCATGCGGGCGTTGAACACGCTCGCTCGTT
GGGCATTCCGGTTATTGTTACCGATCACCATTTGCCGGGCGAAACATTACCCGC
AGCGGAAGCGATCATTAACCCTAACTTGCGCGACTGTAATTTCCCGTCGAAATC
ACTGGCAGGCGTGGGTGTGGCGTTTTATCTGATGCTGGCGCTGCGCACCTTTTTG
CGCGATCAGGGCTGGTTTGATGAGCGTGGCATCGCAATTCCTAACCTGGCAGAA
CTGCTGGATCTGGTCGCGCTGGGAACAGTGGCGGACGTCGTGCCGCTGGACGCT
AATAATCGCATTCTGACCTGGCAGGGGATGAGTCGCATCCGTGCCGGAAAGTGC
CGTCCAGGGATTAAAGCGCTGCTGGAAGTGGCAAACCGTGATGCACAAAAACT
CGCCGCCAGCGATTTAGGTTTTGCGCTGGGGCCACGTCTCAATGCTGCCGGACG
ACTGGACGATATGTCCGTCGGTGTGGCGCTCTTGCTGTGCGACAACATCGGCGA
AGCGCGCGTGCTGGCAAATGAACTCGATGCGCTAAACCAGACGCGAAAAGAGA
TCGAACAAGGAATGCAAGTTGAAGCCCTGACCCTGTGCGAGAAACTGGAGCGA
AGTCGCGACACGCTACCCGGCGGGCTGGCAATGTATCACCCCGAATGGCATCAG
GGCGTTGTCGGTATTCTGGCTTCGCGCATCAAAGAGCGTTTTCACCGTCCGGTTA
TCGCCTTTGCGCCAGCAGGTGATGGTACGCTGAAAGGTTCAGGTCGCTCCATTC
AGGGGCTGCATATGCGTGATGCACTGGAGCGATTAGACACACTCTACCCTGGCA
TGATACTGAAGTTTGGCGGTCATGCGATGGCGGCGGGTTTGTCGCTGGAAGAGG
ATAAATTCGAACTCTTTCAACAACGGTTTGGCGAGCTGGTTACCGAGTGGCTGG
ACCCTTCGCTATTGCAAGGCGAAGTGGTGTCAGACGGCCCGTTAAGCCCGGCCG
AAATGACCATGGAAGTGGCGCAGCTGCTGCGCGATGCTGGCCCGTGGGGGCAG
ATGTTCCCGGAGCCGCTGTTTGATGGTCATTTCCGTCTGCTGCAACAGCGGCTGG
TGGGCGAACGTCATTTGAAAGTCATGGTCGAACCGGTCGGCGGCGGTCCGCTGC
TGGATGGTATTGCTTTTAATGTCGATACCGCCCTCTGGCCGGATAACGGCGTGC
GCGAAGTGCAACTGGCTTACAAGCTCGATATCAACGAGTTTCGCGGCAACCGCA
GCCTGCAAATTATCATCGACAATATCTGGCCAATTCTGCAGAAAAGGCCGGCGG
DIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATR
LKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFIIRLEESFLVEEDKKHERH
PIFGNIVDEVAYHEKYPTIYHIRKKLVDSTDKADLRLIYLALAHMIKFRGHFLI
EGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLEN
LIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNL
LAQIGDQYADLFLAAKNISDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT
LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTE
ELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERM
TNFDKNITNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAI
VDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIK
DKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRR
YTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQ
KAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIE
MARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY
YLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKS
DNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKR
QLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFY
KVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSE
QEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF
ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGG
FDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGY
KEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLAS
HYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADANLDKVLSAY
NKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIH
QSITGLYETRIDLSQLGGDAAALDLQVKQQIQLRMIEVDETADLPAELPPLLRRLY
ASRGVRSAQELERSVKGMLPWQQLSGVEKAVEILYNAFREGTRIIVVGDFDADGAT
STALSVLAMRSLGCSNIDYLVPNRFEDGYGLSPEVVDQAHARGAQLIVTVDNGISSH
AGVEHARSLGIPVIVTDHHLPGETLPAAEAIINPNLRDCNFPSKSLAGVGVAFYLML
ALRTFLRDQGWFDERGIAIPNLAELLDLVALGTVADVVPLDANNRILTWQGMSRIR
AGKCRPGIKALLEVANRDAQKLAASDLGFALGPRLNAAGRLDDMSVGVALLLCDN
IGEARVLANELDALNQTRKEIEQGMQVEALTLCEKLERSRDTLPGGLAMYHPEWH
QGVVGILASRIKERFHRPVIAFAPAGDGTLKGSGRSIQGLHMRDALERLDTLYPGMI
LKFGGHAMAAGLSLEEDKFELFQQRFGELVIEWLDPSLLQGEVVSDGPLSPAEMT
MEVAQLLRDAGPWGQMFPEPLFDGHFRLLQQRLVGERHLKVMVEPVGGGPLLDGI
AFNVDTALWPDNGVREVQLAYKLDINEFRGNRSLQIIIDNIWPILQKRPAATKKAGQ
TGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAGTAC
AAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCACAG
CATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGACCG
CCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGCCGC
AAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCCAAG
GTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGAGGA
GGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACGAGG
TGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGCTGG
TGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTGGCC
CACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAACCCC
GACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAAC
CAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGC
CATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGATCG
CCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATCGCC
CTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAA
CCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGCCAA
GAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACACCG
AGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACGAG
CACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTGCC
CGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCCG
GCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAAG
CCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGAA
CCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATCC
CCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGAG
GACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCTG
ACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCGC
TTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTTC
GAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCAT
GACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTGCAGATGAGCACAAAACCACTCTTCCT
GTTACGGAAAGCGAAAAAATCATCCGGTGAACCTGACGTCGTCCTGTGGGCAA
GCAACGATTTTGAATCGACCTGTGCCACTCTGGACTACCTGATCGTTAAGTCAG
GTAAAAAACTGAGCAGCTATTTTAAAGCTGTTGCCACGAATTTTCCTGTCGTTAA
TGACCTGCCCGCTGAAGGTGAGATCGATTTTACCTGGAGTGAACGCTATCAACT
CAGCAAAGACTCCATGACATGGGAACTAAAACCGGGAGCAGCACCAGACAACG
CTCACTATCAAGGCAATACCAACGTCAACGGCGAAGACATGACTGAGATTGAG
GAGAATATGCTACTCCCAATTTCTGGCCAGGAACTGCCCATTCGTTGGCTTGCTC
AACACGGCAGCGAAAAACCGGTAACGCACGTTTCACGCGACGGACTCCAGGCA
TTACACATTGCTCGGGCTGAAGAACTACCGGCTGTTACTGCCCTGGCTGTTTCCC
ACAAAACCAGCCTGCTCGACCCGCTGGAAATTCGCGAACTCCACAAACTGGTTC
GTGACACTGACAAAGTTTTCCCTAATCCTGGTAATTCAAACCTGGGACTGATAA
CTGCTTTTTTCGAAGCATACCTGAACGCTGACTACACCGATCGAGGACTGCTGA
CAAAAGAGTGGATGAAGGGTAATCGTGTTTCACACATCACTCGCACGGCTTCCG
GTGCTAATGCTGGCGGCGGAAACCTCACCGATCGCGGCGAAGGTTTCGTACACG
ATCTGACGTCACTGGCGCGCGACGTAGCCACTGGCGTACTGGCCCGTTCAATGG
ATCTGGACATCTATAACCTTCATCCGGCACACGCTAAACGCATTGAGGAAATTA
TCGCTGAAAATAAACCGCCCTTTTCTGTTTTCCGCGACAAATTCATCACCATGCC
TGGCGGGCTGGATTATTCCCGCGCCATCGTGGTTGCGTCCGTAAAAGAAGCACC
AATTGGGATCGAGGTCATCCCCGCGCACGTCACTGAATATCTGAACAAAGTACT
GACTGAAACCGATCATGCCAACCCTGATCCGGAAATCGTGGATATTGCCTGCGG
TCGCTCCTCTGCCCCGATGCCGCAGCGAGTAACAGAAGAAGGAAAACAGGATG
ATGAAGAAAAACCGCAACCATCTGGAACAACGGCAGTTGAACAGGGAGAGGCT
GAAACAATGGAACCGGACGCAACTGAACATCATCAGGACACGCAGCCGCTGGA
TGCTCAGTCACAGGTAAATTCTGTTGATGCGAAATATCAGGAACTGCGGGCAGA
ACTCCATGAAGCCCGGAAAAACATTCCATCAAAAAATCCTGTCGATGACGATAA
ATTGCTTGCTGCATCACGTGGTGAATTTGTTGACGGAATTAGCGACCCGAACGA
TCCGAAATGGGTAAAGGGGATCCAGACTCGCGATTGTGTGTACCAGAACCAGCC
AGAAACGGAAAAAACCAGCCCAGATATGAATCAACCTGAGCCAGTAGTGCAAC
AGGAACCGGAAATAGCCTGCAATGCCTGCGGCCAGACTGGCGGGGATAACTGC
CCTGACTGTGGTGCGGTGATGGGCGACGCAACATACCAGGAAACATTCGATGA
AGAGAGTCAGGTTGAAGCTAAGGAAAATGATCCGGAGGAAATGGAAGGCGCTG
AACATCCGCACAATGAGAATGCTGGCAGCGATCCGCATCGCGATTGCAGTGATG
AAACTGGCGAAGTCGCAGATCCCGTAATCGTAGAAGACATAGAGCCAGGTATTT
ATTACGGAATTTCGAATGAGAATTACCACGCGGGTCCCGGTATCAGTAAGTCTC
AGCTCGATGACATTGCTGATACTCCGGCACTATATTTGTGGCGTAAAAATGCCC
CCGTGGACACCACAAAGACAAAAACGCTCGATTTAGGAACTGCTTTCCACTGCC
GGGTACTTGAACCGGAAGAATTCAGTAACCGCTTTATCGTAGCACCTGAATTTA
ACCGCCGTACAAACGCCGGAAAAGAAGAAGAGAAAGCGTTTCTGATGGAATGC
GCAAGCACAGGAAAAACGGTTATCACTGCGGAAGAAGGCCGGAAAATTGAACT
CATGTATCAAAGCGTTATGGCTTTGCCGCTGGGGCAATGGCTTGTTGAAAGCGC
CGGACACGCTGAATCATCAATTTACTGGGAAGATCCTGAAACAGGAATTTTGTG
TCGGTGCCGTCCGGACAAAATTATCCCTGAATTTCACTGGATCATGGACGTGAA
AACTACGGCGGATATTCAACGATTCAAAACCGCTTATTACGACTACCGCTATCA
CGTTCAGGATGCATTCTACAGTGACGGTTATGAAGCACAGTTTGGAGTGCAGCC
AACTTTCGTTTTTCTGGTTGCCAGCACAACTATTGAATGCGGACGTTATCCGGTT
GAAATTTTCATGATGGGCGAAGAAGCAAAACTGGCAGGTCAACAGGAATATCA
CCGCAATCTGCGAACCCTGTCTGACTGCCTGAATACCGATGAATGGCCAGCTAT
TAAGACATTATCACTGCCCCGCTGGGCTAAGGAATATGCAAATGACCTGCAGAA
DIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATR
LKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERH
PIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLI
EGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLEN
LIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNL
LAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT
LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTE
ELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERM
TNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAI
VDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIK
DKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRR
YTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQ
KAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIE
MARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY
YLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKS
DNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKR
QLVETRQITKIIVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFY
KVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSE
QEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF
ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGG
FDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGY
KEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLAS
HYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADANLDKVLSAY
NKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIH
QSITGLYETRIDLSQLGGDAAALDLQMSTKPLFLLRKAKKSSGEPDVVLWASNDF
ESTCATLDYLIVKSGKKLSSYFKAVATNFPVVNDLPAEGEIDFTWSERYQLSKDSMT
WELKPGAAPDNAHYQGNTNVNGEDMTEIEENMLLPISGQELPIRWLAQHGSEKPVT
HVSRDGLQALHIARAEELPAVTALAVSHKTSLLDPLEIRELHKLVRDTDKVFPNPGN
SNLGLITAFFEAYLNADYTDRGLLTKEWMKGNRVSHITRTASGANAGGGNLTDRG
EGFVHDLTSLARDVATGVLARSMDLDIYNLHPAHAKRIEEIIAENKPPFSVFRDKFIT
MPGGLDYSRAIVVASVKEAPIGIEVIPAHVTEYLNKVLTETDHANPDPEIVDIACGRS
SAPMPQRVTEEGKQDDEEKPQPSGTTAVEQGEAETMEPDATEHHQDTQPLDAQSQ
VNSVDAKYQELRAELHEARKNIPSKNPVDDDKLLAASRGEFVDGISDPNDPKWVK
GIQTRDCVYQNQPEIEKTSPDMNQPEPVVQQEPEIACNACGQTGGDNCPDCGAVM
GDATYQETFDEESQVEAKENDPEEMEGAEHPHNENAGSDPHRDCSDETGEVADPVI
VEDIEPGIYYGISNENYHAGPGISKSQLDDIADTPALYLWRKNAPVDTTKTKTLDLG
TAFHCRVLEPEEFSNRFIVAPEFNRRTNAGKEEEKAFLMECASTGKTVITAEEGRKIE
LMYQSVMALPLGQWLVESAGHAESSIYWEDPETGILCRCRPDKIIPEFHWIMDVKT
TADIQRFKTAYYDYRYHVQDAFYSDGYEAQFGVQPTFVFLVASTTIECGRYPVEIF
MMGEEAKLAGQQEYHRNLRTLSDCLNTDEWPAIKTLSLPRWAKEYANDLQKRPA
TGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAGTAC
AAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCACAG
CATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGACCG
CCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGCCGC
AAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCCAAG
GTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGAGGA
GGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACGAGG
TGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGCTGG
TGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTGGCC
CACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAACCCC
GACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAAC
CAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGC
CATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGATCG
CCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATCGCC
CTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAA
CCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGCCAA
GAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACACCG
AGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACGAG
CACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTGCC
CGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCCG
GCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAAG
CCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGAA
CCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATCC
CCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGAG
GACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCTG
ACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCGC
TTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTTC
GAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCAT
GACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTCGAGATGACACCGGACATTATCCTGCA
GCGTACCGGGATCGATGTGAGAGCTGTCGAACAGGGGGATGATGCGTGGCACA
AATTACGGCTCGGCGTCATCACCGCTTCAGAAGTTCACAACGTGATAGCAAAAC
CCCGCTCCGGAAAGAAGTGGCCTGACATGAAAATGTCCTACTTCCACACCCTGC
TTGCTGAGGTTTGCACCGGTGTGGCTCCGGAAGTTAACGCTAAAGCACTGGCCT
GGGGAAAACAGTACGAGAACGACGCCAGAACCCTGTTTGAATTCACTTCCGGC
GTGAATGTTACTGAATCCCCGATCATCTATCGCGACGAAAGTATGCGTACCGCC
TGCTCTCCCGATGGTTTATGCAGTGACGGCAACGGCCTTGAACTGAAATGCCCG
TTTACCTCCCGGGATTTCATGAAGTTCCGGCTCGGTGGTTTCGAGGCCATAAAGT
CAGCTTACATGGCCCAGGTGCAGTACAGCATGTGGGTGACGCGAAAAAATGCCT
GGTACTTTGCCAACTATGACCCGCGTATGAAGCGTGAAGGCCTGCATTATGTCG
TGATTGAGCGGGATGAAAAGTACATGGCGAGTTTTGACGAGATCGTGCCGGAGT
TCATCGAAAAAATGGACGAGGCACTGGCTGAAATTGGTTTTGTATTTGGGGAGC
AATGGCGACTCGAGAAAAGGCCGGCGGCCACGAAAAAGGCCGGCCAGGCAAA
DIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATR
LKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFIIRLEESFLVEEDKKHERH
PIFGNIVDEVAYHEKYPTIYHIRKKLVDSTDKADLRLIYLALAHMIKFRGHFLI
EGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLEN
LIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNL
LAQIGDQYADLFLAAKNISDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT
LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTE
ELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERM
TNFDKNITNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAI
VDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIK
DKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRR
YTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQ
KAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIE
MARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY
YLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKS
DNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKR
QLVETRQITKIIVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFY
KVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSE
QEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF
ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGG
FDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGY
KEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLAS
HYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADANLDKVLSAY
NKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIH
QSITGLYETRIDLSQLGGDAAALDLEMTPDIILQRTGIDVRAVEQGDDAWHKLRL
GVITASEVHNVIAKPRSGKKWPDMKMSYFHTLLAEVCTGVAPEVNAKALAWGKQ
YENDARTLFEFTSGVNVTESPITYRDESMRTACSPDGLCSDGNGLELKCPFTSRDFM
KFRLGGFEAIKSAYMAQVQYSMWVTRKNAWYFANYDPRMKREGLHYVVIERDEK
YMASFDEIVPEFIEKMDEALAEIGFVFGEQWRLEKRPAATKKAGQAKKKKHHHHH
TGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAGTAC
AAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCACAG
CATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGACCG
CCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGCCGC
AAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCCAAG
GTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGAGGA
GGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACGAGG
TGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGCTGG
TGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTGGCC
CACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAACCCC
GACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAAC
CAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGC
CATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGATCG
CCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATCGCC
CTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAA
CCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGCCAA
GAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACACCG
AGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACGAG
CACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTGCC
CGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCCG
GCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAAG
CCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGAA
CCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATCC
CCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGAG
GACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCTG
ACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCGC
TTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTTC
GAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCAT
GACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTGCAGATGCAAACGTTACAGATGAGTCT
GTTGACACAACCTTACGTTCAGCCTCGTTTCCCTTGCAAGCGTTACCCGACCTTC
TCCGCATCCTGCAGAACTCAAAAGACAGCGATCACGAAAACAGAGAAGGTGTT
TTTCAGTGAGTCATTTGATCAAACACGTTGCACGCAGCCTCTCTCGGAAAAGAA
GAAGAGGGTGTTCTTTTTGGACGTTAACCCGCTCTGTTACGAAGGAAGCAAGCC
CAGCTTGCGCTCCTTCGGGCGGTGGCTCTCTCTGTTTCTCCATCAAGTCAGCCTC
ACTGACCCCGTCATTGCTGTTATTGATGGAGAAGGAGGCAGCGAGCATCGCAGA
AAGTTGCTACCTTCATATAAAGCACATAGGAAAAAGTTCATGAGACACATGTCA
AGTGGCCATGTTGGGAGGTCTCATCAAGTTATAAATGATGTTCTTGGAAAATGC
AACGTGCCAGTTATAAAGGTTGCTGGTCATGAAGCTGATGATGTTGTAGCTACT
CTAGCTGGACAAGTTGTCAATAAAGGGTTTCGAGTGGTCATTGGCTCCCCTGAT
AAGGATTTTAAGCAGCTTATATCTGAAGATGTGCAAATAGTTATGCCTTTGCCA
GAGTTACAAAGGTGGTCCTTCTACACTCTGAGGCACTACAGGGATCAGTATAAT
TGTGATCCAGAATCTGATCTGAGCTTTAGATGCATTGTAGGTGATGAAGTAGAC
GGCGTTCCTGGTATCCAGCATTTGGTCCCTAGTTTTGGTCGGAAGACTGCTATGA
AACTTATTAAAAAACATGGTTCCTTGGAAACTTTATTAAATGCGGCTGCAATAA
GGACTGTAGGCAGACCATATGCACAGGATGCCCTCAAAAACCATGCTGATTACC
TTCGGAGAAACTATGAAGTTCTTGCCTTGAAAAGGGATGTAAATATCCAACTTT
ATGATGAGTGGTTGGTTAAGAGAGACAATCACAATGATAAAACTGCACTATCTT
CCTTCTTCAAATATTTGGGAGAAAGTAAGGAGCTCAGTTACAATGGCAGACCTA
TCTCTTACAATGGTCTGCAGAAAAGGCCGGCGGCCACGAAAAAGGCCGGCCAG
DIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATR
LKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERH
PIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLI
EGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLEN
LIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNL
LAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT
LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTE
ELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERM
TNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAI
VDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIK
DKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRR
YTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQ
KAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIE
MARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY
YLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKS
DNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKR
QLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFY
KVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSE
QEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF
ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGG
FDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGY
KEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLAS
HYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADANLDKVLSAY
NKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIH
QSITGLYETRIDLSQLGGDAAALDLQMQTLQMSLLTQPYVQPRFPCKRYPTFSASC
RTQKTAITKTEKVFFSESFDQTRCTQPLSEKKKRVFFLDVNPLCYEGSKPSLRSFGR
WLSLFLHQVSLTDPVIAVIDGEGGSEHRRKLLPSYKAHRKKFMRHMSSGHVGRSHQ
VINDVLGKCNVPVIKVAGHEADDVVATLAGQVVNKGFRVVIGSPDKDFKQLISEDV
QIVMPLPELQRWSFYTLRHYRDQYNCDPESDLSFRCIVGDEVDGVPGIQHLVPSFGR
KTAMKLIKKHGSLETLLNAAAIRTVGRPYAQDALKNHADYLRRNYEVLALKRDVN
IQLYDEWLVKRDNHNDKTALSSFFKYLGESKELSYNGRPISYNGLQKRPAATKKAG
TGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAGTAC
AAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCACAG
CATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGACCG
CCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGCCGC
AAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCCAAG
GTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGAGGA
GGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACGAGG
TGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGCTGG
TGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTGGCC
CACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAACCCC
GACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAAC
CAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGC
CATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGATCG
CCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATCGCC
CTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAA
CCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGCCAA
GAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACACCG
AGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACGAG
CACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTGCC
CGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCCG
GCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAAG
CCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGAA
CCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATCC
CCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGAG
GACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCTG
ACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCGC
TTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTTC
GAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCAT
GACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTGCAGATGGCTTCCCGTCGTAATCTAAT
GATTGTCGATGGAACTAACTTAGGCTTTCGCTTCAAACATAACAATAGTAAAAA
ACCATTTGCCTCAAGTTATGTTTCAACTATTCAATCTCTGGCAAAATCCTACTCT
GCCAGAACTACGATTGTTCTAGGTGATAAGGGAAAATCTGTATTTCGTCTAGAA
CATCTACCAGAGTATAAAGGTAATCGTGATGAAAAGTACGCACAACGTACGGA
AGAGGAGAAAGCGCTAGATGAGCAGTTCTTTGAGTATTTGAAGGATGCTTTCGA
GTTGTGTAAAACTACATTCCCAACTTTTACCATTCGTGGTGTAGAAGCAGACGA
TATGGCAGCTTATATTGTTAAGCTCATCGGGCATCTTTATGATCACGTTTGGCTA
ATATCTACAGATGGTGACTGGGATACTTTATTAACGGATAAAGTTTCTCGTTTTT
CTTTCACAACACGTCGTGAGTATCATCTTCGTGATATGTATGAACATCATAATGT
TGATGATGTTGAGCAGTTTATCTCCCTGAAAGCAATTATGGGAGATCTAGGAGA
TAATATTCGTGGTGTTGAAGGAATAGGAGCAAAACGCGGATATAATATTATTCG
TGAGTTTGGTAACGTACTGGATATTATTGATCAGCTTCCACTGCCTGGAAAGCA
GAAATATATACAGAACCTGAATGCATCGGAAGAACTGCTTTTCCGAAACTTGAT
TCTGGTTGATTTACCTACCTACTGTGTGGATGCTATTGCTGCTGTAGGTCAAGAT
GTGTTAGATAAGTTTACAAAAGATATTTTGGAGATTGCAGAACAACTGCAGAAA
DIGTNSVGWAVITDEYKVPSKKFKVIGNTDRHSIKKNLIGALLFDSGETAEATR
LKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFFIIRLEESFLVEEDKKHERH
PIFGNIVDEVAYHEKYPTIYHIRKKLVDSTDKADLRLIYLALAHMIKFRGHFLI
EGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLEN
LIAQLPGEKKNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNL
LAQIGDQYADLFLAAKNISDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT
LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTE
ELLVKLNREDLLRKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIE
KILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERM
TNFDKNITNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAI
VDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIK
DKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRR
YTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQ
KAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVMGRHKPENIVIE
MARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY
YLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKS
DNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKAGFIKR
QLVETRQITKIIVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFY
KVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSE
QEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF
ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGG
FDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGY
KEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLAS
HYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADANLDKVLSAY
NKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIH
QSITGLYETRIDLSQLGGDAAALDLQMASRRNLMIVDGTNLGFRFKHNNSKKPFA
SSYVSTIQSLAKSYSARTTIVLGDKGKSVFRLEHLPEYKGNRDEKYAQRTEEEKALD
EQFFEYLKDAFELCKTTFPTFTIRGVEADDMAAYIVKLIGHLYDHVWLISTDGDWD
TLLTDKVSRFSFTTRREYHLRDMYEHHNVDDVEQFISLKAIMGDLGDNIRGVEGIG
AKRGYNIIREFGNVLDIIDQLPLPGKQKYIQNLNASEELLFRNLILVDLPTYCVDAIA
AVGQDVLDKFTKDILEIAEQLQKRPAATKKAGQAKKKKHHHHHH
ACAACAGATACAACTTCGTCGCCGTGAAGTCGATGAAACGGCAGACTTGCCCGC
TGAATTGCCTCCCTTGCTGCGCCGTTTATACGCCAGCCGGGGCGTGCGCAGTGC
GCAAGAACTGGAACGCAGTGTTAAAGGTATGTTGCCCTGGCAGCAACTGAGCG
GCGTCGAAAAGGCCGTTGAGATCCTTTACAACGCTTTTCGCGAAGGAACGCGGA
TTATTGTGGTCGGCGATTTTGACGCCGACGGCGCGACCAGCACGGCTCTAAGCG
TGCTGGCGATGCGCTCGCTTGGTTGCAGCAATATCGACTATCTGGTACCAAACC
GTTTCGAAGACGGTTACGGCTTAAGCCCGGAAGTAGTCGATCAGGCCCATGCCC
GTGGCGCGCAGTTAATTGTCACGGTGGATAACGGTATTTCCTCCCATGCGGGCG
TTGAACACGCTCGCTCGTTGGGCATTCCGGTTATTGTTACCGATCACCATTTGCC
GGGCGAAACATTACCCGCAGCGGAAGCGATCATTAACCCTAACTTGCGCGACTG
TAATTTCCCGTCGAAATCACTGGCAGGCGTGGGTGTGGCGTTTTATCTGATGCTG
GCGCTGCGCACCTTTTTGCGCGATCAGGGCTGGTTTGATGAGCGTGGCATCGCA
ATTCCTAACCTGGCAGAACTGCTGGATCTGGTCGCGCTGGGAACAGTGGCGGAC
GTCGTGCCGCTGGACGCTAATAATCGCATTCTGACCTGGCAGGGGATGAGTCGC
ATCCGTGCCGGAAAGTGCCGTCCAGGGATTAAAGCGCTGCTGGAAGTGGCAAA
CCGTGATGCACAAAAACTCGCCGCCAGCGATTTAGGTTTTGCGCTGGGGCCACG
TCTCAATGCTGCCGGACGACTGGACGATATGTCCGTCGGTGTGGCGCTCTTGCT
GTGCGACAACATCGGCGAAGCGCGCGTGCTGGCAAATGAACTCGATGCGCTAA
ACCAGACGCGAAAAGAGATCGAACAAGGAATGCAAGTTGAAGCCCTGACCCTG
TGCGAGAAACTGGAGCGAAGTCGCGACACGCTACCCGGCGGGCTGGCAATGTA
TCACCCCGAATGGCATCAGGGCGTTGTCGGTATTCTGGCTTCGCGCATCAAAGA
GCGTTTTCACCGTCCGGTTATCGCCTTTGCGCCAGCAGGTGATGGTACGCTGAA
AGGTTCAGGTCGCTCCATTCAGGGGCTGCATATGCGTGATGCACTGGAGCGATT
AGACACACTCTACCCTGGCATGATACTGAAGTTTGGCGGTCATGCGATGGCGGC
GGGTTTGTCGCTGGAAGAGGATAAATTCGAACTCTTTCAACAACGGTTTGGCGA
GCTGGTTACCGAGTGGCTGGACCCTTCGCTATTGCAAGGCGAAGTGGTGTCAGA
CGGCCCGTTAAGCCCGGCCGAAATGACCATGGAAGTGGCGCAGCTGCTGCGCG
ATGCTGGCCCGTGGGGGCAGATGTTCCCGGAGCCGCTGTTTGATGGTCATTTCC
GTCTGCTGCAACAGCGGCTGGTGGGCGAACGTCATTTGAAAGTCATGGTCGAAC
CGGTCGGCGGCGGTCCGCTGCTGGATGGTATTGCTTTTAATGTCGATACCGCCCT
CTGGCCGGATAACGGCGTGCGCGAAGTGCAACTGGCTTACAAGCTCGATATCAA
CGAGTTTCGCGGCAACCGCAGCCTGCAAATTATCATCGACAATATCTGGCCAAT
TGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCATGGACAAGAAGT
ACAGCATCGGCCTGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATC
ACCGACGAGTACAAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACAC
CGACCGCCACAGCATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAG
CGGCGAGACCGCCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCT
ACACCCGCCGCAAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACG
AGATGGCCAAGGTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTC
CTGGTGGAGGAGGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACAT
CGTGGACGAGGTGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCG
CAAGAAGCTGGTGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACC
TGGCCCTGGCCCACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCG
ACCTGAACCCCGACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGC
AGACCTACAACCAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTG
GACGCCAAGGCCATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGA
GAACCTGATCGCCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCA
ACCTGATCGCCCTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCG
ACCTGGCCGAGGACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGAC
GACCTGGACAACCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTC
CTGGCCGCCAAGAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCG
CGTGAACACCGAGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGC
GCTACGACGAGCACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGC
CAGCAGCTGCCCGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAAC
GGCTACGCCGGCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAA
GTTCATCAAGCCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGG
TGAAGCTGAACCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAAC
GGCAGCATCCCCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCG
CCGCCAGGAGGACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGA
GAAGATCCTGACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGG
CAACAGCCGCTTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCC
CCTGGAACTTCGAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTC
ATCGAGCGCATGACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTG
CCCAAGCACAGCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACC
AAGGTGAAGTACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGG
CGAGCAGAAGAAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGG
TGACCGTGAAGCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCG
ACAGCGTGGAGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGC
ACCTACCACGACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAAC
GAGGAGAACGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTT
CGAGGACCGCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGT
TCGACGACAAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGG
GGCCGCCTGAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGG
CAAGACCATCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTT
CATGCAGCTGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAA
GGCCCAGGTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACC
TGGCCGGCAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTG
GTGGACGAGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGT
GATCGAGATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACA
GCCGCGAGCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGC
CAGATCCTGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAA
GCTGTACCTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGA
GCTGGACATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCA
GAGCTTCCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCG
ACAAGAACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAG
AAGATGAAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAG
CGCAAGTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCT
GGACAAGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCA
CCAAGCACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGAC
GAGAACGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAA
GCTGGTGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGAT
CAACAACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCAC
CGCCCTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCG
ACTACAAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAG
ATCGGCAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTC
TTCAAGACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCT
GATCGAGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCG
ACTTCGCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGA
AGAAGACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCC
AAGCGCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAA
GAAGTACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGG
TGGCCAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAG
CTGCTGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATC
GACTTCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCAT
CAAGCTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCA
TGCTGGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCC
AGCAAGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAG
GGCAGCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAA
GCACTACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCG
TGATCCTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAG
CACCGCGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTC
ACCCTGACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACC
ATCGACCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCT
GATCCACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCA
GCTGGGCGGCGACGCGGCCGCACTCGACCTCGAGAAAAGGCCGGCGGCCACG
ELPPLLRRLYASRGVRSAQELERSVKGMLPWQQLSGVEKAVEILYNAFREGTRIIVV
GDFDADGATSTALSVLAMRSLGCSNIDYLVPNRFEDGYGLSPEVVDQAHARGAQLI
VTVDNGISSHAGVEHARSLGIPVIVTDHHLPGETLPAAEAIINPNLRDCNFPSKSLAG
VGVAFYLMLALRTFLRDQGWFDERGIAIPNLAELLDLVALGTVADVVPLDANNRIL
TWQGMSRIRAGKCRPGIKALLEVANRDAQKLAASDLGFALGPRLNAAGRLDDMSV
GVALLLCDNIGEARVLANELDALNQTRKEIEQGMQVEALTLCEKLERSRDTLPGGL
AMYHPEWHQGVVGILASRIKERFHRPVIAFAPAGDGTLKGSGRSIQGLHMRDALER
LDTLYPGMILKFGGHAMAAGLSLEEDKFELFQQRFGELVTEWLDPSLLQGEVVSDG
PLSPAEMTMEVAQLLRDAGPWGQMFPEPLFDGHFRLLQQRLVGERHLKVMVEPVG
GGPLLDGIAFNVDTALWPDNGVREVQLAYKLDINEFRGNRSLQIIIDNIWPIGSEFEL
LIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFEHR
LEESELVEEDKKHERHPIEGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLI
YLALAHMIKERGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDA
KAILSARLSKSRRLENLIAQLPGEKKNGLEGNLIALSLGLTPNEKSNFDLAEDAK
LQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLS
ASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEE
FYKFIKPILEKMDGTEELLVKLNREDLLRKQRTEDNGSIPHQIHLGELHAILRR
QEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFE
EVVDKGASAQSFIERMTNEDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTE
GMRKPAELSGEQKKAIVDLLEKTNRKVTVKQLKEDYFKKIECEDSVEISGVED
RFNASLGTYHDLLKIIKDKDELDNEENEDILEDIVLTLTLFEDREMIEERLKTYA
HLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRN
FMQLIHDDSLTEKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDE
LVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEH
PVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSI
DNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKEDNLTKAE
RGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITL
KSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYG
DYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIET
NGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDK
LIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMER
SSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNE
LALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKR
VILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDR
KRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDAAALDLEKRPAATKKAGQA
CACAAAACCACTCTTCCTGTTACGGAAAGCGAAAAAATCATCCGGTGAACCTGA
CGTCGTCCTGTGGGCAAGCAACGATTTTGAATCGACCTGTGCCACTCTGGACTA
CCTGATCGTTAAGTCAGGTAAAAAACTGAGCAGCTATTTTAAAGCTGTTGCCAC
GAATTTTCCTGTCGTTAATGACCTGCCCGCTGAAGGTGAGATCGATTTTACCTGG
AGTGAACGCTATCAACTCAGCAAAGACTCCATGACATGGGAACTAAAACCGGG
AGCAGCACCAGACAACGCTCACTATCAAGGCAATACCAACGTCAACGGCGAAG
ACATGACTGAGATTGAGGAGAATATGCTACTCCCAATTTCTGGCCAGGAACTGC
CCATTCGTTGGCTTGCTCAACACGGCAGCGAAAAACCGGTAACGCACGTTTCAC
GCGACGGACTCCAGGCATTACACATTGCTCGGGCTGAAGAACTACCGGCTGTTA
CTGCCCTGGCTGTTTCCCACAAAACCAGCCTGCTCGACCCGCTGGAAATTCGCG
AACTCCACAAACTGGTTCGTGACACTGACAAAGTTTTCCCTAATCCTGGTAATTC
AAACCTGGGACTGATAACTGCTTTTTTCGAAGCATACCTGAACGCTGACTACAC
CGATCGAGGACTGCTGACAAAAGAGTGGATGAAGGGTAATCGTGTTTCACACAT
CACTCGCACGGCTTCCGGTGCTAATGCTGGCGGCGGAAACCTCACCGATCGCGG
CGAAGGTTTCGTACACGATCTGACGTCACTGGCGCGCGACGTAGCCACTGGCGT
ACTGGCCCGTTCAATGGATCTGGACATCTATAACCTTCATCCGGCACACGCTAA
ACGCATTGAGGAAATTATCGCTGAAAATAAACCGCCCTTTTCTGTTTTCCGCGAC
AAATTCATCACCATGCCTGGCGGGCTGGATTATTCCCGCGCCATCGTGGTTGCGT
CCGTAAAAGAAGCACCAATTGGGATCGAGGTCATCCCCGCGCACGTCACTGAAT
ATCTGAACAAAGTACTGACTGAAACCGATCATGCCAACCCTGATCCGGAAATCG
TGGATATTGCCTGCGGTCGCTCCTCTGCCCCGATGCCGCAGCGAGTAACAGAAG
AAGGAAAACAGGATGATGAAGAAAAACCGCAACCATCTGGAACAACGGCAGTT
GAACAGGGAGAGGCTGAAACAATGGAACCGGACGCAACTGAACATCATCAGGA
CACGCAGCCGCTGGATGCTCAGTCACAGGTAAATTCTGTTGATGCGAAATATCA
GGAACTGCGGGCAGAACTCCATGAAGCCCGGAAAAACATTCCATCAAAAAATC
CTGTCGATGACGATAAATTGCTTGCTGCATCACGTGGTGAATTTGTTGACGGAA
TTAGCGACCCGAACGATCCGAAATGGGTAAAGGGGATCCAGACTCGCGATTGT
GTGTACCAGAACCAGCCAGAAACGGAAAAAACCAGCCCAGATATGAATCAACC
TGAGCCAGTAGTGCAACAGGAACCGGAAATAGCCTGCAATGCCTGCGGCCAGA
CTGGCGGGGATAACTGCCCTGACTGTGGTGCGGTGATGGGCGACGCAACATACC
AGGAAACATTCGATGAAGAGAGTCAGGTTGAAGCTAAGGAAAATGATCCGGAG
GAAATGGAAGGCGCTGAACATCCGCACAATGAGAATGCTGGCAGCGATCCGCA
TCGCGATTGCAGTGATGAAACTGGCGAAGTCGCAGATCCCGTAATCGTAGAAGA
CATAGAGCCAGGTATTTATTACGGAATTTCGAATGAGAATTACCACGCGGGTCC
CGGTATCAGTAAGTCTCAGCTCGATGACATTGCTGATACTCCGGCACTATATTTG
TGGCGTAAAAATGCCCCCGTGGACACCACAAAGACAAAAACGCTCGATTTAGG
AACTGCTTTCCACTGCCGGGTACTTGAACCGGAAGAATTCAGTAACCGCTTTAT
CGTAGCACCTGAATTTAACCGCCGTACAAACGCCGGAAAAGAAGAAGAGAAAG
CGTTTCTGATGGAATGCGCAAGCACAGGAAAAACGGTTATCACTGCGGAAGAA
GGCCGGAAAATTGAACTCATGTATCAAAGCGTTATGGCTTTGCCGCTGGGGCAA
TGGCTTGTTGAAAGCGCCGGACACGCTGAATCATCAATTTACTGGGAAGATCCT
GAAACAGGAATTTTGTGTCGGTGCCGTCCGGACAAAATTATCCCTGAATTTCAC
TGGATCATGGACGTGAAAACTACGGCGGATATTCAACGATTCAAAACCGCTTAT
TACGACTACCGCTATCACGTTCAGGATGCATTCTACAGTGACGGTTATGAAGCA
CAGTTTGGAGTGCAGCCAACTTTCGTTTTTCTGGTTGCCAGCACAACTATTGAAT
GCGGACGTTATCCGGTTGAAATTTTCATGATGGGCGAAGAAGCAAAACTGGCAG
GTCAACAGGAATATCACCGCAATCTGCGAACCCTGTCTGACTGCCTGAATACCG
ATGAATGGCCAGCTATTAAGACATTATCACTGCCCCGCTGGGCTAAGGAATATG
CAAATGACGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCATGGAC
AAGAAGTACAGCATCGGCCTGGACATCGGTACCAACAGCGTGGGCTGGGC
CGTGATCACCGACGAGTACAAGGTGCCCAGCAAGAAGTTCAAGGTGCTGG
GCAACACCGACCGCCACAGCATCAAGAAGAACCTGATCGGCGCCCTGCTGT
TCGACAGCGGCGAGACCGCCGAGGCCACCCGCCTGAAGCGCACCGCCCGC
CGCCGCTACACCCGCCGCAAGAACCGCATCTGCTACCTGCAGGAGATCTTC
AGCAACGAGATGGCCAAGGTGGACGACAGCTTCTTCCACCGCCTGGAGGA
GAGCTTCCTGGTGGAGGAGGACAAGAAGCACGAGCGCCACCCCATCTTCG
GCAACATCGTGGACGAGGTGGCCTACCACGAGAAGTACCCCACCATCTACC
ACCTGCGCAAGAAGCTGGTGGACAGCACCGACAAGGCCGACCTGCGCCTG
ATCTACCTGGCCCTGGCCCACATGATCAAGTTCCGCGGCCACTTCCTGATC
GAGGGCGACCTGAACCCCGACAACAGCGACGTGGACAAGCTGTTCATCCA
GCTGGTGCAGACCTACAACCAGCTGTTCGAGGAGAACCCCATCAACGCCAG
CGGCGTGGACGCCAAGGCCATCCTGAGCGCCCGCCTGAGCAAGAGCCGCC
GCCTGGAGAACCTGATCGCCCAGCTGCCCGGCGAGAAGAAGAACGGCCTG
TTCGGCAACCTGATCGCCCTGAGCCTGGGCCTGACCCCCAACTTCAAGAGC
AACTTCGACCTGGCCGAGGACGCCAAGCTGCAGCTGAGCAAGGACACCTA
CGACGACGACCTGGACAACCTGCTGGCCCAGATCGGCGACCAGTACGCCG
ACCTGTTCCTGGCCGCCAAGAACCTGAGCGACGCCATCCTGCTGAGCGACA
TCCTGCGCGTGAACACCGAGATCACCAAGGCCCCCCTGAGCGCCAGCATG
ATCAAGCGCTACGACGAGCACCACCAGGACCTGACCCTGCTGAAGGCCCT
GGTGCGCCAGCAGCTGCCCGAGAAGTACAAGGAGATCTTCTTCGACCAGA
GCAAGAACGGCTACGCCGGCTACATCGACGGCGGCGCCAGCCAGGAGGAG
TTCTACAAGTTCATCAAGCCCATCCTGGAGAAGATGGACGGCACCGAGGAG
CTGCTGGTGAAGCTGAACCGCGAGGACCTGCTGCGCAAGCAGCGCACCTT
CGACAACGGCAGCATCCCCCACCAGATCCACCTGGGCGAGCTGCACGCCA
TCCTGCGCCGCCAGGAGGACTTCTACCCCTTCCTGAAGGACAACCGCGAGA
AGATCGAGAAGATCCTGACCTTCCGCATCCCCTACTACGTGGGCCCCCTGG
CCCGCGGCAACAGCCGCTTCGCCTGGATGACCCGCAAGAGCGAGGAGACC
ATCACCCCCTGGAACTTCGAGGAGGTGGTGGACAAGGGCGCCAGCGCCCA
GAGCTTCATCGAGCGCATGACCAACTTCGACAAGAACCTGCCCAACGAGAA
GGTGCTGCCCAAGCACAGCCTGCTGTACGAGTACTTCACCGTGTACAACGA
GCTGACCAAGGTGAAGTACGTGACCGAGGGCATGCGCAAGCCCGCCTTCC
TGAGCGGCGAGCAGAAGAAGGCCATCGTGGACCTGCTGTTCAAGACCAAC
CGCAAGGTGACCGTGAAGCAGCTGAAGGAGGACTACTTCAAGAAGATCGA
GTGCTTCGACAGCGTGGAGATCAGCGGCGTGGAGGACCGCTTCAACGCCA
GCCTGGGCACCTACCACGACCTGCTGAAGATCATCAAGGACAAGGACTTCC
TGGACAACGAGGAGAACGAGGACATCCTGGAGGACATCGTGCTGACCCTG
ACCCTGTTCGAGGACCGCGAGATGATCGAGGAGCGCCTGAAGACCTACGC
CCACCTGTTCGACGACAAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACA
CCGGCTGGGGCCGCCTGAGCCGCAAGCTTATCAACGGCATCCGCGACAAG
CAGAGCGGCAAGACCATCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAA
CCGCAACTTCATGCAGCTGATCCACGACGACAGCCTGACCTTCAAGGAGGA
CATCCAGAAGGCCCAGGTGAGCGGCCAGGGCGACAGCCTGCACGAGCACA
TCGCCAACCTGGCCGGCAGCCCCGCCATCAAGAAGGGCATCCTGCAGACC
GTGAAGGTGGTGGACGAGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGA
GAACATCGTGATCGAGATGGCCCGCGAGAACCAGACCACCCAGAAGGGCC
AGAAGAACAGCCGCGAGCGCATGAAGCGCATCGAGGAGGGCATCAAGGAG
CTGGGCAGCCAGATCCTGAAGGAGCACCCCGTGGAGAACACCCAGCTGCA
GAACGAGAAGCTGTACCTGTACTACCTGCAGAACGGCCGCGACATGTACGT
GGACCAGGAGCTGGACATCAACCGCCTGAGCGACTACGACGTGGACCACA
TCGTGCCCCAGAGCTTCCTGAAGGACGACAGCATCGACAACAAGGTGCTGA
CCCGCAGCGACAAGAACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAG
GTGGTGAAGAAGATGAAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCT
GATCACCCAGCGCAAGTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCC
TGAGCGAGCTGGACAAGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACC
CGCCAGATCACCAAGCACGTGGCCCAGATCCTGGACAGCCGCATGAACAC
CAAGTACGACGAGAACGACAAGCTGATCCGCGAGGTGAAGGTGATCACCC
TGAAGAGCAAGCTGGTGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGG
TGCGCGAGATCAACAACTACCACCACGCCCACGACGCCTACCTGAACGCCG
TGGTGGGCACCGCCCTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTC
GTGTACGGCGACTACAAGGTGTACGACGTGCGCAAGATGATCGCCAAGAG
CGAGCAGGAGATCGGCAAGGCCACCGCCAAGTACTTCTTCTACAGCAACAT
CATGAACTTCTTCAAGACCGAGATCACCCTGGCCAACGGCGAGATCCGCAA
GCGCCCCCTGATCGAGACCAACGGCGAGACCGGCGAGATCGTGTGGGACA
AGGGCCGCGACTTCGCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTG
AACATCGTGAAGAAGACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAG
CATCCTGCCCAAGCGCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACT
GGGACCCCAAGAAGTACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGC
GTGCTGGTGGTGGCCAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAG
CGTGAAGGAGCTGCTGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGA
AGAACCCCATCGACTTCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAG
GACCTGATCATCAAGCTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGC
CGCAAGCGCATGCTGGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCT
GGCCCTGCCCAGCAAGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGA
GAAGCTGAAGGGCAGCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGG
AGCAGCACAAGCACTACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCA
GCAAGCGCGTGATCCTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCC
TACAACAAGCACCGCGACAAGCCCATCCGCGAGCAGGCCGAGAACATCAT
CCACCTGTTCACCCTGACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTT
CGACACCACCATCGACCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGG
ACGCCACCCTGATCCACCAGAGCATCACCGGTCTGTACGAGACCCGCATCG
ACCTGAGCCAGCTGGGCGGCGACGCGGCCGCACTCGACCTCGAGAAAAGGCC
VVLWASNDFESTCATLDYLIVKSGKKLSSYFKAVATNFPVVNDLPAEGEIDFTWSE
RYQLSKDSMTWELKPGAAPDNAHYQGNTNVNGEDMTEIEENMLLPISGQELPIRW
LAQHGSEKPVTHVSRDGLQALHIARAEELPAVTALAVSHKTSLLDPLEIRELHKLVR
DTDKVFPNPGNSNLGLITAFFEAYLNADYTDRGLLTKEWMKGNRVSHITRTASGAN
AGGGNLTDRGEGFVHDLTSLARDVATGVLARSMDLDIYNLHPAHAKRIEEIIAENK
PPFSVFRDKFITMPGGLDYSRAIVVASVKEAPIGIEVIPAHVTEYLNKVLTETDHANP
DPEIVDIACGRSSAPMPQRVTEEGKQDDEEKPQPSGTTAVEQGEAETMEPDATEHH
QDTQPLDAQSQVNSVDAKYQELRAELHEARKNIPSKNPVDDDKLLAASRGEFVDGI
SDPNDPKWVKGIQTRDCVYQNQPETEKTSPDMNQPEPVVQQEPEIACNACGQTGG
DNCPDCGAVMGDATYQETFDEESQVEAKENDPEEMEGAEHPHNENAGSDPHRDCS
DETGEVADPVIVEDIEPGIYYGISNENYHAGPGISKSQLDDIADTPALYLWRKNAPV
DTTKTKTLDLGTAFHCRVLEPEEFSNRFIVAPEFNRRTNAGKEEEKAFLMECASTGK
TVITAEEGRKIELMYQSVMALPLGQWLVESAGHAESSIYWEDPETGILCRCRPDKIIP
EFHWIMDVKTTADIQRFKTAYYDYRYHVQDAFYSDGYEAQFGVQPTFVFLVASTTI
ECGRYPVEIFMMGEEAKLAGQQEYHRNLRTLSDCLNTDEWPAIKTLSLPRWAKEY
ANDGSEFELRRQACGRMDKKYSIGLDIGTNSVGWAVITDEYKVPSKKFKVLGNT
DRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAK
VDDSPIIIRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDST
DKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENP
INASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTPNFKSN
FDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVN
TEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYI
DGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHLG
ELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEE
TITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKIISLLYEYFTVYNELT
KVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSV
EISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIE
ERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKS
DGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQ
TVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKEL
GSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQ
SFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKF
DNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLI
REVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPK
LESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNPIRTEITLANGEI
RKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGPSKESI
LPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKE
LLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASA
GELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEII
EQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFK
YFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDAAALDLEKRPAA
AAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGT
GATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACA
TACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCAT
GGCCAACACTTGTCACTACTTTCTCTTATGGTGTTCAATGCTTTTCAAGATACCC
AGATCATATGAAGCGGCACGACTTCTTCAAGAGCGCCATGCCTGAGGGATACGT
GCAGGAGAGGACCATCTCTTTCAAGGACGACGGGAACTACAAGACACGTGCTG
AAGTCAAGTTTGAGGGAGACACCCTCGTCAACAGGATCGAGCTTAAGGGAATC
GATTTCAAGGAGGACGGAAACATCCTCGGCCACAAGTTGGAATACAACTACAA
CTCCCACAACGTATACATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTA
ACTTCAAAATTAGACACAACATTGAAGATGGAAGCGTTCAACTAGCAGACCATT
ATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATT
ACCTGTCCACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACA
TGGTCCTTCTTGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACT
ATACAAAGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCATGGACA
AGAAGTACAGCATCGGCCTGGACATCGGTACCAACAGCGTGGGCTGGGCC
GTGATCACCGACGAGTACAAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGG
CAACACCGACCGCCACAGCATCAAGAAGAACCTGATCGGCGCCCTGCTGTT
CGACAGCGGCGAGACCGCCGAGGCCACCCGCCTGAAGCGCACCGCCCGCC
GCCGCTACACCCGCCGCAAGAACCGCATCTGCTACCTGCAGGAGATCTTCA
GCAACGAGATGGCCAAGGTGGACGACAGCTTCTTCCACCGCCTGGAGGAG
AGCTTCCTGGTGGAGGAGGACAAGAAGCACGAGCGCCACCCCATCTTCGG
CAACATCGTGGACGAGGTGGCCTACCACGAGAAGTACCCCACCATCTACCA
CCTGCGCAAGAAGCTGGTGGACAGCACCGACAAGGCCGACCTGCGCCTGA
TCTACCTGGCCCTGGCCCACATGATCAAGTTCCGCGGCCACTTCCTGATCG
AGGGCGACCTGAACCCCGACAACAGCGACGTGGACAAGCTGTTCATCCAG
CTGGTGCAGACCTACAACCAGCTGTTCGAGGAGAACCCCATCAACGCCAGC
GGCGTGGACGCCAAGGCCATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCG
CCTGGAGAACCTGATCGCCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGT
TCGGCAACCTGATCGCCCTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCA
ACTTCGACCTGGCCGAGGACGCCAAGCTGCAGCTGAGCAAGGACACCTAC
GACGACGACCTGGACAACCTGCTGGCCCAGATCGGCGACCAGTACGCCGA
CCTGTTCCTGGCCGCCAAGAACCTGAGCGACGCCATCCTGCTGAGCGACAT
CCTGCGCGTGAACACCGAGATCACCAAGGCCCCCCTGAGCGCCAGCATGA
TCAAGCGCTACGACGAGCACCACCAGGACCTGACCCTGCTGAAGGCCCTG
GTGCGCCAGCAGCTGCCCGAGAAGTACAAGGAGATCTTCTTCGACCAGAG
CAAGAACGGCTACGCCGGCTACATCGACGGCGGCGCCAGCCAGGAGGAGT
TCTACAAGTTCATCAAGCCCATCCTGGAGAAGATGGACGGCACCGAGGAGC
TGCTGGTGAAGCTGAACCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTC
GACAACGGCAGCATCCCCCACCAGATCCACCTGGGCGAGCTGCACGCCAT
CCTGCGCCGCCAGGAGGACTTCTACCCCTTCCTGAAGGACAACCGCGAGAA
GATCGAGAAGATCCTGACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGC
CCGCGGCAACAGCCGCTTCGCCTGGATGACCCGCAAGAGCGAGGAGACCA
TCACCCCCTGGAACTTCGAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAG
AGCTTCATCGAGCGCATGACCAACTTCGACAAGAACCTGCCCAACGAGAAG
GTGCTGCCCAAGCACAGCCTGCTGTACGAGTACTTCACCGTGTACAACGAG
CTGACCAAGGTGAAGTACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCT
GAGCGGCGAGCAGAAGAAGGCCATCGTGGACCTGCTGTTCAAGACCAACC
GCAAGGTGACCGTGAAGCAGCTGAAGGAGGACTACTTCAAGAAGATCGAG
TGCTTCGACAGCGTGGAGATCAGCGGCGTGGAGGACCGCTTCAACGCCAG
CCTGGGCACCTACCACGACCTGCTGAAGATCATCAAGGACAAGGACTTCCT
GGACAACGAGGAGAACGAGGACATCCTGGAGGACATCGTGCTGACCCTGA
CCCTGTTCGAGGACCGCGAGATGATCGAGGAGCGCCTGAAGACCTACGCC
CACCTGTTCGACGACAAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACAC
CGGCTGGGGCCGCCTGAGCCGCAAGCTTATCAACGGCATCCGCGACAAGC
AGAGCGGCAAGACCATCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAAC
CGCAACTTCATGCAGCTGATCCACGACGACAGCCTGACCTTCAAGGAGGAC
ATCCAGAAGGCCCAGGTGAGCGGCCAGGGCGACAGCCTGCACGAGCACAT
CGCCAACCTGGCCGGCAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCG
TGAAGGTGGTGGACGAGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAG
AACATCGTGATCGAGATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCA
GAAGAACAGCCGCGAGCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGC
TGGGCAGCCAGATCCTGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAG
AACGAGAAGCTGTACCTGTACTACCTGCAGAACGGCCGCGACATGTACGTG
GACCAGGAGCTGGACATCAACCGCCTGAGCGACTACGACGTGGACCACAT
CGTGCCCCAGAGCTTCCTGAAGGACGACAGCATCGACAACAAGGTGCTGA
CCCGCAGCGACAAGAACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAG
GTGGTGAAGAAGATGAAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCT
GATCACCCAGCGCAAGTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCC
TGAGCGAGCTGGACAAGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACC
CGCCAGATCACCAAGCACGTGGCCCAGATCCTGGACAGCCGCATGAACAC
CAAGTACGACGAGAACGACAAGCTGATCCGCGAGGTGAAGGTGATCACCC
TGAAGAGCAAGCTGGTGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGG
TGCGCGAGATCAACAACTACCACCACGCCCACGACGCCTACCTGAACGCCG
TGGTGGGCACCGCCCTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTC
GTGTACGGCGACTACAAGGTGTACGACGTGCGCAAGATGATCGCCAAGAG
CGAGCAGGAGATCGGCAAGGCCACCGCCAAGTACTTCTTCTACAGCAACAT
CATGAACTTCTTCAAGACCGAGATCACCCTGGCCAACGGCGAGATCCGCAA
GCGCCCCCTGATCGAGACCAACGGCGAGACCGGCGAGATCGTGTGGGACA
AGGGCCGCGACTTCGCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTG
AACATCGTGAAGAAGACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAG
CATCCTGCCCAAGCGCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACT
GGGACCCCAAGAAGTACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGC
GTGCTGGTGGTGGCCAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAG
CGTGAAGGAGCTGCTGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGA
AGAACCCCATCGACTTCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAG
GACCTGATCATCAAGCTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGC
CGCAAGCGCATGCTGGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCT
GGCCCTGCCCAGCAAGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGA
GAAGCTGAAGGGCAGCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGG
AGCAGCACAAGCACTACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCA
GCAAGCGCGTGATCCTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCC
TACAACAAGCACCGCGACAAGCCCATCCGCGAGCAGGCCGAGAACATCAT
CCACCTGTTCACCCTGACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTT
CGACACCACCATCGACCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGG
ACGCCACCCTGATCCACCAGAGCATCACCGGTCTGTACGAGACCCGCATCG
ACCTGAGCCAGCTGGGCGGCGACGCGGCCGCACTCGACCTCGAGAAAAGGCC
DVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFSRYPD
HMKRHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKE
DGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGSVQLADHYQQNTPI
GDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYKGSEFEL
LIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFEHR
LEESELVEEDKKHERHPIEGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLI
YLALAHMIKERGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDA
KAILSARLSKSRRLENLIAQLPGEKKNGLEGNLIALSLGLTPNEKSNFDLAEDAK
LQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLS
ASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEE
FYKFIKPILEKMDGTEELLVKLNREDLLRKQRTEDNGSIPHQIHLGELHAILRR
QEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFE
EVVDKGASAQSFIERMTNEDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTE
GMRKPAELSGEQKKAIVDLLEKTNRKVTVKQLKEDYFKKIECEDSVEISGVED
RFNASLGTYHDLLKIIKDKDELDNEENEDILEDIVLTLTLFEDREMIEERLKTYA
HLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRN
FMQLIHDDSLTEKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDE
LVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEH
PVENTQLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSI
DNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKEDNLTKAE
RGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITL
KSKLVSDERKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYG
DYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFEKTEITLANGEIRKRPLIET
NGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDK
LIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMER
SSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNE
LALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKR
VILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDR
KRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDAAALDLEKRPAATKKAGQA
AGCAGAGGCGTAAACAAGGTTATTCTCGTTGGTAATCTGGGTCAGGACCCGGAA
GTACGCTACATGCCAAATGGTGGCGCAGTTGCCAACATTACGCTGGCTACTTCC
GAATCCTGGCGTGATAAAGCGACCGGCGAGATGAAAGAACAGACTGAATGGCA
CCGCGTTGTGCTGTTCGGCAAACTGGCAGAAGTGGCGAGCGAATATCTGCGTAA
AGGTTCTCAGGTTTATATCGAAGGTCAGCTGCGTACCCGTAAATGGACCGATCA
ATCCGGTCAGGATCGCTACACCACAGAAGTCGTGGTGAACGTTGGCGGCACCAT
GCAGATGCTGGGTGGTCGTGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGG
GGGCTGGGCCGTGATCACCGACGAGTACAAGGTGCCCAGCAAGAAGTTCA
AGGTGCTGGGCAACACCGACCGCCACAGCATCAAGAAGAACCTGATCGGC
GCCCTGCTGTTCGACAGCGGCGAGACCGCCGAGGCCACCCGCCTGAAGCG
CACCGCCCGCCGCCGCTACACCCGCCGCAAGAACCGCATCTGCTACCTGCA
GGAGATCTTCAGCAACGAGATGGCCAAGGTGGACGACAGCTTCTTCCACCG
CCTGGAGGAGAGCTTCCTGGTGGAGGAGGACAAGAAGCACGAGCGCCACC
CCATCTTCGGCAACATCGTGGACGAGGTGGCCTACCACGAGAAGTACCCCA
CCATCTACCACCTGCGCAAGAAGCTGGTGGACAGCACCGACAAGGCCGAC
CTGCGCCTGATCTACCTGGCCCTGGCCCACATGATCAAGTTCCGCGGCCAC
TTCCTGATCGAGGGCGACCTGAACCCCGACAACAGCGACGTGGACAAGCT
GTTCATCCAGCTGGTGCAGACCTACAACCAGCTGTTCGAGGAGAACCCCAT
CAACGCCAGCGGCGTGGACGCCAAGGCCATCCTGAGCGCCCGCCTGAGCA
AGAGCCGCCGCCTGGAGAACCTGATCGCCCAGCTGCCCGGCGAGAAGAAG
AACGGCCTGTTCGGCAACCTGATCGCCCTGAGCCTGGGCCTGACCCCCAAC
TTCAAGAGCAACTTCGACCTGGCCGAGGACGCCAAGCTGCAGCTGAGCAA
GGACACCTACGACGACGACCTGGACAACCTGCTGGCCCAGATCGGCGACC
AGTACGCCGACCTGTTCCTGGCCGCCAAGAACCTGAGCGACGCCATCCTGC
TGAGCGACATCCTGCGCGTGAACACCGAGATCACCAAGGCCCCCCTGAGC
GCCAGCATGATCAAGCGCTACGACGAGCACCACCAGGACCTGACCCTGCT
GAAGGCCCTGGTGCGCCAGCAGCTGCCCGAGAAGTACAAGGAGATCTTCT
TCGACCAGAGCAAGAACGGCTACGCCGGCTACATCGACGGCGGCGCCAGC
CAGGAGGAGTTCTACAAGTTCATCAAGCCCATCCTGGAGAAGATGGACGGC
ACCGAGGAGCTGCTGGTGAAGCTGAACCGCGAGGACCTGCTGCGCAAGCA
GCGCACCTTCGACAACGGCAGCATCCCCCACCAGATCCACCTGGGCGAGCT
GCACGCCATCCTGCGCCGCCAGGAGGACTTCTACCCCTTCCTGAAGGACAA
CCGCGAGAAGATCGAGAAGATCCTGACCTTCCGCATCCCCTACTACGTGGG
CCCCCTGGCCCGCGGCAACAGCCGCTTCGCCTGGATGACCCGCAAGAGCG
AGGAGACCATCACCCCCTGGAACTTCGAGGAGGTGGTGGACAAGGGCGCC
AGCGCCCAGAGCTTCATCGAGCGCATGACCAACTTCGACAAGAACCTGCCC
AACGAGAAGGTGCTGCCCAAGCACAGCCTGCTGTACGAGTACTTCACCGTG
TACAACGAGCTGACCAAGGTGAAGTACGTGACCGAGGGCATGCGCAAGCC
CGCCTTCCTGAGCGGCGAGCAGAAGAAGGCCATCGTGGACCTGCTGTTCA
AGACCAACCGCAAGGTGACCGTGAAGCAGCTGAAGGAGGACTACTTCAAG
AAGATCGAGTGCTTCGACAGCGTGGAGATCAGCGGCGTGGAGGACCGCTT
CAACGCCAGCCTGGGCACCTACCACGACCTGCTGAAGATCATCAAGGACAA
GGACTTCCTGGACAACGAGGAGAACGAGGACATCCTGGAGGACATCGTGC
TGACCCTGACCCTGTTCGAGGACCGCGAGATGATCGAGGAGCGCCTGAAG
ACCTACGCCCACCTGTTCGACGACAAGGTGATGAAGCAGCTGAAGCGCCG
CCGCTACACCGGCTGGGGCCGCCTGAGCCGCAAGCTTATCAACGGCATCC
GCGACAAGCAGAGCGGCAAGACCATCCTGGACTTCCTGAAGAGCGACGGC
TTCGCCAACCGCAACTTCATGCAGCTGATCCACGACGACAGCCTGACCTTC
AAGGAGGACATCCAGAAGGCCCAGGTGAGCGGCCAGGGCGACAGCCTGCA
CGAGCACATCGCCAACCTGGCCGGCAGCCCCGCCATCAAGAAGGGCATCC
TGCAGACCGTGAAGGTGGTGGACGAGCTGGTGAAGGTGATGGGCCGCCAC
AAGCCCGAGAACATCGTGATCGAGATGGCCCGCGAGAACCAGACCACCCA
GAAGGGCCAGAAGAACAGCCGCGAGCGCATGAAGCGCATCGAGGAGGGCA
TCAAGGAGCTGGGCAGCCAGATCCTGAAGGAGCACCCCGTGGAGAACACC
CAGCTGCAGAACGAGAAGCTGTACCTGTACTACCTGCAGAACGGCCGCGA
CATGTACGTGGACCAGGAGCTGGACATCAACCGCCTGAGCGACTACGACG
TGGACCACATCGTGCCCCAGAGCTTCCTGAAGGACGACAGCATCGACAACA
AGGTGCTGACCCGCAGCGACAAGAACCGCGGCAAGAGCGACAACGTGCCC
AGCGAGGAGGTGGTGAAGAAGATGAAGAACTACTGGCGCCAGCTGCTGAA
CGCCAAGCTGATCACCCAGCGCAAGTTCGACAACCTGACCAAGGCCGAGC
GCGGCGGCCTGAGCGAGCTGGACAAGGCCGGCTTCATCAAGCGCCAGCTG
GTGGAGACCCGCCAGATCACCAAGCACGTGGCCCAGATCCTGGACAGCCG
CATGAACACCAAGTACGACGAGAACGACAAGCTGATCCGCGAGGTGAAGG
TGATCACCCTGAAGAGCAAGCTGGTGAGCGACTTCCGCAAGGACTTCCAGT
TCTACAAGGTGCGCGAGATCAACAACTACCACCACGCCCACGACGCCTACC
TGAACGCCGTGGTGGGCACCGCCCTGATCAAGAAGTACCCCAAGCTGGAG
AGCGAGTTCGTGTACGGCGACTACAAGGTGTACGACGTGCGCAAGATGAT
CGCCAAGAGCGAGCAGGAGATCGGCAAGGCCACCGCCAAGTACTTCTTCT
ACAGCAACATCATGAACTTCTTCAAGACCGAGATCACCCTGGCCAACGGCG
AGATCCGCAAGCGCCCCCTGATCGAGACCAACGGCGAGACCGGCGAGATC
GTGTGGGACAAGGGCCGCGACTTCGCCACCGTGCGCAAGGTGCTGAGCAT
GCCCCAGGTGAACATCGTGAAGAAGACCGAGGTGCAGACCGGCGGCTTCA
GCAAGGAGAGCATCCTGCCCAAGCGCAACAGCGACAAGCTGATCGCCCGC
AAGAAGGACTGGGACCCCAAGAAGTACGGCGGCTTCGACAGCCCCACCGT
GGCCTACAGCGTGCTGGTGGTGGCCAAGGTGGAGAAGGGCAAGAGCAAGA
AGCTGAAGAGCGTGAAGGAGCTGCTGGGCATCACCATCATGGAGCGCAGC
AGCTTCGAGAAGAACCCCATCGACTTCCTGGAGGCCAAGGGCTACAAGGA
GGTGAAGAAGGACCTGATCATCAAGCTGCCCAAGTACAGCCTGTTCGAGCT
GGAGAACGGCCGCAAGCGCATGCTGGCCAGCGCCGGCGAGCTGCAGAAGG
GCAACGAGCTGGCCCTGCCCAGCAAGTACGTGAACTTCCTGTACCTGGCCA
GCCACTACGAGAAGCTGAAGGGCAGCCCCGAGGACAACGAGCAGAAGCAG
CTGTTCGTGGAGCAGCACAAGCACTACCTGGACGAGATCATCGAGCAGATC
AGCGAGTTCAGCAAGCGCGTGATCCTGGCCGACGCCAACCTGGACAAGGT
GCTGAGCGCCTACAACAAGCACCGCGACAAGCCCATCCGCGAGCAGGCCG
AGAACATCATCCACCTGTTCACCCTGACCAACCTGGGCGCCCCCGCCGCCT
TCAAGTACTTCGACACCACCATCGACCGCAAGCGCTACACCAGCACCAAGG
AGGTGCTGGACGCCACCCTGATCCACCAGAGCATCACCGGTCTGTACGAGA
CCCGCATCGACCTGAGCCAGCTGGGCGGCGACGCGGCCGCACTCGACCTCG
VRYMMPNGGAVANITLATSESWRDKATGEKEQTEWHRVVLFGKLAEVASEYLRK
GSQVYIEGQLRTRKWTDQSGQDRYTTEVVVNVGGTMQMLGGRGSEFELRRQACG
DSGETAEATREKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFEHRLEESELV
EEDKKHERHPIEGNIVDEVAYHEKYPTIYHIRKKLVDSTDKADIRLIYEALAH
MIKERGHFLIEGDENPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSAR
LSKSRRLENLIAQLPGEKKNGLEGNLIALSEGLTPNEKSNFDLAEDAKLQLSKD
TYDDDLDNELAQIGDQYADEFLAAKNESDAILLSDILRVNTEITKAPLSASMIKR
YDEHHQDLTELKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIK
PILEKMDGTEELLVKLNREDLERKQRTEDNGSIPHQIHLGELHAILRRQEDFYP
FLKDNREKIEKILTFRIPYWGPLARGNSRFAWMTRKSEETITPWNFEEVVDKG
ASAQSFIERMTNEDKNITNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPA
FLSGEQKKAIVDLLEKTNRKVTVKQLKEDYFKKIECEDSVEISGVEDRFNASEG
TYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDK
VMKQEKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIH
DDSLTEKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVM
GRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENT
QLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVL
TRSDKNRCKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLS
ELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLV
SDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVY
DVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGE
IVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKK
DWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKN
PIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSK
YVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADA
NLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTST
KEYLDATLIHQSITGLYETRIDLSQLGGDAAALDLEKRPAATKKAGQAKKKKHH
AGCAGAGGCGTAAACAAGGTTATTCTCGTTGGTAATCTGGGTCAGGACCCGGAA
GTACGCTACATGCCAAATGGTGGCGCAGTTGCCAACATTACGCTGGCTACTTCC
GAATCCTGGCGTGATAAAGCGACCGGCGAGATGAAAGAACAGACTGAATGGCA
CCGCGTTGTGCTGTTCGGCAAACTGGCAGAAGTGGCGAGCGAATATCTGCGTAA
AGGTTCTCAGGTTTATATCGAAGGTCAGCTGCGTACCCGTAAATGGACCGATCA
ATCCGGTCAGGATCGCTACACCACAGAAGTCGTGGTGAACGTTGGCGGCACCAT
GCAGATGCTGGGTGGTCGTGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGG
GGGCTGGGCCGTGATCACCGACGAGTACAAGGTGCCCAGCAAGAAGTTCA
AGGTGCTGGGCAACACCGACCGCCACAGCATCAAGAAGAACCTGATCGGC
GCCCTGCTGTTCGACAGCGGCGAGACCGCCGAGGCCACCCGCCTGAAGCG
CACCGCCCGCCGCCGCTACACCCGCCGCAAGAACCGCATCTGCTACCTGCA
GGAGATCTTCAGCAACGAGATGGCCAAGGTGGACGACAGCTTCTTCCACCG
CCTGGAGGAGAGCTTCCTGGTGGAGGAGGACAAGAAGCACGAGCGCCACC
CCATCTTCGGCAACATCGTGGACGAGGTGGCCTACCACGAGAAGTACCCCA
CCATCTACCACCTGCGCAAGAAGCTGGTGGACAGCACCGACAAGGCCGAC
CTGCGCCTGATCTACCTGGCCCTGGCCCACATGATCAAGTTCCGCGGCCAC
TTCCTGATCGAGGGCGACCTGAACCCCGACAACAGCGACGTGGACAAGCT
GTTCATCCAGCTGGTGCAGACCTACAACCAGCTGTTCGAGGAGAACCCCAT
CAACGCCAGCGGCGTGGACGCCAAGGCCATCCTGAGCGCCCGCCTGAGCA
AGAGCCGCCGCCTGGAGAACCTGATCGCCCAGCTGCCCGGCGAGAAGAAG
AACGGCCTGTTCGGCAACCTGATCGCCCTGAGCCTGGGCCTGACCCCCAAC
TTCAAGAGCAACTTCGACCTGGCCGAGGACGCCAAGCTGCAGCTGAGCAA
GGACACCTACGACGACGACCTGGACAACCTGCTGGCCCAGATCGGCGACC
AGTACGCCGACCTGTTCCTGGCCGCCAAGAACCTGAGCGACGCCATCCTGC
TGAGCGACATCCTGCGCGTGAACACCGAGATCACCAAGGCCCCCCTGAGC
GCCAGCATGATCAAGCGCTACGACGAGCACCACCAGGACCTGACCCTGCT
GAAGGCCCTGGTGCGCCAGCAGCTGCCCGAGAAGTACAAGGAGATCTTCT
TCGACCAGAGCAAGAACGGCTACGCCGGCTACATCGACGGCGGCGCCAGC
CAGGAGGAGTTCTACAAGTTCATCAAGCCCATCCTGGAGAAGATGGACGGC
ACCGAGGAGCTGCTGGTGAAGCTGAACCGCGAGGACCTGCTGCGCAAGCA
GCGCACCTTCGACAACGGCAGCATCCCCCACCAGATCCACCTGGGCGAGCT
GCACGCCATCCTGCGCCGCCAGGAGGACTTCTACCCCTTCCTGAAGGACAA
CCGCGAGAAGATCGAGAAGATCCTGACCTTCCGCATCCCCTACTACGTGGG
CCCCCTGGCCCGCGGCAACAGCCGCTTCGCCTGGATGACCCGCAAGAGCG
AGGAGACCATCACCCCCTGGAACTTCGAGGAGGTGGTGGACAAGGGCGCC
AGCGCCCAGAGCTTCATCGAGCGCATGACCAACTTCGACAAGAACCTGCCC
AACGAGAAGGTGCTGCCCAAGCACAGCCTGCTGTACGAGTACTTCACCGTG
TACAACGAGCTGACCAAGGTGAAGTACGTGACCGAGGGCATGCGCAAGCC
CGCCTTCCTGAGCGGCGAGCAGAAGAAGGCCATCGTGGACCTGCTGTTCA
AGACCAACCGCAAGGTGACCGTGAAGCAGCTGAAGGAGGACTACTTCAAG
AAGATCGAGTGCTTCGACAGCGTGGAGATCAGCGGCGTGGAGGACCGCTT
CAACGCCAGCCTGGGCACCTACCACGACCTGCTGAAGATCATCAAGGACAA
GGACTTCCTGGACAACGAGGAGAACGAGGACATCCTGGAGGACATCGTGC
TGACCCTGACCCTGTTCGAGGACCGCGAGATGATCGAGGAGCGCCTGAAG
ACCTACGCCCACCTGTTCGACGACAAGGTGATGAAGCAGCTGAAGCGCCG
CCGCTACACCGGCTGGGGCCGCCTGAGCCGCAAGCTTATCAACGGCATCC
GCGACAAGCAGAGCGGCAAGACCATCCTGGACTTCCTGAAGAGCGACGGC
TTCGCCAACCGCAACTTCATGCAGCTGATCCACGACGACAGCCTGACCTTC
AAGGAGGACATCCAGAAGGCCCAGGTGAGCGGCCAGGGCGACAGCCTGCA
CGAGCACATCGCCAACCTGGCCGGCAGCCCCGCCATCAAGAAGGGCATCC
TGCAGACCGTGAAGGTGGTGGACGAGCTGGTGAAGGTGATGGGCCGCCAC
AAGCCCGAGAACATCGTGATCGAGATGGCCCGCGAGAACCAGACCACCCA
GAAGGGCCAGAAGAACAGCCGCGAGCGCATGAAGCGCATCGAGGAGGGCA
TCAAGGAGCTGGGCAGCCAGATCCTGAAGGAGCACCCCGTGGAGAACACC
CAGCTGCAGAACGAGAAGCTGTACCTGTACTACCTGCAGAACGGCCGCGA
CATGTACGTGGACCAGGAGCTGGACATCAACCGCCTGAGCGACTACGACG
TGGACCACATCGTGCCCCAGAGCTTCCTGAAGGACGACAGCATCGACAACA
AGGTGCTGACCCGCAGCGACAAGAACCGCGGCAAGAGCGACAACGTGCCC
AGCGAGGAGGTGGTGAAGAAGATGAAGAACTACTGGCGCCAGCTGCTGAA
CGCCAAGCTGATCACCCAGCGCAAGTTCGACAACCTGACCAAGGCCGAGC
GCGGCGGCCTGAGCGAGCTGGACAAGGCCGGCTTCATCAAGCGCCAGCTG
GTGGAGACCCGCCAGATCACCAAGCACGTGGCCCAGATCCTGGACAGCCG
CATGAACACCAAGTACGACGAGAACGACAAGCTGATCCGCGAGGTGAAGG
TGATCACCCTGAAGAGCAAGCTGGTGAGCGACTTCCGCAAGGACTTCCAGT
TCTACAAGGTGCGCGAGATCAACAACTACCACCACGCCCACGACGCCTACC
TGAACGCCGTGGTGGGCACCGCCCTGATCAAGAAGTACCCCAAGCTGGAG
AGCGAGTTCGTGTACGGCGACTACAAGGTGTACGACGTGCGCAAGATGAT
CGCCAAGAGCGAGCAGGAGATCGGCAAGGCCACCGCCAAGTACTTCTTCT
ACAGCAACATCATGAACTTCTTCAAGACCGAGATCACCCTGGCCAACGGCG
AGATCCGCAAGCGCCCCCTGATCGAGACCAACGGCGAGACCGGCGAGATC
GTGTGGGACAAGGGCCGCGACTTCGCCACCGTGCGCAAGGTGCTGAGCAT
GCCCCAGGTGAACATCGTGAAGAAGACCGAGGTGCAGACCGGCGGCTTCA
GCAAGGAGAGCATCCTGCCCAAGCGCAACAGCGACAAGCTGATCGCCCGC
AAGAAGGACTGGGACCCCAAGAAGTACGGCGGCTTCGACAGCCCCACCGT
GGCCTACAGCGTGCTGGTGGTGGCCAAGGTGGAGAAGGGCAAGAGCAAGA
AGCTGAAGAGCGTGAAGGAGCTGCTGGGCATCACCATCATGGAGCGCAGC
AGCTTCGAGAAGAACCCCATCGACTTCCTGGAGGCCAAGGGCTACAAGGA
GGTGAAGAAGGACCTGATCATCAAGCTGCCCAAGTACAGCCTGTTCGAGCT
GGAGAACGGCCGCAAGCGCATGCTGGCCAGCGCCGGCGAGCTGCAGAAGG
GCAACGAGCTGGCCCTGCCCAGCAAGTACGTGAACTTCCTGTACCTGGCCA
GCCACTACGAGAAGCTGAAGGGCAGCCCCGAGGACAACGAGCAGAAGCAG
CTGTTCGTGGAGCAGCACAAGCACTACCTGGACGAGATCATCGAGCAGATC
AGCGAGTTCAGCAAGCGCGTGATCCTGGCCGACGCCAACCTGGACAAGGT
GCTGAGCGCCTACAACAAGCACCGCGACAAGCCCATCCGCGAGCAGGCCG
AGAACATCATCCACCTGTTCACCCTGACCAACCTGGGCGCCCCCGCCGCCT
TCAAGTACTTCGACACCACCATCGACCGCAAGCGCTACACCAGCACCAAGG
AGGTGCTGGACGCCACCCTGATCCACCAGAGCATCACCGGTCTGTACGAGA
CCCGCATCGACCTGAGCCAGCTGGGCGGCGACGCGGCCGCACTCGACCTGC
CCGCTGAATTGCCTCCCTTGCTGCGCCGTTTATACGCCAGCCGGGGAGTACGCAGTG
CGCAAGAACTGGAACGCAGTGTTAAAGGTATGCTGCCCTGGCAGCAACTGAGCGGC
GTCGAAAAGGCCGTTGAGATCCTTTACAACGCTTTTCGCGAAGGAACGCGGATTATTG
TGGTCGGTGATTTCGACGCCGACGGCGCGACCAGCACGGCTCTAAGCGTGCTGGCG
ATGCGCTCGCTTGGTTGCAGCAATATCGACTACCTGGTACCAAACCGTTTCGAAGACG
GTTACGGCTTAAGCCCGGAAGTGGTCGATCAGGCCCATGCCCGTGGCGCGCAGTTA
ATTGTCACGGTGGATAACGGTATTTCCTCCCATGCGGGGGTTGAGCACGCTCGCTCG
TTGGGCATCCCGGTTATTGTTACCGATCACCATTTGCCAGGCGACACATTACCCGCAG
CGGAAGCGATCATTAACCCTAACTTGCGCGACTGTAATTTCCCGTCGAAATCACTGGC
AGGCGTGGGTGTGGCGTTTTATCTGATGCTGGCGCTGCGCACCTTTTTGCGCGATCA
GGGCTGGTTTGATGAGCGTAACATCGCAATTCCTAACCTGGCAGAACTGCTGGATCT
GGTCGCGCTGGGGACAGTGGCGGACGTCGTGCCGCTGGACGCTAATAATCGCATTC
TGACCTGGCAGGGGATGAGTCGCATCCGAGCCGGAAAGTGCCGTCCGGGGATTAAA
GCGCTGCTTGAAGTGGCAAACCGTGATGCACAAAAACTCGCCGCCAGCGATTTAGGT
TTTGCGCTGGGGCCACGTCTCAATGCTGCCGGACGACTGGACGATATGTCCGTCGGT
GTGGCGCTGTTGTTGTGCGACAACATCGGCGAAGCGCGCGTGCTGGCAAATGAACT
CGATGCGCTAAACCAGACGCGAAAAGAGATCGAACAAGGAATGCAAATTGAAGCCCT
GACCCTGTGCGAGAAACTGGAGCGCAGCCGTGACACGCTACCCGGCGGGCTGGCAA
TGTATCACCCCGAATGGCATCAGGGCGTTGTCGGTATTCTGGCTTCGCGCATCAAAG
AGCGTTTTCACCGTCCGGTTATCGCGTTTGCGCCAGCAGGTGACGGTACGCTGAAAG
GTTCCGGTCGCTCCATTCAGGGGCTGCATATGCGTGATGCGCTGGAGCGATTAGACA
CACTCTACCCTGGCATGATGCTGAAGTTTGGCGGTCATGCGATGGCGGCGGGTTTGT
CGCTGGAAGAGGATAAATTCAAACTCTTTCAACAACGGTTTGGCGAACTGGTTACTGA
GTGGCTGGACCCTTCGCTATTGCAAGGCGAAGTGGTATCAGACGGTCCGTTAAGCCC
GGCCGAAATGACCATGGAAGTGGCGCAGCTGCTGCGCGATGCTGGCCCGTGGGGG
CAGATGTTCCCGGAGCCGCTGTTTGACGGTCATTTCCGTCTGCTGCAACAGCGGCTG
GTGGGCGAACGTCATTTGAAGGTGATGGTCGAACCGGTCGGCGGCGGTCCACTGCT
GGATGGTATTGCTTTTAATGTCGATACCGCCCTCTGGCCGGATAACGGCGTGCGCGA
AGTGCAACTGGCTTATAAGCTCGATATCAACGAGTTTCGCGGCAACCGCAGCCTGCA
AATTATCATCGACAATATCTGGCCAATTCTGCAGAAAAGGCCGGCGGCCACGAAAA
VRYMPNGGAVANITLATSESWRDKATGEMKEQTEWHRVVLFGKLAEVASEYLRK
GSQVYIEGQLRTRKWTDQSGQDRYTTEVVVNVGGTMQMLGGRGSEFELRRQACG
DSGETAEATRIKRTARRRYTRRKNRICYLQEIFSNEMAKVDDSFEHRLEESELV
EEDKKHERHPIEGNIVDEVAYHEKYPTIYHIRKKLVDSTDKADLRLIYLALAH
MIKERGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSAR
LSKSRRLENLIAQLPGEKKNGLEGNLIALSLGLTPNEKSNFDLAEDAKLQLSKD
TYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKR
YDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIK
PILEKMDGTEELLVKLNREDLLRKQRTEDNGSIPHQIHLGELHAILRRQEDFYP
FLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKG
ASAQSFIERMTNEDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPA
FLSGEQKKAIVDLLEKTNRKVTVKQLKEDYFKKIECEDSVEISGVEDRFNASLG
TYHDLLKIIKDKDELDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDK
VMKQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIH
DDSLTEKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELVKVM
GRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENT
QLQNEKLYLYYLQNGRDMYVDQELDINRLSDYDVDHIVPQSFLKDDSIDNKVL
TRSDKNRCKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKEDNLTKAERGGLS
ELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLV
SDFRKDFQFYKVREINNYHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVY
DVRKMIAKSEQEIGKATAKYFFYSNIMNFIRTEITLANGEIRKRPLIETNGETGE
IVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKK
DWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKELLGITIMERSSFEKN
PIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSK
YVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEHEQISEFSKRVILADA
NLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDTTIDRKRYTST
KEVLDATLIHQSITGLYETRIDLSQLGGDAAALDLQVKQQIQLRRREVDETADLPA
ELPPLLRRLYASRGVRSAQELERSVKGMLPWQQLSGVEKAVEILYNAFREGTRIIVVGDFD
ADGATSTALSVLAMRSLGCSNIDYLVPNRFEDGYGLSPEVVDQAHARGAQLIVTVDNGISS
HAGVEHARSLGIPVIVTDHHLPGDTLPAAEAIINPNLRDCNFPSKSLAGVGVAFYLMLALR
TFLRDQGWFDERNIAIPNLAELLDLVALGTVADVVPLDANNRILTWQGAISRIRAGKCRPG
IKALLEVANRDAQKLAASDLGFALGPRLNAAGRLDDMSVGVALLLCDNIGEARVLANELD
ALNQTRKEIEQGMQIEALTLCEKLERSRDTLPGGLAMYHPEWHQGVVGILASRIKERFHR
PVIAFAPAGDGTLKGSGRSIQGLHMRDALERLDTLYPGABILKEGGHAMAAGLSLEEDK
FKLFQQRFGELVTEWLDPSLLQGEVVSDGPLSPAEMTMEVAQLLRDAGPWGQMFPEPL
FDGHFRLLQQRLVGERHLKVMVEPVGGGPLLDGIAFNVDTALWPDNGVREVQLAYKLD
INEFRGNRSLQIIIDNIWPILQKRPAATKKAGQAKKKKHHHHHH
AAAAAAGAAATGGTTGAATTTGATGAAGCTATCCATGGCGAAGACTTGGCTAA
ATTTATTAAAGAAGCATCTGATCATAAACTGAAAATTTCCGGTTATAATGAACT
GATTAAAGATATTCGAATTCGTGCTAAAGATGAACTTGGCGTTGATGGTAAGAT
GTTTAATCGTCTATTAGCTTTGTATCATAAAGATAACCGTGATGTGTTTGAAGCT
GAAACTGAAGAGGTAGTTGAACTTTATGACACAGTTTTCTCTAAAGGATCCGAA
GCCTGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAG
TACAAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCA
CAGCATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGA
CCGCCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGC
CGCAAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCC
AAGGTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGA
GGAGGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACG
AGGTGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGC
TGGTGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTG
GCCCACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAAC
CCCGACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTAC
AACCAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAA
GGCCATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGA
TCGCCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATC
GCCCTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCC
GAGGACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGA
CAACCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGC
CAAGAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACAC
CGAGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACG
AGCACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTG
CCCGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCC
GGCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAA
GCCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGA
ACCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATC
CCCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGA
GGACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCT
GACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCG
CTTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTT
CGAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCA
TGACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTCGAGAAAAGGCCGGCGGCCACGAAAA
KFIKEASDHKLKISGYNELIKDIRIRAKDELGVDGKMFNRLLALYHKDNRDVFEAET
EEVVELYDTVFSKGSEFELRRQACGRMDKKYSIGLDIGTNSVGWAVITDEYKVPS
KKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYL
QEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIY
HLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQ
TYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALS
LGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSD
AILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFD
QSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFD
NGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSR
FAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFDKNLPNEKVLPKHSLL
YEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKE
DYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLT
LTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQ
SGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLA
GSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRER
MKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRL
SDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQL
LNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRM
NTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAV
VGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFF
KTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEV
QTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGK
SKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELEN
GRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVE
QHKHYLDEHEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTL
TNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDA
AAAAAAGAAATGGTTGAATTTGATGAAGCTATCCATGGCGAAGACTTGGCTAA
ATTTATTAAAGAAGCATCTGATCATAAACTGAAAATTTCCGGTTATAATGAACT
GATTAAAGATATTCGAATTCGTGCTAAAGATGAACTTGGCGTTGATGGTAAGAT
GTTTAATCGTCTATTAGCTTTGTATCATAAAGATAACCGTGATGTGTTTGAAGCT
GAAACTGAAGAGGTAGTTGAACTTTATGACACAGTTTTCTCTAAAGGATCCGAA
GCCTGGACATCGGTACCAACAGCGTGGGCTGGGCCGTGATCACCGACGAG
TACAAGGTGCCCAGCAAGAAGTTCAAGGTGCTGGGCAACACCGACCGCCA
CAGCATCAAGAAGAACCTGATCGGCGCCCTGCTGTTCGACAGCGGCGAGA
CCGCCGAGGCCACCCGCCTGAAGCGCACCGCCCGCCGCCGCTACACCCGC
CGCAAGAACCGCATCTGCTACCTGCAGGAGATCTTCAGCAACGAGATGGCC
AAGGTGGACGACAGCTTCTTCCACCGCCTGGAGGAGAGCTTCCTGGTGGA
GGAGGACAAGAAGCACGAGCGCCACCCCATCTTCGGCAACATCGTGGACG
AGGTGGCCTACCACGAGAAGTACCCCACCATCTACCACCTGCGCAAGAAGC
TGGTGGACAGCACCGACAAGGCCGACCTGCGCCTGATCTACCTGGCCCTG
GCCCACATGATCAAGTTCCGCGGCCACTTCCTGATCGAGGGCGACCTGAAC
CCCGACAACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTAC
AACCAGCTGTTCGAGGAGAACCCCATCAACGCCAGCGGCGTGGACGCCAA
GGCCATCCTGAGCGCCCGCCTGAGCAAGAGCCGCCGCCTGGAGAACCTGA
TCGCCCAGCTGCCCGGCGAGAAGAAGAACGGCCTGTTCGGCAACCTGATC
GCCCTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCC
GAGGACGCCAAGCTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGA
CAACCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTCCTGGCCGC
CAAGAACCTGAGCGACGCCATCCTGCTGAGCGACATCCTGCGCGTGAACAC
CGAGATCACCAAGGCCCCCCTGAGCGCCAGCATGATCAAGCGCTACGACG
AGCACCACCAGGACCTGACCCTGCTGAAGGCCCTGGTGCGCCAGCAGCTG
CCCGAGAAGTACAAGGAGATCTTCTTCGACCAGAGCAAGAACGGCTACGCC
GGCTACATCGACGGCGGCGCCAGCCAGGAGGAGTTCTACAAGTTCATCAA
GCCCATCCTGGAGAAGATGGACGGCACCGAGGAGCTGCTGGTGAAGCTGA
ACCGCGAGGACCTGCTGCGCAAGCAGCGCACCTTCGACAACGGCAGCATC
CCCCACCAGATCCACCTGGGCGAGCTGCACGCCATCCTGCGCCGCCAGGA
GGACTTCTACCCCTTCCTGAAGGACAACCGCGAGAAGATCGAGAAGATCCT
GACCTTCCGCATCCCCTACTACGTGGGCCCCCTGGCCCGCGGCAACAGCCG
CTTCGCCTGGATGACCCGCAAGAGCGAGGAGACCATCACCCCCTGGAACTT
CGAGGAGGTGGTGGACAAGGGCGCCAGCGCCCAGAGCTTCATCGAGCGCA
TGACCAACTTCGACAAGAACCTGCCCAACGAGAAGGTGCTGCCCAAGCACA
GCCTGCTGTACGAGTACTTCACCGTGTACAACGAGCTGACCAAGGTGAAGT
ACGTGACCGAGGGCATGCGCAAGCCCGCCTTCCTGAGCGGCGAGCAGAAG
AAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGCAAGGTGACCGTGAA
GCAGCTGAAGGAGGACTACTTCAAGAAGATCGAGTGCTTCGACAGCGTGG
AGATCAGCGGCGTGGAGGACCGCTTCAACGCCAGCCTGGGCACCTACCAC
GACCTGCTGAAGATCATCAAGGACAAGGACTTCCTGGACAACGAGGAGAA
CGAGGACATCCTGGAGGACATCGTGCTGACCCTGACCCTGTTCGAGGACC
GCGAGATGATCGAGGAGCGCCTGAAGACCTACGCCCACCTGTTCGACGAC
AAGGTGATGAAGCAGCTGAAGCGCCGCCGCTACACCGGCTGGGGCCGCCT
GAGCCGCAAGCTTATCAACGGCATCCGCGACAAGCAGAGCGGCAAGACCA
TCCTGGACTTCCTGAAGAGCGACGGCTTCGCCAACCGCAACTTCATGCAGC
TGATCCACGACGACAGCCTGACCTTCAAGGAGGACATCCAGAAGGCCCAG
GTGAGCGGCCAGGGCGACAGCCTGCACGAGCACATCGCCAACCTGGCCGG
CAGCCCCGCCATCAAGAAGGGCATCCTGCAGACCGTGAAGGTGGTGGACG
AGCTGGTGAAGGTGATGGGCCGCCACAAGCCCGAGAACATCGTGATCGAG
ATGGCCCGCGAGAACCAGACCACCCAGAAGGGCCAGAAGAACAGCCGCGA
GCGCATGAAGCGCATCGAGGAGGGCATCAAGGAGCTGGGCAGCCAGATCC
TGAAGGAGCACCCCGTGGAGAACACCCAGCTGCAGAACGAGAAGCTGTAC
CTGTACTACCTGCAGAACGGCCGCGACATGTACGTGGACCAGGAGCTGGA
CATCAACCGCCTGAGCGACTACGACGTGGACCACATCGTGCCCCAGAGCTT
CCTGAAGGACGACAGCATCGACAACAAGGTGCTGACCCGCAGCGACAAGA
ACCGCGGCAAGAGCGACAACGTGCCCAGCGAGGAGGTGGTGAAGAAGATG
AAGAACTACTGGCGCCAGCTGCTGAACGCCAAGCTGATCACCCAGCGCAA
GTTCGACAACCTGACCAAGGCCGAGCGCGGCGGCCTGAGCGAGCTGGACA
AGGCCGGCTTCATCAAGCGCCAGCTGGTGGAGACCCGCCAGATCACCAAG
CACGTGGCCCAGATCCTGGACAGCCGCATGAACACCAAGTACGACGAGAA
CGACAAGCTGATCCGCGAGGTGAAGGTGATCACCCTGAAGAGCAAGCTGG
TGAGCGACTTCCGCAAGGACTTCCAGTTCTACAAGGTGCGCGAGATCAACA
ACTACCACCACGCCCACGACGCCTACCTGAACGCCGTGGTGGGCACCGCC
CTGATCAAGAAGTACCCCAAGCTGGAGAGCGAGTTCGTGTACGGCGACTAC
AAGGTGTACGACGTGCGCAAGATGATCGCCAAGAGCGAGCAGGAGATCGG
CAAGGCCACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTCTTCAA
GACCGAGATCACCCTGGCCAACGGCGAGATCCGCAAGCGCCCCCTGATCG
AGACCAACGGCGAGACCGGCGAGATCGTGTGGGACAAGGGCCGCGACTTC
GCCACCGTGCGCAAGGTGCTGAGCATGCCCCAGGTGAACATCGTGAAGAA
GACCGAGGTGCAGACCGGCGGCTTCAGCAAGGAGAGCATCCTGCCCAAGC
GCAACAGCGACAAGCTGATCGCCCGCAAGAAGGACTGGGACCCCAAGAAG
TACGGCGGCTTCGACAGCCCCACCGTGGCCTACAGCGTGCTGGTGGTGGC
CAAGGTGGAGAAGGGCAAGAGCAAGAAGCTGAAGAGCGTGAAGGAGCTGC
TGGGCATCACCATCATGGAGCGCAGCAGCTTCGAGAAGAACCCCATCGACT
TCCTGGAGGCCAAGGGCTACAAGGAGGTGAAGAAGGACCTGATCATCAAG
CTGCCCAAGTACAGCCTGTTCGAGCTGGAGAACGGCCGCAAGCGCATGCT
GGCCAGCGCCGGCGAGCTGCAGAAGGGCAACGAGCTGGCCCTGCCCAGCA
AGTACGTGAACTTCCTGTACCTGGCCAGCCACTACGAGAAGCTGAAGGGCA
GCCCCGAGGACAACGAGCAGAAGCAGCTGTTCGTGGAGCAGCACAAGCAC
TACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCAGCAAGCGCGTGATC
CTGGCCGACGCCAACCTGGACAAGGTGCTGAGCGCCTACAACAAGCACCG
CGACAAGCCCATCCGCGAGCAGGCCGAGAACATCATCCACCTGTTCACCCT
GACCAACCTGGGCGCCCCCGCCGCCTTCAAGTACTTCGACACCACCATCGA
CCGCAAGCGCTACACCAGCACCAAGGAGGTGCTGGACGCCACCCTGATCC
ACCAGAGCATCACCGGTCTGTACGAGACCCGCATCGACCTGAGCCAGCTG
GGCGGCGACGCGGCCGCACTCGACCTGCAGGTGAAACAACAGATACAACTTCGTC
GCCGTGAAGTCGATGAAACGGCAGACTTGCCCGCTGAATTGCCTCCCTTGCTGCGCC
GTTTATACGCCAGCCGGGGAGTACGCAGTGCGCAAGAACTGGAACGCAGTGTTAAAG
GTATGCTGCCCTGGCAGCAACTGAGCGGCGTCGAAAAGGCCGTTGAGATCCTTTACA
ACGCTTTTCGCGAAGGAACGCGGATTATTGTGGTCGGTGATTTCGACGCCGACGGCG
CGACCAGCACGGCTCTAAGCGTGCTGGCGATGCGCTCGCTTGGTTGCAGCAATATCG
ACTACCTGGTACCAAACCGTTTCGAAGACGGTTACGGCTTAAGCCCGGAAGTGGTCG
ATCAGGCCCATGCCCGTGGCGCGCAGTTAATTGTCACGGTGGATAACGGTATTTCCT
CCCATGCGGGGGTTGAGCACGCTCGCTCGTTGGGCATCCCGGTTATTGTTACCGATC
ACCATTTGCCAGGCGACACATTACCCGCAGCGGAAGCGATCATTAACCCTAACTTGC
GCGACTGTAATTTCCCGTCGAAATCACTGGCAGGCGTGGGTGTGGCGTTTTATCTGAT
GCTGGCGCTGCGCACCTTTTTGCGCGATCAGGGCTGGTTTGATGAGCGTAACATCGC
AATTCCTAACCTGGCAGAACTGCTGGATCTGGTCGCGCTGGGGACAGTGGCGGACG
TCGTGCCGCTGGACGCTAATAATCGCATTCTGACCTGGCAGGGGATGAGTCGCATCC
GAGCCGGAAAGTGCCGTCCGGGGATTAAAGCGCTGCTTGAAGTGGCAAACCGTGAT
GCACAAAAACTCGCCGCCAGCGATTTAGGTTTTGCGCTGGGGCCACGTCTCAATGCT
GCCGGACGACTGGACGATATGTCCGTCGGTGTGGCGCTGTTGTTGTGCGACAACATC
GGCGAAGCGCGCGTGCTGGCAAATGAACTCGATGCGCTAAACCAGACGCGAAAAGA
GATCGAACAAGGAATGCAAATTGAAGCCCTGACCCTGTGCGAGAAACTGGAGCGCAG
CCGTGACACGCTACCCGGCGGGCTGGCAATGTATCACCCCGAATGGCATCAGGGCG
TTGTCGGTATTCTGGCTTCGCGCATCAAAGAGCGTTTTCACCGTCCGGTTATCGCGTT
TGCGCCAGCAGGTGACGGTACGCTGAAAGGTTCCGGTCGCTCCATTCAGGGGCTGC
ATATGCGTGATGCGCTGGAGCGATTAGACACACTCTACCCTGGCATGATGCTGAAGTT
TGGCGGTCATGCGATGGCGGCGGGTTTGTCGCTGGAAGAGGATAAATTCAAACTCTT
TCAACAACGGTTTGGCGAACTGGTTACTGAGTGGCTGGACCCTTCGCTATTGCAAGG
CGAAGTGGTATCAGACGGTCCGTTAAGCCCGGCCGAAATGACCATGGAAGTGGCGC
AGCTGCTGCGCGATGCTGGCCCGTGGGGGCAGATGTTCCCGGAGCCGCTGTTTGAC
GGTCATTTCCGTCTGCTGCAACAGCGGCTGGTGGGCGAACGTCATTTGAAGGTGATG
GTCGAACCGGTCGGCGGCGGTCCACTGCTGGATGGTATTGCTTTTAATGTCGATACC
GCCCTCTGGCCGGATAACGGCGTGCGCGAAGTGCAACTGGCTTATAAGCTCGATATC
AACGAGTTTCGCGGCAACCGCAGCCTGCAAATTATCATCGACAATATCTGGCCAATTC
KFIKEASDHKLKISGYNELIKDIRIRAKDELGVDGKATFNRLLALYHKDNRDVFEAET
EEVVELYDTVFSKGSEFELRRQACGRMDKKYSIGLDIGTNSVGWAVITDEYKVPS
KKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRIKRTARRRYTRRKNRICYL
QEIFSNEMAKVDDSFEHRLEESELVEEDKKHERHPIEGNIVDEVAYHEKYPTIY
HLRKKLVDSTDKADLRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQ
TYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALS
LGLTPNEKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSD
AILLSDILRVNTEITKAPLSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFD
QSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTED
NGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSR
FAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNEDKNLPNEKVLPKHSLL
YEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKE
DYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLT
LTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRKLINGIRDKQ
SGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLA
GSPAIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRER
MKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDINRL
SDYDVDHIVPQSFLKDDSIDNKVLTRSDKNRGKSDNVPSEEVVKKMKNYWRQL
LNAKLITQRKFDNLTKAERGGLSELDKAGFIKRQLVETRQITKIIVAQILDSRM
NTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAV
VGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFF
KTEITLANGEIRKRPLIETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEV
QTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGK
SKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELEN
GRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLKGSPEDNEQKQLFVE
QHKHYLDEHEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTL
TNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDA
LSGVEKAVEILYNAFREGTRIIVVGDFDADGATSTALSVLAMRSLGCSNIDYLVPNRFEDG
YGLSPEVVDQAHARGAQLIVTVDNGISSHAGVEHARSLGIPVIVTDHHLPGDTLPAAEAII
NPNLRDCNFPSKSLAGVGVAFYLMLALRTFLRDQGWFDERNIAIPNLAELLDLVALGTVA
DVVPLDANNRILTWQGMSRIRAGKCRPGIKALLEVANRDAQKLAASDLGFALGPRLNAA
GRLDDMSVGVALLLCDNIGEARVLANELDALNQTRKEIEQGMQIEALTLCEKLERSRDTL
PGGLAMYHPEWHQGVVGILASRIKERFHRPVIAFAPAGDGTLKGSGRSIQGLHMRDALE
RLDTLYPGMMLKFGGHAMAAGLSLEEDKFKLFQQRFGELVTEWLDPSLLQGEVVSDGP
LSPAEMTMEVAQLLRDAGPWGQMFPEPLFDGHFRLLQQRLVGERHLKVMVEPVGGGP
LLDGIAFNVDTALWPDNGVREVQLAYKLDINEFRGNRSLQIIIDNIWPILQKRPAATKKA
TAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGTAAA
ACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAAAGA
GCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAGTTTT
TTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTACAAAA
CTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCTACAA
AAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGAATAT
ATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATCGATG
CTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCTAAGG
ATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATAGATG
AGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTAAGG
GTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTACATC
TATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAATAAA
GCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTATGAA
CAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTACAAA
ACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGATAG
CAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATACTAT
TATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTATAAA
TGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAAAAA
TATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTAAAT
CTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGATGC
AAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATCTA
TTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTTGA
TTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCACAA
CAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATATAA
CTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCAAG
AATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAACTAT
AAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACAGTG
TAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATTTGAT
GAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATATCAA
AATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGTTAAA
GCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTAAAAA
TATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAGGATG
AGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAATATAGT
GCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATAGTGAT
GAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTTGGGAT
AAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATGATAAAT
ATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATGATAAAG
CTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATAAACTTTT
ACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAAATCTATA
AAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCATTCCACAC
ATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAGTTTAATA
TTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAAGTAAGCA
TCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAAGATATAAT
TCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACAAACTAACTT
TTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCAGGGTAAAT
TGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCG
ACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTT
CAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAA
CAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCAATAGCTAAT
AAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCA
AAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAAT
CAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAATCAATTTATTG
CTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGATAGAGGTGAA
AGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAATATCATCAAA
CAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAAACTACCAT
GATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGG
AAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTA
GTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTG
AGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGG
TCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTT
CAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCT
AACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTAT
CTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTT
GTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTC
TTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGT
TTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGA
CTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAA
ATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAAT
TGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAG
CTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCC
TAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTA
TCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACA
GGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATAT
TGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGG
CAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCA
GAATAGGAATAACCAAGCGGCCGCACTCGAGAAAAGGCCGGCGGCCACGAAA
KYSLSKTERFELIPQGKTLENIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEE
ILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDEKSAKDTIKKQISEYIKDSEKE
KNLFNQNLIDAKKGQESDLIEWLKQSKDNGIELFKANSDITDIDEALEIIKSFKG
WTTYFKGEHENRKNVYSSNDIPTSIIYRIVDDNLPKFLENKAKYESLKDKAPEAI
NYEQIKKDLAEELTEDIDYKTSEVNQRVESLDEVFEIANFNNYLNQSGITKENTII
GGKEVNGENTKRKGINEYINLYSQQINDKTLKKYKMSVLEKQILSDTESKSFVI
DKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSELFDDLKAQKLDLSKIYF
KNDKSLTDESQQVFDDYSVIGTAVLEYITQQIAPKNEDNPSKKEQELIAKKTEK
AKYLSLETIKLALEEFNKHRDIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQI
SIKYQNQGKKDLLQASAEDDVKAIKDLLDQTNNLLHKLKIFHISQSEDKANILD
KDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNFENSTLANGWD
KNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGEGYKKIVYKLLP
GANKMLPKVFFSAKSIKFYNPSEDILRIRNHSTHTKNGSPQKGYEKFEFNIEDC
RKFIDFYKQSISKHPEWKDFGFRFSDTQRYNSIDEFYREVENQGYKLTFENISES
YIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLHTLYWKALFDERNLQDVVYKLN
GEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIKDKRFTEDKFF
FHCPITINFKSSGANKFNDEINLLLKEKANDVHILSIDRGERHLAYYTLVDGKG
NIIKQDTFNIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNIKEMKEGYLS
QVVHEIAKLVIEYNAIVVFEDLNFGFKRGRFKVEKQVYQKLEKMLIEKLNYLV
FKDNEFDKTGGVLRAYQLTAPFETFKKMGKQTGIIYYVPAGFTSKICPVTGFV
NQLYPKYESVSKSQEFFSKFDKICYNLDKGYFEFSFDYKNFGDKAAKGKWTIA
SFGSRLINFRNSDKNHNWDTREVYPTKELEKLLKDYSIEYGHGECIKAAICGES
DKKFFAKLTSVLNTILQMRNSKTGTELDYLISPVADVNGNFFDSRQAPKNMPQ
DADANGAYHIGLKGLMLLGRIKNNQEGKKLNLVIKNEEYFEFVQNRNNQAAA
TAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGTAAA
ACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAAAGA
GCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAGTTTT
TTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTACAAAA
CTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCTACAA
AAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGAATAT
ATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATCGATG
CTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCTAAGG
ATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATAGATG
AGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTAAGG
GTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTACATC
TATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAATAAA
GCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTATGAA
CAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTACAAA
ACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGATAG
CAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATACTAT
TATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTATAAA
TGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAAAAA
TATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTAAAT
CTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGATGC
AAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATCTA
TTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTTGA
TTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCACAA
CAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATATAA
CTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCAAG
AATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAACTAT
AAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACAGTG
TAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATTTGAT
GAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATATCAA
AATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGTTAAA
GCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTAAAAA
TATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAGGATG
AGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAATATAGT
GCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATAGTGAT
GAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTTGGGAT
AAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATGATAAAT
ATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATGATAAAG
CTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATAAACTTTT
ACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAAATCTATA
AAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCATTCCACAC
ATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAGTTTAATA
TTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAAGTAAGCA
TCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAAGATATAAT
TCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACAAACTAACTT
TTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCAGGGTAAAT
TGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCG
ACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTT
CAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAA
CAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCAATAGCTAAT
AAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCA
AAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAAT
CAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAATCAATTTATTG
CTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGATAGAGGTGAA
AGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAATATCATCAAA
CAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAAACTACCAT
GATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGG
AAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTA
GTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTG
AGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGG
TCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTT
CAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCT
AACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTAT
CTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTT
GTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTC
TTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGT
TTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGA
CTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAA
ATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAAT
TGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAG
CTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCC
TAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTA
TCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACA
GGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATAT
TGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGG
CAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCA
GAATAGGAATAACCAAGCGGCCGCACTCGACCTGCAGGTGAAACAACAGATA
CAACTTCGTCGCCGTGAAGTCGATGAAACGGCAGACTTGCCCGCTGAATTGCCT
CCCTTGCTGCGCCGTTTATACGCCAGCCGGGGCGTGCGCAGTGCGCAAGAACTG
GAACGCAGTGTTAAAGGTATGTTGCCCTGGCAGCAACTGAGCGGCGTCGAAAA
GGCCGTTGAGATCCTTTACAACGCTTTTCGCGAAGGAACGCGGATTATTGTGGT
CGGCGATTTTGACGCCGACGGCGCGACCAGCACGGCTCTAAGCGTGCTGGCGAT
GCGCTCGCTTGGTTGCAGCAATATCGACTATCTGGTACCAAACCGTTTCGAAGA
CGGTTACGGCTTAAGCCCGGAAGTAGTCGATCAGGCCCATGCCCGTGGCGCGCA
GTTAATTGTCACGGTGGATAACGGTATTTCCTCCCATGCGGGCGTTGAACACGC
TCGCTCGTTGGGCATTCCGGTTATTGTTACCGATCACCATTTGCCGGGCGAAACA
TTACCCGCAGCGGAAGCGATCATTAACCCTAACTTGCGCGACTGTAATTTCCCG
TCGAAATCACTGGCAGGCGTGGGTGTGGCGTTTTATCTGATGCTGGCGCTGCGC
ACCTTTTTGCGCGATCAGGGCTGGTTTGATGAGCGTGGCATCGCAATTCCTAACC
TGGCAGAACTGCTGGATCTGGTCGCGCTGGGAACAGTGGCGGACGTCGTGCCGC
TGGACGCTAATAATCGCATTCTGACCTGGCAGGGGATGAGTCGCATCCGTGCCG
GAAAGTGCCGTCCAGGGATTAAAGCGCTGCTGGAAGTGGCAAACCGTGATGCA
CAAAAACTCGCCGCCAGCGATTTAGGTTTTGCGCTGGGGCCACGTCTCAATGCT
GCCGGACGACTGGACGATATGTCCGTCGGTGTGGCGCTCTTGCTGTGCGACAAC
ATCGGCGAAGCGCGCGTGCTGGCAAATGAACTCGATGCGCTAAACCAGACGCG
AAAAGAGATCGAACAAGGAATGCAAGTTGAAGCCCTGACCCTGTGCGAGAAAC
TGGAGCGAAGTCGCGACACGCTACCCGGCGGGCTGGCAATGTATCACCCCGAAT
GGCATCAGGGCGTTGTCGGTATTCTGGCTTCGCGCATCAAAGAGCGTTTTCACC
GTCCGGTTATCGCCTTTGCGCCAGCAGGTGATGGTACGCTGAAAGGTTCAGGTC
GCTCCATTCAGGGGCTGCATATGCGTGATGCACTGGAGCGATTAGACACACTCT
ACCCTGGCATGATACTGAAGTTTGGCGGTCATGCGATGGCGGCGGGTTTGTCGC
TGGAAGAGGATAAATTCGAACTCTTTCAACAACGGTTTGGCGAGCTGGTTACCG
AGTGGCTGGACCCTTCGCTATTGCAAGGCGAAGTGGTGTCAGACGGCCCGTTAA
GCCCGGCCGAAATGACCATGGAAGTGGCGCAGCTGCTGCGCGATGCTGGCCCGT
GGGGGCAGATGTTCCCGGAGCCGCTGTTTGATGGTCATTTCCGTCTGCTGCAAC
AGCGGCTGGTGGGCGAACGTCATTTGAAAGTCATGGTCGAACCGGTCGGCGGC
GGTCCGCTGCTGGATGGTATTGCTTTTAATGTCGATACCGCCCTCTGGCCGGATA
ACGGCGTGCGCGAAGTGCAACTGGCTTACAAGCTCGATATCAACGAGTTTCGCG
GCAACCGCAGCCTGCAAATTATCATCGACAATATCTGGCCAATTCTGCAGAAAA
KYSLSKTERFELIPQGKTLENIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEE
ILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDEKSAKDTIKKQISEYIKDSEKE
KNLENQNLIDAKKGQESDLIEWLKQSKDNGIELFKANSDITDIDEALEIIKSFKG
WTTYFKGEHENRKNVYSSNDIPTSIIYRIVDDNLPKFLENKAKYESLKDKAPEAI
NYEQIKKDLAEELTEDIDYKTSEVNQRVESLDEVFEIANENNYLNQSGITKENTII
GGKEVNGENTKRKGINEYINLYSQQINDKTEKKYKMSVLEKQILSDTESKSFVI
DKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSELFDDLKAQKLDLSKIYF
KNDKSLTDESQQVFDDYSVIGTAVLEYITQQIAPKNEDNPSKKEQELIAKKTEK
AKYLSLETIKLALEEENKHRDIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQI
SIKYQNQGKKDLLQASAEDDVKAIKDELDQTNNELHKEKIFHISQSEDKANILD
KDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNFENSTLANGWD
KNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGEGYKKIVYKLLP
GANKMLPKVFFSAKSIKEYNPSEDILRIRNHSTHTKNGSPQKGYEKFEENIEDC
RKFIDEYKQSISKHPEWKDEGFRESDTQRYNSIDEFYREVENQGYKLTFENISES
YIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLIITLYWKALFDERNLQDVVYKLN
GEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIKDKRFTEDKFF
FHCPITINEKSSGANKENDEINELLKEKANDVHILSIDRGERHLAYYTLVDGKG
NIIKQDTENIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNIKEMKEGYLS
QVVHEIAKLVIEYNAIVVFEDLNEGFKRGREKVEKQVYQKLEKMLIEKLNYLV
FKDNEFDKTGGVERAYQLTAPFETFKKMGKQTGIIYYVPAGFTSKICPVTGEV
NQLYPKYE SVSKSQEFFSKEDKICYNEDKGYFEFSFDYKNEGDKAAKGKWTIA
SEGSRLINFRNSDKNHNWDTREVYPTKELEKELKDYSIEYGHGECIKAAICGES
DKKFFAKLTSVENTILQMRNSKTGTELDYLISPVADVNGNFEDSRQAPKNMPQ
DADANGAYHIGLKGEMLLGRIKNNQEGKKLNLVIKNEEYFEFVQNRNNQAAA
QLSGVEKAVEILYNAFREGTRIIVVGDFDADGATSTALSVLAMRSLGCSNIDYLVPN
RFEDGYGLSPEVVDQAHARGAQLIVTVDNGISSHAGVEHARSLGIPVIVTDHHLPGE
TLPAAEAIINPNLRDCNFPSKSLAGVGVAFYLMLALRTFLRDQGWFDERGIAIPNLA
ELLDLVALGTVADVVPLDANNRILTWQGMSRIRAGKCRPGIKALLEVANRDAQKL
AASDLGFALGPRLNAAGRLDDMSVGVALLLCDNIGEARVLANELDALNQTRKEIE
QGMQVEALTLCEKLERSRDTLPGGLAMYHPEWHQGVVGILASRIKERFHRPVIAFA
PAGDGTLKGSGRSIQGLHMRDALERLDTLYPGMILKFGGHAMAAGLSLEEDKFELF
QQRFGELVTEWLDPSLLQGEVVSDGPLSPAEMTMEVAQLLRDAGPWGQMFPEPLF
DGHFRLLQQRLVGERHLKVMVEPVGGGPLLDGIAFNVDTALWPDNGVREVQLAY
KLDINEFRGNRSLQIIIDNIWPILQKRPAATKKAGQAKKKKHHHHHH
TAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGTAAA
ACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAAAGA
GCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAGTTTT
TTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTACAAAA
CTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCTACAA
AAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGAATAT
ATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATCGATG
CTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCTAAGG
ATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATAGATG
AGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTAAGG
GTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTACATC
TATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAATAAA
GCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTATGAA
CAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTACAAA
ACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGATAG
CAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATACTAT
TATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTATAAA
TGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAAAAA
TATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTAAAT
CTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGATGC
AAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATCTA
TTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTTGA
TTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCACAA
CAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATATAA
CTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCAAG
AATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAACTAT
AAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACAGTG
TAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATTTGAT
GAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATATCAA
AATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGTTAAA
GCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTAAAAA
TATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAGGATG
AGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAATATAGT
GCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATAGTGAT
GAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTTGGGAT
AAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATGATAAAT
ATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATGATAAAG
CTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATAAACTTTT
ACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAAATCTATA
AAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCATTCCACAC
ATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAGTTTAATA
TTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAAGTAAGCA
TCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAAGATATAAT
TCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACAAACTAACTT
TTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCAGGGTAAAT
TGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCG
ACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTT
CAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAA
CAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCAATAGCTAAT
AAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCA
AAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAAT
CAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAATCAATTTATTG
CTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGATAGAGGTGAA
AGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAATATCATCAAA
CAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAAACTACCAT
GATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGG
AAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTA
GTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTG
AGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGG
TCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTT
CAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCT
AACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTAT
CTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTT
GTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTC
TTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGT
TTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGA
CTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAA
ATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAAT
TGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAG
CTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCC
TAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTA
TCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACA
GGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATAT
TGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGG
CAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCA
GAATAGGAATAACCAAGCGGCCGCACTCGACCTGCAGATGAGCACAAAACCA
CTCTTCCTGTTACGGAAAGCGAAAAAATCATCCGGTGAACCTGACGTCGTCCTG
TGGGCAAGCAACGATTTTGAATCGACCTGTGCCACTCTGGACTACCTGATCGTT
AAGTCAGGTAAAAAACTGAGCAGCTATTTTAAAGCTGTTGCCACGAATTTTCCT
GTCGTTAATGACCTGCCCGCTGAAGGTGAGATCGATTTTACCTGGAGTGAACGC
TATCAACTCAGCAAAGACTCCATGACATGGGAACTAAAACCGGGAGCAGCACC
AGACAACGCTCACTATCAAGGCAATACCAACGTCAACGGCGAAGACATGACTG
AGATTGAGGAGAATATGCTACTCCCAATTTCTGGCCAGGAACTGCCCATTCGTT
GGCTTGCTCAACACGGCAGCGAAAAACCGGTAACGCACGTTTCACGCGACGGA
CTCCAGGCATTACACATTGCTCGGGCTGAAGAACTACCGGCTGTTACTGCCCTG
GCTGTTTCCCACAAAACCAGCCTGCTCGACCCGCTGGAAATTCGCGAACTCCAC
AAACTGGTTCGTGACACTGACAAAGTTTTCCCTAATCCTGGTAATTCAAACCTG
GGACTGATAACTGCTTTTTTCGAAGCATACCTGAACGCTGACTACACCGATCGA
GGACTGCTGACAAAAGAGTGGATGAAGGGTAATCGTGTTTCACACATCACTCGC
ACGGCTTCCGGTGCTAATGCTGGCGGCGGAAACCTCACCGATCGCGGCGAAGGT
TTCGTACACGATCTGACGTCACTGGCGCGCGACGTAGCCACTGGCGTACTGGCC
CGTTCAATGGATCTGGACATCTATAACCTTCATCCGGCACACGCTAAACGCATT
GAGGAAATTATCGCTGAAAATAAACCGCCCTTTTCTGTTTTCCGCGACAAATTC
ATCACCATGCCTGGCGGGCTGGATTATTCCCGCGCCATCGTGGTTGCGTCCGTA
AAAGAAGCACCAATTGGGATCGAGGTCATCCCCGCGCACGTCACTGAATATCTG
AACAAAGTACTGACTGAAACCGATCATGCCAACCCTGATCCGGAAATCGTGGAT
ATTGCCTGCGGTCGCTCCTCTGCCCCGATGCCGCAGCGAGTAACAGAAGAAGGA
AAACAGGATGATGAAGAAAAACCGCAACCATCTGGAACAACGGCAGTTGAACA
GGGAGAGGCTGAAACAATGGAACCGGACGCAACTGAACATCATCAGGACACGC
AGCCGCTGGATGCTCAGTCACAGGTAAATTCTGTTGATGCGAAATATCAGGAAC
TGCGGGCAGAACTCCATGAAGCCCGGAAAAACATTCCATCAAAAAATCCTGTCG
ATGACGATAAATTGCTTGCTGCATCACGTGGTGAATTTGTTGACGGAATTAGCG
ACCCGAACGATCCGAAATGGGTAAAGGGGATCCAGACTCGCGATTGTGTGTACC
AGAACCAGCCAGAAACGGAAAAAACCAGCCCAGATATGAATCAACCTGAGCCA
GTAGTGCAACAGGAACCGGAAATAGCCTGCAATGCCTGCGGCCAGACTGGCGG
GGATAACTGCCCTGACTGTGGTGCGGTGATGGGCGACGCAACATACCAGGAAA
CATTCGATGAAGAGAGTCAGGTTGAAGCTAAGGAAAATGATCCGGAGGAAATG
GAAGGCGCTGAACATCCGCACAATGAGAATGCTGGCAGCGATCCGCATCGCGA
TTGCAGTGATGAAACTGGCGAAGTCGCAGATCCCGTAATCGTAGAAGACATAG
AGCCAGGTATTTATTACGGAATTTCGAATGAGAATTACCACGCGGGTCCCGGTA
TCAGTAAGTCTCAGCTCGATGACATTGCTGATACTCCGGCACTATATTTGTGGCG
TAAAAATGCCCCCGTGGACACCACAAAGACAAAAACGCTCGATTTAGGAACTG
CTTTCCACTGCCGGGTACTTGAACCGGAAGAATTCAGTAACCGCTTTATCGTAG
CACCTGAATTTAACCGCCGTACAAACGCCGGAAAAGAAGAAGAGAAAGCGTTT
CTGATGGAATGCGCAAGCACAGGAAAAACGGTTATCACTGCGGAAGAAGGCCG
GAAAATTGAACTCATGTATCAAAGCGTTATGGCTTTGCCGCTGGGGCAATGGCT
TGTTGAAAGCGCCGGACACGCTGAATCATCAATTTACTGGGAAGATCCTGAAAC
AGGAATTTTGTGTCGGTGCCGTCCGGACAAAATTATCCCTGAATTTCACTGGATC
ATGGACGTGAAAACTACGGCGGATATTCAACGATTCAAAACCGCTTATTACGAC
TACCGCTATCACGTTCAGGATGCATTCTACAGTGACGGTTATGAAGCACAGTTT
GGAGTGCAGCCAACTTTCGTTTTTCTGGTTGCCAGCACAACTATTGAATGCGGA
CGTTATCCGGTTGAAATTTTCATGATGGGCGAAGAAGCAAAACTGGCAGGTCAA
CAGGAATATCACCGCAATCTGCGAACCCTGTCTGACTGCCTGAATACCGATGAA
TGGCCAGCTATTAAGACATTATCACTGCCCCGCTGGGCTAAGGAATATGCAAAT
GACCTGCAGAAAAGGCCGGCGGCCACGAAAAAGGCCGGCCAGGCAAAAAAGA
KYSLSKTLRFELIPQGKTLENIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEE
ILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDFKSAKDTIKKQISEYIKDSEKF
KNLFNQNLIDAKKGQESDLILWLKQSKDNGIELFKANSDITDIDEALEIIKSFKG
WTTYFKGFHENRKNVYSSNDIPTSHYRIVDDNLPKFLENKAKYESLKDKAPEAI
NYEQIKKDLAEELTFDIDYKTSEVNQRVFSLDEVFEIANFNNYLNQSGITKFNTII
GGKFVNGENTKRKGINEYINLYSQQINDKTLKKYKMSVLFKQILSDTESKSFVI
DKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSLLFDDLKAQKLDLSKIYF
KNDKSLTDLSQQVFDDYSVIGTAVLEYITQQIAPKNLDNPSKKEQELIAKKTEK
AKYLSLETIKLALEEFNKHRDIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQI
SIKYQNQGKKDLLQASAEDDVKAIKDLLDQTNNLLHKLKIFHISQSEDKANILD
KDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNFENSTLANGWD
KNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGEGYKKIVYKLLP
GANKMLPKVFFSAKSIKFYNPSEDILRIRNHSTHTKNGSPQKGYEKFEFNIEDC
RKFIDFYKQSISKHPEWKDFGFRFSDTQRYNSIDEFYREVENQGYKLTFENISES
YIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLHTLYWKALFDERNLQDVVYKLN
GEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIKDKRFTEDKFF
FHCPITINFKSSGANKFNDEINLLLKEKANDVHILSIDRGERHLAYYTLVDGKG
NIIKQDTFNIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNIKEMKEGYLS
QVVHEIAKLVIEYNAIVVFEDLNFGFKRGRFKVEKQVYQKLEKMLIEKLNYLV
FKDNEFDKTGGVLRAYQLTAPFETFKKMGKQTGIIYYVPAGFTSKICPVTGFV
NQLYPKYESVSKSQEFFSKFDKICYNLDKGYFEFSFDYKNFGDKAAKGKWTIA
SFGSRLINFRNSDKNHNWDTREVYPTKELEKLLKDYSIEYGHGECIKAAICGES
DKKFFAKLTSVLNTILQMRNSKTGTELDYLISPVADVNGNFFDSRQAPKNMPQ
DADANGAYHIGLKGLMLLGRIKNNQEGKKLNLVIKNEEYFEFVQNRNNQAAA
AVATNFPVVNDLPAEGEIDFTWSERYQLSKDSMTWELKPGAAPDNAHYQGNTNVN
GEDMTEIEENMLLPISGQELPIRWLAQHGSEKPVTHVSRDGLQALHIARAEELPAVT
ALAVSHKTSLLDPLEIRELHKLVRDTDKVFPNPGNSNLGLITAFFEAYLNADYTDRG
LLTKEWMKGNRVSHITRTASGANAGGGNLTDRGEGFVHDLTSLARDVATGVLARS
MDLDIYNLHPAHAKRIEEIIAENKPPFSVFRDKFITMPGGLDYSRAIVVASVKEAPIGI
EVIPAHVTEYLNKVLTETDHANPDPEIVDIACGRSSAPMPQRVTEEGKQDDEEKPQP
SGTTAVEQGEAETMEPDATEHHQDTQPLDAQSQVNSVDAKYQELRAELHEARKNI
PSKNPVDDDKLLAASRGEFVDGISDPNDPKWVKGIQTRDCVYQNQPEIEKTSPDMN
QPEPVVQQEPEIACNACGQTGGDNCPDCGAVMGDATYQETFDEESQVEAKENDPE
EMEGAEHPHNENAGSDPHRDCSDETGEVADPVIVEDIEPGIYYGISNENYHAGPGIS
KSQLDDTADTPALYLWRKNAPVDTTKTKTLDLGTAFHCRVLEPEEFSNRFIVAPEFN
RRTNAGKEEEKAFLMECASTGKTVITAEEGRKIELMYQSVMALPLGQWLVESAGH
AESSIYWEDPETGILCRCRPDKIIPEFHWIMDVKTTADIQRFKTAYYDYRYHVQDAF
YSDGYEAQFGVQPTFVFLVASTTIECGRYPVEIFMMGEEAKLAGQQEYHRNLRTLS
DCLNTDEWPAIKTLSLPRWAKEYANDLQKRPAATKKAGQAKKKKHHHHHH
TAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGTAAA
ACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAAAGA
GCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAGTTTT
TTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTACAAAA
CTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCTACAA
AAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGAATAT
ATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATCGATG
CTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCTAAGG
ATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATAGATG
AGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTAAGG
GTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTACATC
TATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAATAAA
GCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTATGAA
CAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTACAAA
ACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGATAG
CAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATACTAT
TATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTATAAA
TGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAAAAA
TATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTAAAT
CTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGATGC
AAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATCTA
TTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTTGA
TTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCACAA
CAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATATAA
CTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCAAG
AATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAACTAT
AAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACAGTG
TAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATTTGAT
GAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATATCAA
AATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGTTAAA
GCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTAAAAA
TATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAGGATG
AGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAATATAGT
GCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATAGTGAT
GAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTTGGGAT
AAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATGATAAAT
ATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATGATAAAG
CTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATAAACTTTT
ACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAAATCTATA
AAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCATTCCACAC
ATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAGTTTAATA
TTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAAGTAAGCA
TCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAAGATATAAT
TCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACAAACTAACTT
TTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCAGGGTAAAT
TGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCG
ACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTT
CAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAA
CAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCAATAGCTAAT
AAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCA
AAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAAT
CAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAATCAATTTATTG
CTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGATAGAGGTGAA
AGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAATATCATCAAA
CAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAAACTACCAT
GATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGG
AAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTA
GTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTG
AGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGG
TCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTT
CAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCT
AACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTAT
CTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTT
GTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTC
TTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGT
TTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGA
CTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAA
ATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAAT
TGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAG
CTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCC
TAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTA
TCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACA
GGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATAT
TGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGG
CAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCA
GAATAGGAATAACCAAGCGGCCGCACTCGACCTCGAGATGGATCCACCACGAG
CGTCCCACTTGAGCCCTCGGAAGAAGAGACCCCGGCAGACGGGTGCCTTGATGG
CCTCCTCTCCTCAAGACATCAAATTTCAAGATTTGGTCGTCTTCATTTTGGAGAA
GAAAATGGGAACCACCCGCAGAGCGTTCCTCATGGAGCTGGCCCGCAGGAAAG
GGTTCAGGGTTGAAAATGAGCTCAGTGATTCTGTCACCCACATTGTAGCAGAGA
ACAACTCGGGTTCGGATGTTCTGGAGTGGCTTCAAGCACAGAAAGTACAAGTCA
GCTCACAACCAGAGCTCCTCGATGTCTCCTGGCTGATCGAATGCATAGGAGCAG
GGAAACCGGTGGAAATGACAGGAAAACACCAGCTTGTTGTGAGAAGAGACTAT
TCAGATAGCACCAACCCAGGCCCCCCGAAGACTCCACCAATTGCTGTACAAAAG
ATCTCCCAGTATGCGTGTCAGAGAAGAACCACTTTAAACAACTGTAACCAGATA
TTCACGGATGCCTTTGATATACTGGCTGAAAACTGTGAGTTTAGAGAAAATGAA
GACTCCTGTGTGACATTTATGAGAGCAGCTTCTGTATTGAAATCTCTGCCATTCA
CAATCATCAGTATGAAGGACACAGAAGGAATTCCCTGCCTGGGGTCCAAGGTG
AAGGGTATCATAGAGGAGATTATTGAAGATGGAGAAAGTTCTGAAGTTAAAGC
TGTGTTAAATGATGAACGATATCAATCCTTCAAACTCTTTACTTCTGTATTTGGA
GTGGGGCTGAAGACTTCTGAGAAGTGGTTCAGGATGGGTTTCAGAACTCTGAGT
AAAGTAAGGTCGGACAAAAGCCTGAAATTTACACGAATGCAGAAAGCAGGATT
TCTGTATTATGAAGACCTTGTCAGCTGTGTGACCAGGGCAGAAGCAGAGGCCGT
CAGTGTGCTGGTTAAAGAGGCTGTCTGGGCATTTCTTCCGGATGCTTTCGTCACC
ATGACAGGAGGGTTCCGGAGGGGTAAGAAGATGGGGCATGATGTAGATTTTTT
AATTACCAGCCCAGGATCAACAGAGGATGAAGAGCAACTTTTACAGAAAGTGA
TGAACTTATGGGAAAAGAAGGGATTACTTTTATATTATGACCTTGTGGAGTCAA
CATTTGAAAAGCTCAGGTTGCCTAGCAGGAAGGTTGATGCTTTGGATCATTTTC
AAAAGTGCTTTCTGATTTTCAAATTGCCTCGTCAAAGAGTGGACAGTGACCAGT
CCAGCTGGCAGGAAGGAAAGACCTGGAAGGCCATCCGTGTGGATTTAGTTCTGT
GCCCCTACGAGCGTCGTGCCTTTGCCCTGTTGGGATGGACTGGCTCCCGGCAGTT
TGAGAGAGACCTCCGGCGCTATGCCACACATGAGCGGAAGATGATTCTGGATA
ACCATGCTTTATATGACAAGACCAAGAGGATATTCCTCAAAGCAGAAAGTGAA
GAAGAAATTTTTGCGCATCTGGGATTGGATTATATTGAACCGTGGGAAAGAAAT
GCCCTCGAGAAAAGGCCGGCGGCCACGAAAAAGGCCGGCCAGGCAAAAAAGA
KYSLSKTERFELIPQGKTLENIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEE
ILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDEKSAKDTIKKQISEYIKDSEKE
KNLENQNLIDAKKGQESDLIEWLKQSKDNGIELFKANSDITDIDEALEIIKSFKG
WTTYFKGEHENRKNVYSSNDIPTSIIYRIVDDNLPKFLENKAKYESLKDKAPEAI
NYEQIKKDLAEELTEDIDYKTSEVNQRVESLDEVFEIANENNYLNQSGITKENTII
GGKEVNGENTKRKGINEYINLYSQQINDKTEKKYKMSVLEKQILSDTESKSFVI
DKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSELFDDLKAQKLDLSKIYF
KNDKSLTDESQQVFDDYSVIGTAVLEYITQQIAPKNEDNPSKKEQELIAKKTEK
AKYLSLETIKLALEEENKHRDIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQI
SIKYQNQGKKDLLQASAEDDVKAIKDELDQTNNELHKEKIFHISQSEDKANILD
KDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNFENSTLANGWD
KNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGEGYKKIVYKLLP
GANKMLPKVFFSAKSIKEYNPSEDILRIRNHSTHTKNGSPQKGYEKFEENIEDC
RKFIDEYKQSISKHPEWKDEGFRESDTQRYNSIDEFYREVENQGYKLTFENISES
YIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLIITLYWKALFDERNLQDVVYKLN
GEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIKDKRFTEDKFF
FHCPITINEKSSGANKENDEINELLKEKANDVHILSIDRGERHLAYYTLVDGKG
NIIKQDTENIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNIKEMKEGYLS
QVVHEIAKLVIEYNAIVVFEDLNEGFKRGREKVEKQVYQKLEKMLIEKLNYLV
FKDNEFDKTGGVERAYQLTAPFETFKKMGKQTGIIYYVPAGFTSKICPVTGEV
NQLYPKYESVSKSQEFFSKEDKICYNEDKGYFEFSFDYKNEGDKAAKGKWTIA
SFGSRLINFRNSDKNHNWDTREVYPTKELEKELKDYSIEYGHGECIKAAICGES
DKKFFAKETSVENTILQMRNSKTGTELDYLISPVADVNGNFEDSRQAPKNMPQ
DADANGAYHIGLKGEMLLGRIKNNQEGKKLNLVIKNEEYFEFVQNRNNQAAA
MELARRKGFRVENELSDSVTHIVAENNSGSDVLEWLQAQKVQVSSQPELLDVSWLI
ECIGAGKPVEMTGKHQLVVRRDYSDSTNPGPPKTPPIAVQKISQYACQRRTTLNNC
NQIFTDAFDILAENCEFRENEDSCVTFMRAASVLKSLPFTIISMKDTEGIPCLGSKVK
GIIEEIIEDGESSEVKAVLNDERYQSFKLFTSVFGVGLKTSEKWFRMGFRTLSKVRSD
KSLKFTRMQKAGFLYYEDLVSCVTRAEAEAVSVLVKEAVWAFLPDAFVTMTGGFR
RGKKMGHDVDFLITSPGSTEDEEQLLQKVMNLWEKKGLLLYYDLVESTFEKLRLPS
RKVDALDHFQKCFLIFKLPRQRVDSDQSSWQEGKTWKAIRVDLVLCPYERRAFALL
GWTGSRQFERDLRRYATHERKMILDNHALYDKTKRIFLKAESEEEIFAHLGLDYIEP
WERNALEKRPAATKKAGQAKKKKHHHHH
TAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGTAAA
ACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAAAGA
GCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAGTTTT
TTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTACAAAA
CTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCTACAA
AAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGAATAT
ATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATCGATG
CTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCTAAGG
ATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATAGATG
AGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTAAGG
GTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTACATC
TATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAATAAA
GCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTATGAA
CAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTACAAA
ACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGATAG
CAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATACTAT
TATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTATAAA
TGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAAAAA
TATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTAAAT
CTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGATGC
AAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATCTA
TTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTTGA
TTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCACAA
CAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATATAA
CTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCAAG
AATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAACTAT
AAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACAGTG
TAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATTTGAT
GAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATATCAA
AATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGTTAAA
GCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTAAAAA
TATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAGGATG
AGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAATATAGT
GCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATAGTGAT
GAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTTGGGAT
AAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATGATAAAT
ATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATGATAAAG
CTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATAAACTTTT
ACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAAATCTATA
AAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCATTCCACAC
ATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAGTTTAATA
TTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAAGTAAGCA
TCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAAGATATAAT
TCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACAAACTAACTT
TTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCAGGGTAAAT
TGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCG
ACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTT
CAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAA
CAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCAATAGCTAAT
AAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCA
AAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAAT
CAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAATCAATTTATTG
CTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGATAGAGGTGAA
AGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAATATCATCAAA
CAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAAACTACCAT
GATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGG
AAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTA
GTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTG
AGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGG
TCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTT
CAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCT
AACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTAT
CTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTT
GTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTC
TTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGT
TTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGA
CTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAA
ATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAAT
TGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAG
CTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCC
TAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTA
TCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACA
GGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATAT
TGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGG
CAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCA
GAATAGGAATAACCAAGCGGCCGCACTCGACCTGCAGATGGCTTCCCGTCGTA
ATCTAATGATTGTCGATGGAACTAACTTAGGCTTTCGCTTCAAACATAACAATA
GTAAAAAACCATTTGCCTCAAGTTATGTTTCAACTATTCAATCTCTGGCAAAATC
CTACTCTGCCAGAACTACGATTGTTCTAGGTGATAAGGGAAAATCTGTATTTCGT
CTAGAACATCTACCAGAGTATAAAGGTAATCGTGATGAAAAGTACGCACAACG
TACGGAAGAGGAGAAAGCGCTAGATGAGCAGTTCTTTGAGTATTTGAAGGATG
CTTTCGAGTTGTGTAAAACTACATTCCCAACTTTTACCATTCGTGGTGTAGAAGC
AGACGATATGGCAGCTTATATTGTTAAGCTCATCGGGCATCTTTATGATCACGTT
TGGCTAATATCTACAGATGGTGACTGGGATACTTTATTAACGGATAAAGTTTCTC
GTTTTTCTTTCACAACACGTCGTGAGTATCATCTTCGTGATATGTATGAACATCA
TAATGTTGATGATGTTGAGCAGTTTATCTCCCTGAAAGCAATTATGGGAGATCT
AGGAGATAATATTCGTGGTGTTGAAGGAATAGGAGCAAAACGCGGATATAATA
TTATTCGTGAGTTTGGTAACGTACTGGATATTATTGATCAGCTTCCACTGCCTGG
AAAGCAGAAATATATACAGAACCTGAATGCATCGGAAGAACTGCTTTTCCGAA
ACTTGATTCTGGTTGATTTACCTACCTACTGTGTGGATGCTATTGCTGCTGTAGG
TCAAGATGTGTTAGATAAGTTTACAAAAGATATTTTGGAGATTGCAGAACAACT
KYSLSKTERFELIPQGKTLENIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEE
ILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDEKSAKDTIKKQISEYIKDSEKE
KNLENQNLIDAKKGQESDLIEWLKQSKDNGIELFKANSDITDIDEALEIIKSFKG
WTTYFKGEHENRKNVYSSNDIPTSIIYRIVDDNLPKFLENKAKYESLKDKAPEAI
NYEQIKKDLAEELTEDIDYKTSEVNQRVESLDEVFEIANENNYLNQSGITKENTII
GGKEVNGENTKRKGINEYINLYSQQINDKTEKKYKMSVLEKQILSDTESKSFVI
DKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSELFDDLKAQKLDLSKIYF
KNDKSLTDESQQVFDDYSVIGTAVLEYITQQIAPKNEDNPSKKEQELIAKKTEK
AKYLSLETIKLALEEFNKHRDIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQI
SIKYQNQGKKDLLQASAEDDVKAIKDELDQTNNELHKEKIFHISQSEDKANILD
KDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNFENSTLANGWD
KNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGEGYKKIVYKLLP
GANKMLPKVFFSAKSIKFYNPSEDILRIRNHSTHTKNGSPQKGYEKFEFNIEDC
RKFIDFYKQSISKHPEWKDFGFRFSDTQRYNSIDEFYREVENQGYKLTFENISES
YIDSVVNQGKLYLFQIYNKDFSAYSKGRPNEHTLYWKALFDERNLQDVVYKLN
GEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIKDKRFTEDKFF
FHCPITINFKSSGANKFNDEINELLKEKANDVHILSIDRGERHLAYYTLVDGKG
NIIKQDTFNIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNIKEMKEGYLS
QVVHEIAKLVIEYNAIVVFEDLNFGFKRGRFKVEKQVYQKLEKMLIEKLNYLV
FKDNEFDKTGGVERAYQLTAPFETFKKAIGKQTGIIYYVPAGFTSKICPVTGFV
NQLYPKYESVSKSQEFFSKFDKICYNEDKGYFEFSFDYKNFGDKAAKGKWTIA
SFGSRLINFRNSDKNHNWDTREVYPTKELEKELKDYSIEYGHGECIKAAICGES
DKKFFAKETSVENTILQMRNSKTGTELDYLISPVADVNGNFFDSRQAPKNMPQ
DADANGAYHIGLKGEMLLGRIKNNQEGKKLNLVIKNEEYFEFVQNRNNQAAA
KGKSVFRLEHLPEYKGNRDEKYAQRTEEEKALDEQFFEYLKDAFELCKTTFPTFTIR
GVEADDMAAYIVKLIGHLYDHVWLISTDGDWDTLLTDKVSRFSFTTRREYHLRDM
YEHHNVDDVEQFISLKAIMGDLGDNIRGVEGIGAKRGYNIIREFGNVLDIIDQLPLPG
KQKYIQNLNASEELLFRNLILVDLPTYCVDAIAAVGQDVLDKFTKDILEIAEQLQKR
TAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGTAAA
ACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAAAGA
GCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAGTTTT
TTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTACAAAA
CTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCTACAA
AAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGAATAT
ATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATCGATG
CTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCTAAGG
ATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATAGATG
AGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTAAGG
GTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTACATC
TATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAATAAA
GCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTATGAA
CAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTACAAA
ACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGATAG
CAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATACTAT
TATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTATAAA
TGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAAAAA
TATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTAAAT
CTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGATGC
AAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATCTA
TTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTTGA
TTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCACAA
CAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATATAA
CTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCAAG
AATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAACTAT
AAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACAGTG
TAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATTTGAT
GAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATATCAA
AATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGTTAAA
GCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTAAAAA
TATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAGGATG
AGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAATATAGT
GCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATAGTGAT
GAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTTGGGAT
AAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATGATAAAT
ATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATGATAAAG
CTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATAAACTTTT
ACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAAATCTATA
AAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCATTCCACAC
ATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAGTTTAATA
TTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAAGTAAGCA
TCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAAGATATAAT
TCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACAAACTAACTT
TTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCAGGGTAAAT
TGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCG
ACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTT
CAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAA
CAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCAATAGCTAAT
AAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCA
AAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAAT
CAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAATCAATTTATTG
CTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGATAGAGGTGAA
AGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAATATCATCAAA
CAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAAACTACCAT
GATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGG
AAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTA
GTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTG
AGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGG
TCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTT
CAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCT
AACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTAT
CTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTT
GTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTC
TTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGT
TTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGA
CTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAA
ATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAAT
TGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAG
CTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCC
TAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTA
TCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACA
GGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATAT
TGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGG
CAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCA
GAATAGGAATAACCAAGCGGCCGCACTCGACCTCGAGATGACACCGGACATTA
TCCTGCAGCGTACCGGGATCGATGTGAGAGCTGTCGAACAGGGGGATGATGCGT
GGCACAAATTACGGCTCGGCGTCATCACCGCTTCAGAAGTTCACAACGTGATAG
CAAAACCCCGCTCCGGAAAGAAGTGGCCTGACATGAAAATGTCCTACTTCCACA
CCCTGCTTGCTGAGGTTTGCACCGGTGTGGCTCCGGAAGTTAACGCTAAAGCAC
TGGCCTGGGGAAAACAGTACGAGAACGACGCCAGAACCCTGTTTGAATTCACTT
CCGGCGTGAATGTTACTGAATCCCCGATCATCTATCGCGACGAAAGTATGCGTA
CCGCCTGCTCTCCCGATGGTTTATGCAGTGACGGCAACGGCCTTGAACTGAAAT
GCCCGTTTACCTCCCGGGATTTCATGAAGTTCCGGCTCGGTGGTTTCGAGGCCAT
AAAGTCAGCTTACATGGCCCAGGTGCAGTACAGCATGTGGGTGACGCGAAAAA
ATGCCTGGTACTTTGCCAACTATGACCCGCGTATGAAGCGTGAAGGCCTGCATT
ATGTCGTGATTGAGCGGGATGAAAAGTACATGGCGAGTTTTGACGAGATCGTGC
CGGAGTTCATCGAAAAAATGGACGAGGCACTGGCTGAAATTGGTTTTGTATTTG
GGGAGCAATGGCGACTCGAGAAAAGGCCGGCGGCCACGAAAAAGGCCGGCCA
KYSLSKTERFELIPQGKTLENIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEE
ILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDEKSAKDTIKKQISEYIKDSEKE
KNLENQNLIDAKKGQESDLIEWLKQSKDNGIELFKANSDITDIDEALEIIKSFKG
WTTYFKGEHENRKNVYSSNDIPTSIIYRIVDDNLPKFLENKAKYESLKDKAPEAI
NYEQIKKDLAEELTEDIDYKTSEVNQRVESLDEVFEIANENNYLNQSGITKENTII
GGKEVNGENTKRKGINEYINLYSQQINDKTEKKYKMSVLEKQILSDTESKSFVI
DKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSELFDDLKAQKLDLSKIYF
KNDKSLTDESQQVFDDYSVIGTAVLEYITQQIAPKNEDNPSKKEQELIAKKTEK
AKYLSLETIKLALEEENKHRDIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQI
SIKYQNQGKKDLLQASAEDDVKAIKDELDQTNNELHKEKIFHISQSEDKANILD
KDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNFENSTLANGWD
KNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGEGYKKIVYKLLP
GANKMLPKVFFSAKSIKEYNPSEDILRIRNHSTHTKNGSPQKGYEKFEENIEDC
RKFIDEYKQSISKHPEWKDEGFRESDTQRYNSIDEFYREVENQGYKLTFENISES
YIDSVVNQGKLYLFQIYNKDFSAYSKGRPNEHTLYWKALFDERNLQDVVYKLN
GEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIKDKRFTEDKFF
FHCPITINEKSSGANKENDEINELLKEKANDVHILSIDRGERHLAYYTLVDGKG
NIIKQDTENIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNIKEMKEGYLS
QVVHEIAKLVIEYNAIVVFEDLNEGFKRGREKVEKQVYQKLEKMLIEKLNYLV
FKDNEFDKTGGVERAYQLTAPFETFKKAIGKQTGIIYYVPAGFTSKICPVTGEV
NQLYPKYESVSKSQEFFSKEDKICYNEDKGYFEFSFDYKNEGDKAAKGKWTIA
SEGSRLINFRNSDKNHNWDTREVYPTKELEKELKDYSIEYGHGECIKAAICGES
DKKFFAKETSVENTILQMRNSKTGTELDYLISPVADVNGNFEDSRQAPKNMPQ
DADANGAYHIGLKGEMLLGRIKNNQEGKKLNLVIKNEEYFEFVQNRNNQAAA
MKMSYFHTLLAEVCTGVAPEVNAKALAWGKQYENDARTLFEFTSGVNVTESPITYR
DESMRTACSPDGLCSDGNGLELKCPFTSRDFMKFRLGGFEAIKSAYMAQVQYSMW
VIRKNAWYFANYDPRMKREGLHYVVIERDEKYMASFDEIVPEFIEKMDEALAEIGF
VFGEQWRLEKRPAATKKAGQAKKKKHHHHH
TAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGTAAA
ACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAAAGA
GCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAGTTTT
TTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTACAAAA
CTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCTACAA
AAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGAATAT
ATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATCGATG
CTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCTAAGG
ATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATAGATG
AGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTAAGG
GTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTACATC
TATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAATAAA
GCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTATGAA
CAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTACAAA
ACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGATAG
CAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATACTAT
TATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTATAAA
TGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAAAAA
TATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTAAAT
CTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGATGC
AAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATCTA
TTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTTGA
TTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCACAA
CAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATATAA
CTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCAAG
AATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAACTAT
AAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACAGTG
TAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATTTGAT
GAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATATCAA
AATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGTTAAA
GCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTAAAAA
TATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAGGATG
AGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAATATAGT
GCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATAGTGAT
GAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTTGGGAT
AAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATGATAAAT
ATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATGATAAAG
CTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATAAACTTTT
ACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAAATCTATA
AAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCATTCCACAC
ATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAGTTTAATA
TTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAAGTAAGCA
TCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAAGATATAAT
TCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACAAACTAACTT
TTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCAGGGTAAAT
TGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCG
ACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTT
CAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAA
CAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCAATAGCTAAT
AAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCA
AAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAAT
CAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAATCAATTTATTG
CTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGATAGAGGTGAA
AGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAATATCATCAAA
CAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAAACTACCAT
GATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGG
AAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTA
GTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTG
AGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGG
TCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTT
CAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCT
AACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTAT
CTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTT
GTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTC
TTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGT
TTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGA
CTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAA
ATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAAT
TGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAG
CTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCC
TAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTA
TCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACA
GGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATAT
TGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGG
CAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCA
GAATAGGAATAACCAAGCGGCCGCACTCGACCTGCAGATGCAAACGTTACAGA
TGAGTCTGTTGACACAACCTTACGTTCAGCCTCGTTTCCCTTGCAAGCGTTACCC
GACCTTCTCCGCATCCTGCAGAACTCAAAAGACAGCGATCACGAAAACAGAGA
AGGTGTTTTTCAGTGAGTCATTTGATCAAACACGTTGCACGCAGCCTCTCTCGGA
AAAGAAGAAGAGGGTGTTCTTTTTGGACGTTAACCCGCTCTGTTACGAAGGAAG
CAAGCCCAGCTTGCGCTCCTTCGGGCGGTGGCTCTCTCTGTTTCTCCATCAAGTC
AGCCTCACTGACCCCGTCATTGCTGTTATTGATGGAGAAGGAGGCAGCGAGCAT
CGCAGAAAGTTGCTACCTTCATATAAAGCACATAGGAAAAAGTTCATGAGACAC
ATGTCAAGTGGCCATGTTGGGAGGTCTCATCAAGTTATAAATGATGTTCTTGGA
AAATGCAACGTGCCAGTTATAAAGGTTGCTGGTCATGAAGCTGATGATGTTGTA
GCTACTCTAGCTGGACAAGTTGTCAATAAAGGGTTTCGAGTGGTCATTGGCTCC
CCTGATAAGGATTTTAAGCAGCTTATATCTGAAGATGTGCAAATAGTTATGCCTT
TGCCAGAGTTACAAAGGTGGTCCTTCTACACTCTGAGGCACTACAGGGATCAGT
ATAATTGTGATCCAGAATCTGATCTGAGCTTTAGATGCATTGTAGGTGATGAAG
TAGACGGCGTTCCTGGTATCCAGCATTTGGTCCCTAGTTTTGGTCGGAAGACTGC
TATGAAACTTATTAAAAAACATGGTTCCTTGGAAACTTTATTAAATGCGGCTGC
AATAAGGACTGTAGGCAGACCATATGCACAGGATGCCCTCAAAAACCATGCTG
ATTACCTTCGGAGAAACTATGAAGTTCTTGCCTTGAAAAGGGATGTAAATATCC
AACTTTATGATGAGTGGTTGGTTAAGAGAGACAATCACAATGATAAAACTGCAC
TATCTTCCTTCTTCAAATATTTGGGAGAAAGTAAGGAGCTCAGTTACAATGGCA
GACCTATCTCTTACAATGGTCTGCAGAAAAGGCCGGCGGCCACGAAAAAGGCC
KYSLSKTLRFELIPQGKTLENIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEE
ILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDFKSAKDTIKKQISEYIKDSEKF
KNLFNQNLIDAKKGQESDLILWLKQSKDNGIELFKANSDITDIDEALEIIKSFKG
WTTYFKGFHENRKNVYSSNDIPTSHYRIVDDNLPKFLENKAKYESLKDKAPEAI
NYEQIKKDLAEELTFDIDYKTSEVNQRVFSLDEVFEIANFNNYLNQSGITKFNTII
GGKFVNGENTKRKGINEYINLYSQQINDKTLKKYKMSVLFKQILSDTESKSFVI
DKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSLLFDDLKAQKLDLSKIYF
KNDKSLTDLSQQVFDDYSVIGTAVLEYITQQIAPKNLDNPSKKEQELIAKKTEK
AKYLSLETIKLALEEFNKHRDIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQI
SIKYQNQGKKDLLQASAEDDVKAIKDLLDQTNNLLHKLKIFHISQSEDKANILD
KDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNFENSTLANGWD
KNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGEGYKKIVYKLLP
GANKMLPKVFFSAKSIKFYNPSEDILRIRNHSTHTKNGSPQKGYEKFEFNIEDC
RKFIDFYKQSISKHPEWKDFGFRFSDTQRYNSIDEFYREVENQGYKLTFENISES
YIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLHTLYWKALFDERNLQDVVYKLN
GEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIKDKRFTEDKFF
FHCPITINFKSSGANKFNDEINLLLKEKANDVHILSIDRGERHLAYYTLVDGKG
NIIKQDTFNIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNIKEMKEGYLS
QVVHEIAKLVIEYNAIVVFEDLNFGFKRGRFKVEKQVYQKLEKMLIEKLNYLV
FKDNEFDKTGGVLRAYQLTAPFETFKKMGKQTGIIYYVPAGFTSKICPVTGFV
NQLYPKYESVSKSQEFFSKFDKICYNLDKGYFEFSFDYKNFGDKAAKGKWTIA
SFGSRLINFRNSDKNHNWDTREVYPTKELEKLLKDYSIEYGHGECIKAAICGES
DKKFFAKLTSVLNTILQMRNSKTGTELDYLISPVADVNGNFFDSRQAPKNMPQ
DADANGAYHIGLKGLMLLGRIKNNQEGKKLNLVIKNEEYFEFVQNRNNQAAA
CTQPLSEKKKRVFFLDVNPLCYEGSKPSLRSFGRWLSLFLHQVSLTDPVIAVIDGEG
GSEHRRKLLPSYKAHRKKFMRHMSSGHVGRSHQVINDVLGKCNVPVIKVAGHEAD
DVVATLAGQVVNKGFRVVIGSPDKDFKQLISEDVQIVMPLPELQRWSFYTLRHYRD
QYNCDPESDLSFRCIVGDEVDGVPGIQHLVPSFGRKTAMKLIKKHGSLETLLNAAAI
RTVGRPYAQDALKNHADYLRRNYEVLALKRDVNIQLYDEWLVKRDNHNDKTALS
SFFKYLGESKELSYNGRPISYNGLQKRPAATKKAGQAKKKKHHHHH
TAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGTAAA
ACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAAAGA
GCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAGTTTT
TTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTACAAAA
CTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCTACAA
AAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGAATAT
ATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATCGATG
CTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCTAAGG
ATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATAGATG
AGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTAAGG
GTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTACATC
TATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAATAAA
GCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTATGAA
CAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTACAAA
ACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGATAG
CAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATACTAT
TATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTATAAA
TGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAAAAA
TATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTAAAT
CTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGATGC
AAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATCTA
TTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTTGA
TTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCACAA
CAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATATAA
CTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCAAG
AATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAACTAT
AAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACAGTG
TAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATTTGAT
GAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATATCAA
AATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGTTAAA
GCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTAAAAA
TATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAGGATG
AGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAATATAGT
GCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATAGTGAT
GAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTTGGGAT
AAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATGATAAAT
ATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATGATAAAG
CTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATAAACTTTT
ACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAAATCTATA
AAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCATTCCACAC
ATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAGTTTAATA
TTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAAGTAAGCA
TCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAAGATATAAT
TCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACAAACTAACTT
TTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCAGGGTAAAT
TGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCG
ACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTT
CAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAA
CAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCAATAGCTAAT
AAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCA
AAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAAT
CAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAATCAATTTATTG
CTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGATAGAGGTGAA
AGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAATATCATCAAA
CAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAAACTACCAT
GATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGG
AAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTA
GTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTG
AGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGG
TCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTT
CAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCT
AACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTAT
CTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTT
GTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTC
TTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGT
TTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGA
CTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAA
ATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAAT
TGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAG
CTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCC
TAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTA
TCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACA
GGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATAT
TGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGG
CAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCA
GAATAGGAATAACCAAGCGGCCGCACTCGACCTCGAGATGAGTAAAGGAGAA
GAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATG
GGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAA
CTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACAC
TTGTCACTACTTTCTCTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATAT
GAAGCGGCACGACTTCTTCAAGAGCGCCATGCCTGAGGGATACGTGCAGGAGA
GGACCATCTCTTTCAAGGACGACGGGAACTACAAGACACGTGCTGAAGTCAAGT
TTGAGGGAGACACCCTCGTCAACAGGATCGAGCTTAAGGGAATCGATTTCAAGG
AGGACGGAAACATCCTCGGCCACAAGTTGGAATACAACTACAACTCCCACAAC
GTATACATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTAACTTCAAAAT
TAGACACAACATTGAAGATGGAAGCGTTCAACTAGCAGACCATTATCAACAAA
ATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTCCAC
ACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTTCT
TGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAACT
KYSLSKTLRFELIPQGKTLENIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEE
ILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDFKSAKDTIKKQISEYIKDSEKF
KNLFNQNLIDAKKGQESDLILWLKQSKDNGIELFKANSDITDIDEALEIIKSFKG
WTTYFKGFHENRKNVYSSNDIPTSHYRIVDDNLPKFLENKAKYESLKDKAPEAI
NYEQIKKDLAEELTFDIDYKTSEVNQRVFSLDEVFEIANFNNYLNQSGITKFNTII
GGKFVNGENTKRKGINEYINLYSQQINDKTLKKYKMSVLFKQILSDTESKSFVI
DKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSLLFDDLKAQKLDLSKIYF
KNDKSLTDLSQQVFDDYSVIGTAVLEYITQQIAPKNLDNPSKKEQELIAKKTEK
AKYLSLETIKLALEEFNKHRDIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQI
SIKYQNQGKKDLLQASAEDDVKAIKDLLDQTNNLLHKLKIFHISQSEDKANILD
KDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNFENSTLANGWD
KNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGEGYKKIVYKLLP
GANKMLPKVFFSAKSIKFYNPSEDILRIRNHSTHTKNGSPQKGYEKFEFNIEDC
RKFIDFYKQSISKHPEWKDFGFRFSDTQRYNSIDEFYREVENQGYKLTFENISES
YIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLHTLYWKALFDERNLQDVVYKLN
GEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIKDKRFTEDKFF
FHCPITINFKSSGANKFNDEINLLLKEKANDVHILSIDRGERHLAYYTLVDGKG
NIIKQDTFNIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNIKEMKEGYLS
QVVHEIAKLVIEYNAIVVFEDLNEGFKRGREKVEKQVYQKLEKMLIEKLNYLV
FKDNEFDKTGGVLRAYQLTAPFETFKKMGKQTGIIYYVPAGFTSKICPVTGEV
NQLYPKYESVSKSQEFFSKEDKICYNLDKGYFEFSFDYKNEGDKAAKGKWTIA
SEGSRLINFRNSDKNHNWDTREVYPTKELEKLLKDYSIEYGHGECIKAAICGES
DKKFFAKLTSVLNTILQMRNSKTGTELDYLISPVADVNGNFEDSRQAPKNMPQ
DADANGAYHIGLKGLMLLGRIKNNQEGKKLNLVIKNEEYFEFVQNRNNQAAA
LPVPWPTLVTTFSYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGNYKT
RAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKAN
FKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVL
LEFVTAAGITHGMDELYKLEKRPAATKKAGQAKKKKHHHHH
ACAACAGATACAACTTCGTCGCCGTGAAGTCGATGAAACGGCAGACTTGCCCGC
TGAATTGCCTCCCTTGCTGCGCCGTTTATACGCCAGCCGGGGCGTGCGCAGTGC
GCAAGAACTGGAACGCAGTGTTAAAGGTATGTTGCCCTGGCAGCAACTGAGCG
GCGTCGAAAAGGCCGTTGAGATCCTTTACAACGCTTTTCGCGAAGGAACGCGGA
TTATTGTGGTCGGCGATTTTGACGCCGACGGCGCGACCAGCACGGCTCTAAGCG
TGCTGGCGATGCGCTCGCTTGGTTGCAGCAATATCGACTATCTGGTACCAAACC
GTTTCGAAGACGGTTACGGCTTAAGCCCGGAAGTAGTCGATCAGGCCCATGCCC
GTGGCGCGCAGTTAATTGTCACGGTGGATAACGGTATTTCCTCCCATGCGGGCG
TTGAACACGCTCGCTCGTTGGGCATTCCGGTTATTGTTACCGATCACCATTTGCC
GGGCGAAACATTACCCGCAGCGGAAGCGATCATTAACCCTAACTTGCGCGACTG
TAATTTCCCGTCGAAATCACTGGCAGGCGTGGGTGTGGCGTTTTATCTGATGCTG
GCGCTGCGCACCTTTTTGCGCGATCAGGGCTGGTTTGATGAGCGTGGCATCGCA
ATTCCTAACCTGGCAGAACTGCTGGATCTGGTCGCGCTGGGAACAGTGGCGGAC
GTCGTGCCGCTGGACGCTAATAATCGCATTCTGACCTGGCAGGGGATGAGTCGC
ATCCGTGCCGGAAAGTGCCGTCCAGGGATTAAAGCGCTGCTGGAAGTGGCAAA
CCGTGATGCACAAAAACTCGCCGCCAGCGATTTAGGTTTTGCGCTGGGGCCACG
TCTCAATGCTGCCGGACGACTGGACGATATGTCCGTCGGTGTGGCGCTCTTGCT
GTGCGACAACATCGGCGAAGCGCGCGTGCTGGCAAATGAACTCGATGCGCTAA
ACCAGACGCGAAAAGAGATCGAACAAGGAATGCAAGTTGAAGCCCTGACCCTG
TGCGAGAAACTGGAGCGAAGTCGCGACACGCTACCCGGCGGGCTGGCAATGTA
TCACCCCGAATGGCATCAGGGCGTTGTCGGTATTCTGGCTTCGCGCATCAAAGA
GCGTTTTCACCGTCCGGTTATCGCCTTTGCGCCAGCAGGTGATGGTACGCTGAA
AGGTTCAGGTCGCTCCATTCAGGGGCTGCATATGCGTGATGCACTGGAGCGATT
AGACACACTCTACCCTGGCATGATACTGAAGTTTGGCGGTCATGCGATGGCGGC
GGGTTTGTCGCTGGAAGAGGATAAATTCGAACTCTTTCAACAACGGTTTGGCGA
GCTGGTTACCGAGTGGCTGGACCCTTCGCTATTGCAAGGCGAAGTGGTGTCAGA
CGGCCCGTTAAGCCCGGCCGAAATGACCATGGAAGTGGCGCAGCTGCTGCGCG
ATGCTGGCCCGTGGGGGCAGATGTTCCCGGAGCCGCTGTTTGATGGTCATTTCC
GTCTGCTGCAACAGCGGCTGGTGGGCGAACGTCATTTGAAAGTCATGGTCGAAC
CGGTCGGCGGCGGTCCGCTGCTGGATGGTATTGCTTTTAATGTCGATACCGCCCT
CTGGCCGGATAACGGCGTGCGCGAAGTGCAACTGGCTTACAAGCTCGATATCAA
CGAGTTTCGCGGCAACCGCAGCCTGCAAATTATCATCGACAATATCTGGCCAAT
TGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCATGTCAATTTATCA
AGAATTTGTTAATAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATC
CCACAGGGTAAAACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGAT
GATGAGAAAAGAGCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAA
TATCATCAGTTTTTTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAG
ATTTATTACAAAACTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGA
TGATAATCTACAAAAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACA
AATATCTGAATATATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAA
AACCTTATCGATGCTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTA
AAGCAATCTAAGGATAATGGTATAGAACTATTTAAAGCCAATAGTGATATC
ACAGATATAGATGAGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACA
ACTTATTTTAAGGGTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATG
ATATTCCTACATCTATTATTTATAGGATAGTAGATGATAATTTGCCTAAATT
TCTAGAAAATAAAGCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGC
TATAAACTATGAACAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGA
TATTGACTACAAAACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAA
GTTTTTGAGATAGCAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTA
AATTTAATACTATTATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAG
AAAAGGTATAAATGAATATATAAATCTATACTCACAGCAAATAAATGATAAA
ACACTCAAAAAATATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATA
CAGAATCTAAATCTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGT
TACAACGATGCAAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGA
AGAAAAATCTATTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCT
CAAAAACTTGATTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTG
ATCTATCACAACAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACT
AGAATATATAACTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAG
AAAGAGCAAGAATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCT
CTAGAAACTATAAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATA
GATAAACAGTGTAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCG
ATGATATTTGATGAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCT
ATCAAATATCAAAATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAA
GATGATGTTAAAGCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTAC
ATAAACTAAAAATATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTT
AGACAAGGATGAGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCT
AGCGAATATAGTGCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAG
CCATATAGTGATGAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCT
AATGGTTGGGATAAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATC
AAAGATGATAAATATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATA
TTTGATGATAAAGCTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATT
GTTTATAAACTTTTACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTT
CTGCTAAATCTATAAAATTTTATAATCCTAGTGAAGATATACTTAGAATAAG
AAATCATTCCACACATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAA
ATTTGAGTTTAATATTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAG
TCTATAAGTAAGCATCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGAT
ACTCAAAGATATAATTCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAG
GCTACAAACTAACTTTTGAAAATATATCAGAGAGCTATATTGATAGCGTAG
TTAATCAGGGTAAATTGTACCTATTCCAAATCTATAATAAAGATTTTTCAGC
TTATAGCAAAGGGCGACCAAATCTACATACTTTATATTGGAAAGCGCTGTT
TGATGAGAGAAATCTTCAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGA
GCTTTTTTATCGTAAACAATCAATACCTAAAAAAATCACTCACCCAGCTAAA
GAGGCAATAGCTAATAAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTT
GAATATGATTTAATCAAAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTC
ACTGTCCTATTACAATCAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGA
TGAAATCAATTTATTGCTAAAAGAAAAAGCAAATGATGTTCATATATTAAGT
ATAGATAGAGGTGAAAGACATTTAGCTTACTATACTTTGGTAGATGGTAAA
GGCAATATCATCAAACAAGATACTTTCAACATCATTGGTAATGATAGAATG
AAAACAAACTACCATGATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCA
GCTAGGAAAGACTGGAAAAAGATAAATAACATCAAAGAGATGAAAGAGGG
CTATCTATCTCAGGTAGTTCATGAAATAGCTAAGCTAGTTATAGAGTATAAT
GCTATTGTGGTTTTTGAGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCA
AGGTAGAGAAGCAGGTCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAAC
TAAACTATCTAGTTTTCAAAGATAATGAGTTTGATAAAACTGGGGGAGTGC
TTAGAGCTTATCAGCTAACAGCACCTTTTGAGACTTTTAAAAAGATGGGTA
AACAAACAGGTATTATCTACTATGTACCAGCTGGTTTTACTTCAAAAATTTG
TCCTGTAACTGGTTTTGTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGC
AAATCTCAAGAGTTCTTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATA
AGGGCTATTTTGAGTTTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTG
CCAAAGGCAAGTGGACTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTA
GAAATTCAGATAAAAATCATAATTGGGATACTCGAGAAGTTTATCCAACTA
AAGAGTTGGAGAAATTGCTAAAAGATTATTCTATCGAATATGGGCATGGCG
AATGTATCAAAGCAGCTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTA
AGCTAACTAGTGTCCTAAATACTATCTTACAAATGCGTAACTCAAAAACAG
GTACTGAGTTAGATTATCTAATTTCACCAGTAGCAGATGTAAATGGCAATTT
CTTTGATTCGCGACAGGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAA
TGGTGCTTATCATATTGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAA
AAATAATCAAGAGGGCAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTA
TTTTGAGTTCGTGCAGAATAGGAATAACCAAGCGGCCGCACTCGAGAAAAGG
ELPPLLRRLYASRGVRSAQELERSVKGMLPWQQLSGVEKAVEILYNAFREGTRIIVV
GDFDADGATSTALSVLAMRSLGCSNIDYLVPNRFEDGYGLSPEVVDQAHARGAQLI
VTVDNGISSHAGVEHARSLGIPVIVTDHHLPGETLPAAEAIINPNLRDCNFPSKSLAG
VGVAFYLMLALRTFLRDQGWFDERGIAIPNLAELLDLVALGTVADVVPLDANNRIL
TWQGMSRIRAGKCRPGIKALLEVANRDAQKLAASDLGFALGPRLNAAGRLDDMSV
GVALLLCDNIGEARVLANELDALNQTRKEIEQGMQVEALTLCEKLERSRDTLPGGL
AMYHPEWHQGVVGILASRIKERFHRPVIAFAPAGDGTLKGSGRSIQGLHMRDALER
LDTLYPGMILKFGGHAMAAGLSLEEDKFELFQQRFGELVTEWLDPSLLQGEVVSDG
PLSPAEMTMEVAQLLRDAGPWGQMFPEPLFDGHFRLLQQRLVGERHLKVMVEPVG
GGPLLDGIAFNVDTALWPDNGVREVQLAYKLDINEFRGNRSLQIIIDNIWPIGSEFEL
KKAKQIIDKYHQFFIEEILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDFKSAK
DTIKKQISEYIKDSEKFKNLFNQNLIDAKKGQESDLILWLKQSKDNGIELFKANS
DITDIDEALEIIKSFKGWTTYFKGFHENRKNVYSSNDIPTSHYRIVDDNLPKFLE
NKAKYESLKDKAPEAINYEQIKKDLAEELTFDIDYKTSEVNQRVFSLDEVFEIA
NFNNYLNQSGITKFNTIIGGKFVNGENTKRKGINEYINLYSQQINDKTLKKYKM
SVLFKQILSDTESKSFVIDKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSLL
FDDLKAQKLDLSKIYFKNDKSLTDLSQQVFDDYSVIGTAVLEYITQQIAPKNLD
NPSKKEQELIAKKTEKAKYLSLETIKLALEEFNKHRDIDKQCRFEEILANFAAIP
MIFDEIAQNKDNLAQISIKYQNQGKKDLLQASAEDDVKAIKDLLDQTNNLLHK
LKIFHISQSEDKANILDKDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDE
KFKLNFENSTLANGWDKNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIK
ENKGEGYKKIVYKLLPGANKMLPKVFFSAKSIKFYNPSEDILRIRNHSTHTKNG
SPQKGYEKFEFNIEDCRKFIDFYKQSISKHPEWKDFGFRFSDTQRYNSIDEFYRE
VENQGYKLTFENISESYIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLIITLYWKA
LFDERNLQDVVYKLNGEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFE
YDLIKDKRFTEDKFFFHCPITINFKSSGANKFNDEINLLLKEKANDVHILSIDRG
ERHLAYYTLVDGKGNIIKQDTFNIIGNDRMKTNYHDKLAAIEKDRDSARKDWK
KINNIKEMKEGYLSQVVHEIAKLVIEYNAIVVFEDLNFGFKRGRFKVEKQVYQ
KLEKMLIEKLNYLVFKDNEFDKTGGVLRAYQLTAPFETFKKMGKQTGIIYYVP
AGFTSKICPVTGFVNQLYPKYESVSKSQEFFSKFDKICYNLDKGYFEFSFDYKNF
GDKAAKGKWTIASEGSRLINFRNSDKNHNWDTREVYPTKELEKLLKDYSIEYG
HGECIKAAICGESDKKFFAKLTSVLNTILQMRNSKTGTELDYLISPVADVNGNF
FDSRQAPKNMPQDADANGAYHIGLKGLMLLGRIKNNQEGKKLNLVIKNEEYF
EFVQNRNNQAAALEKRPAATKKAGQAKKKKSTPPPPPLRSGC
AAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGT
GATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACA
TACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCAT
GGCCAACACTTGTCACTACTTTCTCTTATGGTGTTCAATGCTTTTCAAGATACCC
AGATCATATGAAGCGGCACGACTTCTTCAAGAGCGCCATGCCTGAGGGATACGT
GCAGGAGAGGACCATCTCTTTCAAGGACGACGGGAACTACAAGACACGTGCTG
AAGTCAAGTTTGAGGGAGACACCCTCGTCAACAGGATCGAGCTTAAGGGAATC
GATTTCAAGGAGGACGGAAACATCCTCGGCCACAAGTTGGAATACAACTACAA
CTCCCACAACGTATACATCACGGCAGACAAACAAAAGAATGGAATCAAAGCTA
ACTTCAAAATTAGACACAACATTGAAGATGGAAGCGTTCAACTAGCAGACCATT
ATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATT
ACCTGTCCACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACA
TGGTCCTTCTTGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACT
ATACAAAGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCATGTCAA
TTTATCAAGAATTTGTTAATAAATATAGTTTAAGTAAAACTCTAAGATTTGA
GTTAATCCCACAGGGTAAAACACTTGAAAACATAAAAGCAAGAGGTTTGAT
TTTAGATGATGAGAAAAGAGCTAAAGACTACAAAAAGGCTAAACAAATAAT
TGATAAATATCATCAGTTTTTTATAGAGGAGATATTAAGTTCGGTTTGTATT
AGCGAAGATTTATTACAAAACTATTCTGATGTTTATTTTAAACTTAAAAAGA
GTGATGATGATAATCTACAAAAAGATTTTAAAAGTGCAAAAGATACGATAA
AGAAACAAATATCTGAATATATAAAGGACTCAGAGAAATTTAAGAATTTGT
TTAATCAAAACCTTATCGATGCTAAAAAAGGGCAAGAGTCAGATTTAATTC
TATGGCTAAAGCAATCTAAGGATAATGGTATAGAACTATTTAAAGCCAATA
GTGATATCACAGATATAGATGAGGCGTTAGAAATAATCAAATCTTTTAAAG
GTTGGACAACTTATTTTAAGGGTTTTCATGAAAATAGAAAAAATGTTTATAG
TAGCAATGATATTCCTACATCTATTATTTATAGGATAGTAGATGATAATTTG
CCTAAATTTCTAGAAAATAAAGCTAAGTATGAGAGTTTAAAAGACAAAGCT
CCAGAAGCTATAAACTATGAACAAATTAAAAAAGATTTGGCAGAAGAGCTA
ACCTTTGATATTGACTACAAAACATCTGAAGTTAATCAAAGAGTTTTTTCAC
TTGATGAAGTTTTTGAGATAGCAAACTTTAATAATTATCTAAATCAAAGTGG
TATTACTAAATTTAATACTATTATTGGTGGTAAATTTGTAAATGGTGAAAAT
ACAAAGAGAAAAGGTATAAATGAATATATAAATCTATACTCACAGCAAATA
AATGATAAAACACTCAAAAAATATAAAATGAGTGTTTTATTTAAGCAAATTT
TAAGTGATACAGAATCTAAATCTTTTGTAATTGATAAGTTAGAAGATGATAG
TGATGTAGTTACAACGATGCAAAGTTTTTATGAGCAAATAGCAGCTTTTAA
AACAGTAGAAGAAAAATCTATTAAAGAAACACTATCTTTATTATTTGATGAT
TTAAAAGCTCAAAAACTTGATTTGAGTAAAATTTATTTTAAAAATGATAAAT
CTCTTACTGATCTATCACAACAAGTTTTTGATGATTATAGTGTTATTGGTAC
AGCGGTACTAGAATATATAACTCAACAAATAGCACCTAAAAATCTTGATAA
CCCTAGTAAGAAAGAGCAAGAATTAATAGCCAAAAAAACTGAAAAAGCAAA
ATACTTATCTCTAGAAACTATAAAGCTTGCCTTAGAAGAATTTAATAAGCAT
AGAGATATAGATAAACAGTGTAGGTTTGAAGAAATACTTGCAAACTTTGCG
GCTATTCCGATGATATTTGATGAAATAGCTCAAAACAAAGACAATTTGGCA
CAGATATCTATCAAATATCAAAATCAAGGTAAAAAAGACCTACTTCAAGCTA
GTGCGGAAGATGATGTTAAAGCTATCAAGGATCTTTTAGATCAAACTAATA
ATCTCTTACATAAACTAAAAATATTTCATATTAGTCAGTCAGAAGATAAGGC
AAATATTTTAGACAAGGATGAGCATTTTTATCTAGTATTTGAGGAGTGCTAC
TTTGAGCTAGCGAATATAGTGCCTCTTTATAACAAAATTAGAAACTATATAA
CTCAAAAGCCATATAGTGATGAGAAATTTAAGCTCAATTTTGAGAACTCGA
CTTTGGCTAATGGTTGGGATAAAAATAAAGAGCCTGACAATACGGCAATTT
TATTTATCAAAGATGATAAATATTATCTGGGTGTGATGAATAAGAAAAATAA
CAAAATATTTGATGATAAAGCTATCAAAGAAAATAAAGGCGAGGGTTATAA
AAAAATTGTTTATAAACTTTTACCTGGCGCAAATAAAATGTTACCTAAGGTT
TTCTTTTCTGCTAAATCTATAAAATTTTATAATCCTAGTGAAGATATACTTA
GAATAAGAAATCATTCCACACATACAAAAAATGGTAGTCCTCAAAAAGGAT
ATGAAAAATTTGAGTTTAATATTGAAGATTGCCGAAAATTTATAGATTTTTA
TAAACAGTCTATAAGTAAGCATCCGGAGTGGAAAGATTTTGGATTTAGATT
TTCTGATACTCAAAGATATAATTCTATAGATGAATTTTATAGAGAAGTTGAA
AATCAAGGCTACAAACTAACTTTTGAAAATATATCAGAGAGCTATATTGATA
GCGTAGTTAATCAGGGTAAATTGTACCTATTCCAAATCTATAATAAAGATTT
TTCAGCTTATAGCAAAGGGCGACCAAATCTACATACTTTATATTGGAAAGC
GCTGTTTGATGAGAGAAATCTTCAAGATGTGGTTTATAAGCTAAATGGTGA
GGCAGAGCTTTTTTATCGTAAACAATCAATACCTAAAAAAATCACTCACCCA
GCTAAAGAGGCAATAGCTAATAAAAACAAAGATAATCCTAAAAAAGAGAGT
GTTTTTGAATATGATTTAATCAAAGATAAACGCTTTACTGAAGATAAGTTTT
TCTTTCACTGTCCTATTACAATCAATTTTAAATCTAGTGGAGCTAATAAGTT
TAATGATGAAATCAATTTATTGCTAAAAGAAAAAGCAAATGATGTTCATATA
TTAAGTATAGATAGAGGTGAAAGACATTTAGCTTACTATACTTTGGTAGAT
GGTAAAGGCAATATCATCAAACAAGATACTTTCAACATCATTGGTAATGAT
AGAATGAAAACAAACTACCATGATAAGCTTGCTGCAATAGAGAAAGATAGG
GATTCAGCTAGGAAAGACTGGAAAAAGATAAATAACATCAAAGAGATGAAA
GAGGGCTATCTATCTCAGGTAGTTCATGAAATAGCTAAGCTAGTTATAGAG
TATAATGCTATTGTGGTTTTTGAGGATTTAAATTTTGGATTTAAAAGAGGGC
GTTTCAAGGTAGAGAAGCAGGTCTATCAAAAGTTAGAAAAAATGCTAATTG
AGAAACTAAACTATCTAGTTTTCAAAGATAATGAGTTTGATAAAACTGGGG
GAGTGCTTAGAGCTTATCAGCTAACAGCACCTTTTGAGACTTTTAAAAAGA
TGGGTAAACAAACAGGTATTATCTACTATGTACCAGCTGGTTTTACTTCAAA
AATTTGTCCTGTAACTGGTTTTGTAAATCAGTTATATCCTAAGTATGAAAGT
GTCAGCAAATCTCAAGAGTTCTTTAGTAAGTTTGACAAGATTTGTTATAACC
TTGATAAGGGCTATTTTGAGTTTAGTTTTGATTATAAAAACTTTGGTGACAA
GGCTGCCAAAGGCAAGTGGACTATAGCTAGCTTTGGGAGTAGATTGATTAA
CTTTAGAAATTCAGATAAAAATCATAATTGGGATACTCGAGAAGTTTATCCA
ACTAAAGAGTTGGAGAAATTGCTAAAAGATTATTCTATCGAATATGGGCAT
GGCGAATGTATCAAAGCAGCTATTTGCGGTGAGAGCGACAAAAAGTTTTTT
GCTAAGCTAACTAGTGTCCTAAATACTATCTTACAAATGCGTAACTCAAAAA
CAGGTACTGAGTTAGATTATCTAATTTCACCAGTAGCAGATGTAAATGGCA
ATTTCTTTGATTCGCGACAGGCGCCAAAAAATATGCCTCAAGATGCTGATG
CCAATGGTGCTTATCATATTGGGCTAAAAGGTCTGATGCTACTAGGTAGGA
TCAAAAATAATCAAGAGGGCAAAAAACTCAATTTGGTTATCAAAAATGAAG
AGTATTTTGAGTTCGTGCAGAATAGGAATAACCAAGCGGCCGCACTCGAGAA
DVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFSYGVQCFSRYPD
HMKRHDFFKSAMPEGYVQERTISFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKE
DGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGSVQLADHYQQNTPI
GDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYKGSEFEL
KKAKQIIDKYHQFFIEEILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDFKSAK
DTIKKQISEYIKDSEKFKNLFNQNLIDAKKGQESDLILWLKQSKDNGIELFKANS
DITDIDEALEIIKSFKGWTTYFKGFHENRKNVYSSNDIPTSHYRIVDDNLPKFLE
NKAKYESLKDKAPEAINYEQIKKDLAEELTFDIDYKTSEVNQRVFSLDEVFEIA
NFNNYLNQSGITKFNTIIGGKFVNGENTKRKGINEYINLYSQQINDKTLKKYKM
SVLFKQILSDTESKSFVIDKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSLL
FDDLKAQKLDLSKIYFKNDKSLTDISQQVFDDYSVIGTAVLEYITQQIAPKNLD
NPSKKEQELIAKKTEKAKYLSLETIKLALEEFNKHRDIDKQCRFEEILANFAMP
MIFDEIAQNKDNLAQISIKYQNQGKKDLLQASAEDDVKAIKDLLDQTNNLLHK
LKIFHISQSEDKANILDKDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDE
KFKLNFENSTLANGWDKNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIK
ENKGEGYKKIVYKLLPGANKMLPKVFFSAKSIKFYNPSEDILRIRNHSTHTKNG
SPQKGYEKFEFNIEDCRKFIDFYKQSISKHPEWKDFGFRFSDTQRYNSIDEFYRE
VENQGYKLTFENISESYIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLHTLYWKA
LFDERNLQDVVYKLNGEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFE
YDLIKDKRFTEDKFFFHCPITINFKSSGANKFNDEINLLLKEKANDVHILSIDRG
ERHLAYYTLVDGKGNIIKQDTFNIIGNDRMKTNYHDKLAAIEKDRDSARKDWK
KINNIKEMKEGYLSQVVHEIAKLVIEYNAIVVFEDLNFGFKRGRFKVEKQVYQ
KLEKMLIEKLNYLVFKDNEFDKTGGVLRAYQLTAPFETFKKMGKQTGIIYYVP
AGFTSKICPVTGFVNQLYPKYESVSKSQEFFSKFDKICYNLDKGYFEFSFDYKNF
GDKAAKGKWTIASFGSRLINFRNSDKNHNWDTREVYPTKELEKLLKDYSIEYG
HGECIKAAICGESDKKFFAKLTSVLNTILQMRNSKTGTELDYLISPVADVNGNF
FDSRQAPKNMPQDADANGAYHIGLKGLMLLGRIKNNQEGKKLNLVIKNEEYF
EFVQNRNNQAAALEKRPAATKKAGQAKKKKSTPPPPPLRSGC
AGCAGAGGCGTAAACAAGGTTATTCTCGTTGGTAATCTGGGTCAGGACCCGGAA
GTACGCTACATGCCAAATGGTGGCGCAGTTGCCAACATTACGCTGGCTACTTCC
GAATCCTGGCGTGATAAAGCGACCGGCGAGATGAAAGAACAGACTGAATGGCA
CCGCGTTGTGCTGTTCGGCAAACTGGCAGAAGTGGCGAGCGAATATCTGCGTAA
AGGTTCTCAGGTTTATATCGAAGGTCAGCTGCGTACCCGTAAATGGACCGATCA
ATCCGGTCAGGATCGCTACACCACAGAAGTCGTGGTGAACGTTGGCGGCACCAT
GCAGATGCTGGGTGGTCGTGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGG
CTAAGATTTGAGTTAATCCCACAGGGTAAAACACTTGAAAACATAAAAGCA
AGAGGTTTGATTTTAGATGATGAGAAAAGAGCTAAAGACTACAAAAAGGCT
AAACAAATAATTGATAAATATCATCAGTTTTTTATAGAGGAGATATTAAGTT
CGGTTTGTATTAGCGAAGATTTATTACAAAACTATTCTGATGTTTATTTTAA
ACTTAAAAAGAGTGATGATGATAATCTACAAAAAGATTTTAAAAGTGCAAA
AGATACGATAAAGAAACAAATATCTGAATATATAAAGGACTCAGAGAAATT
TAAGAATTTGTTTAATCAAAACCTTATCGATGCTAAAAAAGGGCAAGAGTC
AGATTTAATTCTATGGCTAAAGCAATCTAAGGATAATGGTATAGAACTATTT
AAAGCCAATAGTGATATCACAGATATAGATGAGGCGTTAGAAATAATCAAA
TCTTTTAAAGGTTGGACAACTTATTTTAAGGGTTTTCATGAAAATAGAAAAA
ATGTTTATAGTAGCAATGATATTCCTACATCTATTATTTATAGGATAGTAGA
TGATAATTTGCCTAAATTTCTAGAAAATAAAGCTAAGTATGAGAGTTTAAAA
GACAAAGCTCCAGAAGCTATAAACTATGAACAAATTAAAAAAGATTTGGCA
GAAGAGCTAACCTTTGATATTGACTACAAAACATCTGAAGTTAATCAAAGA
GTTTTTTCACTTGATGAAGTTTTTGAGATAGCAAACTTTAATAATTATCTAA
ATCAAAGTGGTATTACTAAATTTAATACTATTATTGGTGGTAAATTTGTAAA
TGGTGAAAATACAAAGAGAAAAGGTATAAATGAATATATAAATCTATACTC
ACAGCAAATAAATGATAAAACACTCAAAAAATATAAAATGAGTGTTTTATTT
AAGCAAATTTTAAGTGATACAGAATCTAAATCTTTTGTAATTGATAAGTTAG
AAGATGATAGTGATGTAGTTACAACGATGCAAAGTTTTTATGAGCAAATAG
CAGCTTTTAAAACAGTAGAAGAAAAATCTATTAAAGAAACACTATCTTTATT
ATTTGATGATTTAAAAGCTCAAAAACTTGATTTGAGTAAAATTTATTTTAAA
AATGATAAATCTCTTACTGATCTATCACAACAAGTTTTTGATGATTATAGTG
TTATTGGTACAGCGGTACTAGAATATATAACTCAACAAATAGCACCTAAAA
ATCTTGATAACCCTAGTAAGAAAGAGCAAGAATTAATAGCCAAAAAAACTG
AAAAAGCAAAATACTTATCTCTAGAAACTATAAAGCTTGCCTTAGAAGAATT
TAATAAGCATAGAGATATAGATAAACAGTGTAGGTTTGAAGAAATACTTGC
AAACTTTGCGGCTATTCCGATGATATTTGATGAAATAGCTCAAAACAAAGA
CAATTTGGCACAGATATCTATCAAATATCAAAATCAAGGTAAAAAAGACCT
ACTTCAAGCTAGTGCGGAAGATGATGTTAAAGCTATCAAGGATCTTTTAGA
TCAAACTAATAATCTCTTACATAAACTAAAAATATTTCATATTAGTCAGTCA
GAAGATAAGGCAAATATTTTAGACAAGGATGAGCATTTTTATCTAGTATTT
GAGGAGTGCTACTTTGAGCTAGCGAATATAGTGCCTCTTTATAACAAAATT
AGAAACTATATAACTCAAAAGCCATATAGTGATGAGAAATTTAAGCTCAATT
TTGAGAACTCGACTTTGGCTAATGGTTGGGATAAAAATAAAGAGCCTGACA
ATACGGCAATTTTATTTATCAAAGATGATAAATATTATCTGGGTGTGATGAA
TAAGAAAAATAACAAAATATTTGATGATAAAGCTATCAAAGAAAATAAAGG
CGAGGGTTATAAAAAAATTGTTTATAAACTTTTACCTGGCGCAAATAAAAT
GTTACCTAAGGTTTTCTTTTCTGCTAAATCTATAAAATTTTATAATCCTAGT
GAAGATATACTTAGAATAAGAAATCATTCCACACATACAAAAAATGGTAGT
CCTCAAAAAGGATATGAAAAATTTGAGTTTAATATTGAAGATTGCCGAAAA
TTTATAGATTTTTATAAACAGTCTATAAGTAAGCATCCGGAGTGGAAAGATT
TTGGATTTAGATTTTCTGATACTCAAAGATATAATTCTATAGATGAATTTTA
TAGAGAAGTTGAAAATCAAGGCTACAAACTAACTTTTGAAAATATATCAGA
GAGCTATATTGATAGCGTAGTTAATCAGGGTAAATTGTACCTATTCCAAAT
CTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCGACCAAATCTACATACT
TTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTTCAAGATGTGGTTTAT
AAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAACAATCAATACCTAAA
AAAATCACTCACCCAGCTAAAGAGGCAATAGCTAATAAAAACAAAGATAAT
CCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCAAAGATAAACGCTTTA
CTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAATCAATTTTAAATCTAG
TGGAGCTAATAAGTTTAATGATGAAATCAATTTATTGCTAAAAGAAAAAGC
AAATGATGTTCATATATTAAGTATAGATAGAGGTGAAAGACATTTAGCTTA
CTATACTTTGGTAGATGGTAAAGGCAATATCATCAAACAAGATACTTTCAA
CATCATTGGTAATGATAGAATGAAAACAAACTACCATGATAAGCTTGCTGC
AATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGGAAAAAGATAAATAA
CATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTAGTTCATGAAATAGC
TAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTGAGGATTTAAATTTT
GGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGGTCTATCAAAAGTTA
GAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTTCAAAGATAATGAG
TTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCTAACAGCACCTTTT
GAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTATCTACTATGTACCA
GCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTTGTAAATCAGTTAT
ATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTCTTTAGTAAGTTTG
ACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGTTTAGTTTTGATTA
TAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGACTATAGCTAGCTT
TGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAAATCATAATTGGGA
TACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAATTGCTAAAAGATTA
TTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAGCTATTTGCGGTGA
GAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCCTAAATACTATCTTA
CAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTATCTAATTTCACCA
GTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACAGGCGCCAAAAAAT
ATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATATTGGGCTAAAAGGT
CTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGGCAAAAAACTCAAT
TTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCAGAATAGGAATAAC
CAAGCGGCCGCACTCGAGAAAAGGCCGGCGGCCACGAAAAAGGCCGGCCAGG
VRYMMPNGGAVANITLATSESWRDKATGEKEQTEWHRVVLFGKLAEVASEYLRK
GSQVYIEGQLRTRKWTDQSGQDRYTTEVVVNVGGTMQMLGGRGSEFELRRQACG
IDKYHQFFIEEILSSVCISEDLLQNYSDVYFKLKICSDDDNLQKDFKSAKDTIKKQ
ISEYIKDSEKEKNLENQNLIDAKKGQESDLIEWLKQSKDNGIELFKANSDITDID
EALEIIKSFKGWTTYFKGEHENRKNVYSSNDIPTSIIYRIVDDNLPKFLENKAKY
ESLKDKAPEAINYEQIKKDLAEELTEDIDYKTSEVNQRVESLDEVFEIANENNYL
NQSGITKENTIIGGKEVNGENTKRKGINEYINLYSQQINDKTEKKYKMSVLEKQ
ILSDTESKSEVIDKLEDDSDVVTTMQSFYEQIAAFKTVEEKSIKETLSELFDDLK
AQKLDLSKIYEKNDKSLTDESQQVFDDYSVIGTAVLEYITQQIAPKNEDNPSKK
EQELIAKKTEKAKYLSLETIKLALEEENKHRDIDKQCRFEEILANFAAIPMIFDE
IAQNKDNLAQISIKYQNQGKKDLLQASAEDDVKAIKDELDQTNNELHKEKIFHI
SQSEDKANILDKDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNE
ENSTLANGWDKNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGE
GYKKIVYKLLPGANKMLPKVFFSAKSIKEYNPSEDILRIRNHSTHTKNGSPQKG
YEKFEENIEDCRKFIDEYKQSISKHPEWKDEGFRESDTQRYNSIDEFYREVENQG
YKLTFENISESYIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLIITLYWKALFDER
NLQDVVYKENGEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIK
DKRFTEDKFFFHCPITINFKSSGANKFNDEINLLLKEKANDVHILSIDRGERHLA
YYTLVDGKGNIIKQDTFNIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNI
KEMKEGYLSQVVHEIAKLVIEYNAIVVFEDLNFGFKRGRFKVEKQVYQKLEK
MLIEKLNYLVFKDNEFDKTGGVLRAYQLTAPFETFKKMGKQTGIIYYVPAGFT
SKICPVTGFVNQLYPKYESVSKSQEFFSKFDKICYNLDKGYFEFSFDYKNFGDK
AAKGKWTIASFGSRLINFRNSDKNHNWDTREVYPTKELEKLLKDYSIEYGHGE
CIKAAICGESDKKFFAKLTSVLNTILQMRNSKTGTELDYLISPVADVNGNFFDSR
QAPKNMPQDADANGAYHIGLKGLMLLGRIKNNQEGKKLNLVIKNEEYFEFVQ
NRNNQAAALEKRPAATKKAGQAKKKKSTPPPPPLRSGC
AGCAGAGGCGTAAACAAGGTTATTCTCGTTGGTAATCTGGGTCAGGACCCGGAA
GTACGCTACATGCCAAATGGTGGCGCAGTTGCCAACATTACGCTGGCTACTTCC
GAATCCTGGCGTGATAAAGCGACCGGCGAGATGAAAGAACAGACTGAATGGCA
CCGCGTTGTGCTGTTCGGCAAACTGGCAGAAGTGGCGAGCGAATATCTGCGTAA
AGGTTCTCAGGTTTATATCGAAGGTCAGCTGCGTACCCGTAAATGGACCGATCA
ATCCGGTCAGGATCGCTACACCACAGAAGTCGTGGTGAACGTTGGCGGCACCAT
GCAGATGCTGGGTGGTCGTGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGG
CTAAGATTTGAGTTAATCCCACAGGGTAAAACACTTGAAAACATAAAAGCA
AGAGGTTTGATTTTAGATGATGAGAAAAGAGCTAAAGACTACAAAAAGGCT
AAACAAATAATTGATAAATATCATCAGTTTTTTATAGAGGAGATATTAAGTT
CGGTTTGTATTAGCGAAGATTTATTACAAAACTATTCTGATGTTTATTTTAA
ACTTAAAAAGAGTGATGATGATAATCTACAAAAAGATTTTAAAAGTGCAAA
AGATACGATAAAGAAACAAATATCTGAATATATAAAGGACTCAGAGAAATT
TAAGAATTTGTTTAATCAAAACCTTATCGATGCTAAAAAAGGGCAAGAGTC
AGATTTAATTCTATGGCTAAAGCAATCTAAGGATAATGGTATAGAACTATTT
AAAGCCAATAGTGATATCACAGATATAGATGAGGCGTTAGAAATAATCAAA
TCTTTTAAAGGTTGGACAACTTATTTTAAGGGTTTTCATGAAAATAGAAAAA
ATGTTTATAGTAGCAATGATATTCCTACATCTATTATTTATAGGATAGTAGA
TGATAATTTGCCTAAATTTCTAGAAAATAAAGCTAAGTATGAGAGTTTAAAA
GACAAAGCTCCAGAAGCTATAAACTATGAACAAATTAAAAAAGATTTGGCA
GAAGAGCTAACCTTTGATATTGACTACAAAACATCTGAAGTTAATCAAAGA
GTTTTTTCACTTGATGAAGTTTTTGAGATAGCAAACTTTAATAATTATCTAA
ATCAAAGTGGTATTACTAAATTTAATACTATTATTGGTGGTAAATTTGTAAA
TGGTGAAAATACAAAGAGAAAAGGTATAAATGAATATATAAATCTATACTC
ACAGCAAATAAATGATAAAACACTCAAAAAATATAAAATGAGTGTTTTATTT
AAGCAAATTTTAAGTGATACAGAATCTAAATCTTTTGTAATTGATAAGTTAG
AAGATGATAGTGATGTAGTTACAACGATGCAAAGTTTTTATGAGCAAATAG
CAGCTTTTAAAACAGTAGAAGAAAAATCTATTAAAGAAACACTATCTTTATT
ATTTGATGATTTAAAAGCTCAAAAACTTGATTTGAGTAAAATTTATTTTAAA
AATGATAAATCTCTTACTGATCTATCACAACAAGTTTTTGATGATTATAGTG
TTATTGGTACAGCGGTACTAGAATATATAACTCAACAAATAGCACCTAAAA
ATCTTGATAACCCTAGTAAGAAAGAGCAAGAATTAATAGCCAAAAAAACTG
AAAAAGCAAAATACTTATCTCTAGAAACTATAAAGCTTGCCTTAGAAGAATT
TAATAAGCATAGAGATATAGATAAACAGTGTAGGTTTGAAGAAATACTTGC
AAACTTTGCGGCTATTCCGATGATATTTGATGAAATAGCTCAAAACAAAGA
CAATTTGGCACAGATATCTATCAAATATCAAAATCAAGGTAAAAAAGACCT
ACTTCAAGCTAGTGCGGAAGATGATGTTAAAGCTATCAAGGATCTTTTAGA
TCAAACTAATAATCTCTTACATAAACTAAAAATATTTCATATTAGTCAGTCA
GAAGATAAGGCAAATATTTTAGACAAGGATGAGCATTTTTATCTAGTATTT
GAGGAGTGCTACTTTGAGCTAGCGAATATAGTGCCTCTTTATAACAAAATT
AGAAACTATATAACTCAAAAGCCATATAGTGATGAGAAATTTAAGCTCAATT
TTGAGAACTCGACTTTGGCTAATGGTTGGGATAAAAATAAAGAGCCTGACA
ATACGGCAATTTTATTTATCAAAGATGATAAATATTATCTGGGTGTGATGAA
TAAGAAAAATAACAAAATATTTGATGATAAAGCTATCAAAGAAAATAAAGG
CGAGGGTTATAAAAAAATTGTTTATAAACTTTTACCTGGCGCAAATAAAAT
GTTACCTAAGGTTTTCTTTTCTGCTAAATCTATAAAATTTTATAATCCTAGT
GAAGATATACTTAGAATAAGAAATCATTCCACACATACAAAAAATGGTAGT
CCTCAAAAAGGATATGAAAAATTTGAGTTTAATATTGAAGATTGCCGAAAA
TTTATAGATTTTTATAAACAGTCTATAAGTAAGCATCCGGAGTGGAAAGATT
TTGGATTTAGATTTTCTGATACTCAAAGATATAATTCTATAGATGAATTTTA
TAGAGAAGTTGAAAATCAAGGCTACAAACTAACTTTTGAAAATATATCAGA
GAGCTATATTGATAGCGTAGTTAATCAGGGTAAATTGTACCTATTCCAAAT
CTATAATAAAGATTTTTCAGCTTATAGCAAAGGGCGACCAAATCTACATACT
TTATATTGGAAAGCGCTGTTTGATGAGAGAAATCTTCAAGATGTGGTTTAT
AAGCTAAATGGTGAGGCAGAGCTTTTTTATCGTAAACAATCAATACCTAAA
AAAATCACTCACCCAGCTAAAGAGGCAATAGCTAATAAAAACAAAGATAAT
CCTAAAAAAGAGAGTGTTTTTGAATATGATTTAATCAAAGATAAACGCTTTA
CTGAAGATAAGTTTTTCTTTCACTGTCCTATTACAATCAATTTTAAATCTAG
TGGAGCTAATAAGTTTAATGATGAAATCAATTTATTGCTAAAAGAAAAAGC
AAATGATGTTCATATATTAAGTATAGATAGAGGTGAAAGACATTTAGCTTA
CTATACTTTGGTAGATGGTAAAGGCAATATCATCAAACAAGATACTTTCAA
CATCATTGGTAATGATAGAATGAAAACAAACTACCATGATAAGCTTGCTGC
AATAGAGAAAGATAGGGATTCAGCTAGGAAAGACTGGAAAAAGATAAATAA
CATCAAAGAGATGAAAGAGGGCTATCTATCTCAGGTAGTTCATGAAATAGC
TAAGCTAGTTATAGAGTATAATGCTATTGTGGTTTTTGAGGATTTAAATTTT
GGATTTAAAAGAGGGCGTTTCAAGGTAGAGAAGCAGGTCTATCAAAAGTTA
GAAAAAATGCTAATTGAGAAACTAAACTATCTAGTTTTCAAAGATAATGAG
TTTGATAAAACTGGGGGAGTGCTTAGAGCTTATCAGCTAACAGCACCTTTT
GAGACTTTTAAAAAGATGGGTAAACAAACAGGTATTATCTACTATGTACCA
GCTGGTTTTACTTCAAAAATTTGTCCTGTAACTGGTTTTGTAAATCAGTTAT
ATCCTAAGTATGAAAGTGTCAGCAAATCTCAAGAGTTCTTTAGTAAGTTTG
ACAAGATTTGTTATAACCTTGATAAGGGCTATTTTGAGTTTAGTTTTGATTA
TAAAAACTTTGGTGACAAGGCTGCCAAAGGCAAGTGGACTATAGCTAGCTT
TGGGAGTAGATTGATTAACTTTAGAAATTCAGATAAAAATCATAATTGGGA
TACTCGAGAAGTTTATCCAACTAAAGAGTTGGAGAAATTGCTAAAAGATTA
TTCTATCGAATATGGGCATGGCGAATGTATCAAAGCAGCTATTTGCGGTGA
GAGCGACAAAAAGTTTTTTGCTAAGCTAACTAGTGTCCTAAATACTATCTTA
CAAATGCGTAACTCAAAAACAGGTACTGAGTTAGATTATCTAATTTCACCA
GTAGCAGATGTAAATGGCAATTTCTTTGATTCGCGACAGGCGCCAAAAAAT
ATGCCTCAAGATGCTGATGCCAATGGTGCTTATCATATTGGGCTAAAAGGT
CTGATGCTACTAGGTAGGATCAAAAATAATCAAGAGGGCAAAAAACTCAAT
TTGGTTATCAAAAATGAAGAGTATTTTGAGTTCGTGCAGAATAGGAATAAC
CAAGCGGCCGCACTCGACCTGCAGGTGAAACAACAGATACAACTTCGTCGCCGTGA
AGTCGATGAAACGGCAGACTTGCCCGCTGAATTGCCTCCCTTGCTGCGCCGTTTATA
CGCCAGCCGGGGAGTACGCAGTGCGCAAGAACTGGAACGCAGTGTTAAAGGTATGC
TGCCCTGGCAGCAACTGAGCGGCGTCGAAAAGGCCGTTGAGATCCTTTACAACGCTT
TTCGCGAAGGAACGCGGATTATTGTGGTCGGTGATTTCGACGCCGACGGCGCGACC
AGCACGGCTCTAAGCGTGCTGGCGATGCGCTCGCTTGGTTGCAGCAATATCGACTAC
CTGGTACCAAACCGTTTCGAAGACGGTTACGGCTTAAGCCCGGAAGTGGTCGATCAG
GCCCATGCCCGTGGCGCGCAGTTAATTGTCACGGTGGATAACGGTATTTCCTCCCAT
GCGGGGGTTGAGCACGCTCGCTCGTTGGGCATCCCGGTTATTGTTACCGATCACCAT
TTGCCAGGCGACACATTACCCGCAGCGGAAGCGATCATTAACCCTAACTTGCGCGAC
TGTAATTTCCCGTCGAAATCACTGGCAGGCGTGGGTGTGGCGTTTTATCTGATGCTGG
CGCTGCGCACCTTTTTGCGCGATCAGGGCTGGTTTGATGAGCGTAACATCGCAATTC
CTAACCTGGCAGAACTGCTGGATCTGGTCGCGCTGGGGACAGTGGCGGACGTCGTG
CCGCTGGACGCTAATAATCGCATTCTGACCTGGCAGGGGATGAGTCGCATCCGAGCC
GGAAAGTGCCGTCCGGGGATTAAAGCGCTGCTTGAAGTGGCAAACCGTGATGCACAA
AAACTCGCCGCCAGCGATTTAGGTTTTGCGCTGGGGCCACGTCTCAATGCTGCCGGA
CGACTGGACGATATGTCCGTCGGTGTGGCGCTGTTGTTGTGCGACAACATCGGCGAA
GCGCGCGTGCTGGCAAATGAACTCGATGCGCTAAACCAGACGCGAAAAGAGATCGAA
CAAGGAATGCAAATTGAAGCCCTGACCCTGTGCGAGAAACTGGAGCGCAGCCGTGAC
ACGCTACCCGGCGGGCTGGCAATGTATCACCCCGAATGGCATCAGGGCGTTGTCGG
TATTCTGGCTTCGCGCATCAAAGAGCGTTTTCACCGTCCGGTTATCGCGTTTGCGCCA
GCAGGTGACGGTACGCTGAAAGGTTCCGGTCGCTCCATTCAGGGGCTGCATATGCGT
GATGCGCTGGAGCGATTAGACACACTCTACCCTGGCATGATGCTGAAGTTTGGCGGT
CATGCGATGGCGGCGGGTTTGTCGCTGGAAGAGGATAAATTCAAACTCTTTCAACAAC
GGTTTGGCGAACTGGTTACTGAGTGGCTGGACCCTTCGCTATTGCAAGGCGAAGTGG
TATCAGACGGTCCGTTAAGCCCGGCCGAAATGACCATGGAAGTGGCGCAGCTGCTG
CGCGATGCTGGCCCGTGGGGGCAGATGTTCCCGGAGCCGCTGTTTGACGGTCATTT
CCGTCTGCTGCAACAGCGGCTGGTGGGCGAACGTCATTTGAAGGTGATGGTCGAAC
CGGTCGGCGGCGGTCCACTGCTGGATGGTATTGCTTTTAATGTCGATACCGCCCTCT
GGCCGGATAACGGCGTGCGCGAAGTGCAACTGGCTTATAAGCTCGATATCAACGAGT
TTCGCGGCAACCGCAGCCTGCAAATTATCATCGACAATATCTGGCCAATTCTGCAGA
VRYMPNGGAVANITLATSESWRDKATGEMKEQTEWHRVVLFGKLAEVASEYLRK
GSQVYIEGQLRTRKWTDQSGQDRYTTEVVVNVGGTMQMLGGRGSEFELRRQACG
IDKYHQFFIEEILSSVCISEDLLQNYSDVYFKLKKSDDDNLQKDEKSAKDTIKKQ
ISEYIKDSEKEKNLENQNLIDAKKGQESDLIEWLKQSKDNGIELFKANSDITDID
EALEIIKSFKGWTTYFKGEHENRKNVYSSNDIPTSIIYRIVDDNLPKFLENKAKY
ESLKDKAPEAINYEQIKKDLAEELTEDIDYKTSEVNQRVESLDEVFEIANENNYL
NQSGITKENTIIGGKEVNGENTKRKGINEYINLYSQQINDKTEKKYKMSVLEKQ
ILSDTESKSEVIDKLEDDSDVVTTMQSFYEQ1AAFKTVEEKSIKETLSELFDDLK
AQKLDLSKIYEKNDKSLTDESQQVFDDYSVIGTAVLEYITQQIAPKNEDNPSKK
EQELIAKKTEKAKYLSLETIKLALEEENKHRDIDKQCRFEEILANFAAIPMIFDE
IAQNKDNLAQISIKYQNQGKKDLLQASAEDDVKAIKDELDQTNNELHKEKIFHI
SQSEDKANILDKDEHFYLVFEECYFELANIVPLYNKIRNYITQKPYSDEKFKLNE
ENSTLANGWDKNKEPDNTAILFIKDDKYYLGVMNKKNNKIFDDKAIKENKGE
GYKKIVYKLLPGANKMLPKVFFSAKSIKEYNPSEDILRIRNHSTHTKNGSPQKG
YEKFEENIEDCRKFIDEYKQSISKHPEWKDEGFRESDTQRYNSIDEFYREVENQG
YKLTFENISESYIDSVVNQGKLYLFQIYNKDFSAYSKGRPNLIITLYWKALFDER
NLQDVVYKENGEAELFYRKQSIPKKITHPAKEAIANKNKDNPKKESVFEYDLIK
DKRFTEDKEFFHCPITINEKSSGANKENDEINELLKEKANDVHILSIDRGERHLA
YYTLVDGKGNIIKQDTENIIGNDRMKTNYHDKLAAIEKDRDSARKDWKKINNI
KEMKEGYLSQVVHEIAKLVIEYNAIVVFEDLNEGFKRGREKVEKQVYQKLEK
MLIEKLNYLVEKDNEFDKTGGVERAYQLTAPFETFKKMGKQTGIIYYVPAGFT
SKICPVTGEVNQLYPKYESVSKSQEFFSKEDKICYNEDKGYFEFSFDYKNEGDK
AAKGKWTIASEGSRLINFRNSDKNHNWDTREVYPTKELEKELKDYSIEYGHGE
CIKAAICGESDKKFFAKETSVENTILQMRNSKTGTELDYLISPVADVNGNFEDSR
QAPKNMPQDADANGAYHIGLKGEMLLGRIKNNQEGKKENLVIKNEEYFEFVQ
NRNNQAAALDLQVKQQIQLRRREVDETADLPAELPPLLRRLYASRGVRSAQELERSVKG
MLPWQQLSGVEKAVEILYNAFREGTRIIVVGDFDADGATSTALSVLAMRSLGCSNIDYLVP
NRFEDGYGLSPEVVDQAHARGAQLIVTVDNGISSHAGVEHARSLGIPVIVTDHHLPGDTL
PAAPAIINPNLRDCNEPSKSLAGVGVAFYLAILALRTFLRDQGWFDERNIAIPNLAELLDLV
ALGTVADVVPLDANNRILTWQGMSRIRAGKCRPGIKALLEVANRDAQKLAASDLGFALG
PRLNAAGRLDDAISVGVALLLCDNIGEARVLANELDALNQTRKEIEQGAVIEALTLCEKLE
RSRDTLPGGLAAIYHPEWLIQGVVGILASRIKERFHRPVIAFAPAGDGTLKGSGRSIQGLH
AIRDALERLDTLYPGAIVILKFGGHAMAAGLSLEEDKFKLFQQRFGELVTEWLDPSLLQG
EVVSDGPLSPAEAITMEVAQLLRDAGPWGQAIFPEPLFDGHFRLLQQRLVGERHLKVAIV
EPVGGGPLLDGIAENVDTALWPDNGVREVQLAYKLDINEFRGNRSLQIIIDNIWPILQKR
AAAAAAGAAATGGTTGAATTTGATGAAGCTATCCATGGCGAAGACTTGGCTAA
ATTTATTAAAGAAGCATCTGATCATAAACTGAAAATTTCCGGTTATAATGAACT
GATTAAAGATATTCGAATTCGTGCTAAAGATGAACTTGGCGTTGATGGTAAGAT
GTTTAATCGTCTATTAGCTTTGTATCATAAAGATAACCGTGATGTGTTTGAAGCT
GAAACTGAAGAGGTAGTTGAACTTTATGACACAGTTTTCTCTAAAGGATCCGAA
TAATAAATATAGTTTAAGTAAAACTCTAAGATTTGAGTTAATCCCACAGGGT
AAAACACTTGAAAACATAAAAGCAAGAGGTTTGATTTTAGATGATGAGAAA
AGAGCTAAAGACTACAAAAAGGCTAAACAAATAATTGATAAATATCATCAG
TTTTTTATAGAGGAGATATTAAGTTCGGTTTGTATTAGCGAAGATTTATTAC
AAAACTATTCTGATGTTTATTTTAAACTTAAAAAGAGTGATGATGATAATCT
ACAAAAAGATTTTAAAAGTGCAAAAGATACGATAAAGAAACAAATATCTGA
ATATATAAAGGACTCAGAGAAATTTAAGAATTTGTTTAATCAAAACCTTATC
GATGCTAAAAAAGGGCAAGAGTCAGATTTAATTCTATGGCTAAAGCAATCT
AAGGATAATGGTATAGAACTATTTAAAGCCAATAGTGATATCACAGATATA
GATGAGGCGTTAGAAATAATCAAATCTTTTAAAGGTTGGACAACTTATTTTA
AGGGTTTTCATGAAAATAGAAAAAATGTTTATAGTAGCAATGATATTCCTAC
ATCTATTATTTATAGGATAGTAGATGATAATTTGCCTAAATTTCTAGAAAAT
AAAGCTAAGTATGAGAGTTTAAAAGACAAAGCTCCAGAAGCTATAAACTAT
GAACAAATTAAAAAAGATTTGGCAGAAGAGCTAACCTTTGATATTGACTAC
AAAACATCTGAAGTTAATCAAAGAGTTTTTTCACTTGATGAAGTTTTTGAGA
TAGCAAACTTTAATAATTATCTAAATCAAAGTGGTATTACTAAATTTAATAC
TATTATTGGTGGTAAATTTGTAAATGGTGAAAATACAAAGAGAAAAGGTAT
AAATGAATATATAAATCTATACTCACAGCAAATAAATGATAAAACACTCAAA
AAATATAAAATGAGTGTTTTATTTAAGCAAATTTTAAGTGATACAGAATCTA
AATCTTTTGTAATTGATAAGTTAGAAGATGATAGTGATGTAGTTACAACGAT
GCAAAGTTTTTATGAGCAAATAGCAGCTTTTAAAACAGTAGAAGAAAAATC
TATTAAAGAAACACTATCTTTATTATTTGATGATTTAAAAGCTCAAAAACTT
GATTTGAGTAAAATTTATTTTAAAAATGATAAATCTCTTACTGATCTATCAC
AACAAGTTTTTGATGATTATAGTGTTATTGGTACAGCGGTACTAGAATATAT
AACTCAACAAATAGCACCTAAAAATCTTGATAACCCTAGTAAGAAAGAGCA
AGAATTAATAGCCAAAAAAACTGAAAAAGCAAAATACTTATCTCTAGAAAC
TATAAAGCTTGCCTTAGAAGAATTTAATAAGCATAGAGATATAGATAAACA
GTGTAGGTTTGAAGAAATACTTGCAAACTTTGCGGCTATTCCGATGATATT
TGATGAAATAGCTCAAAACAAAGACAATTTGGCACAGATATCTATCAAATA
TCAAAATCAAGGTAAAAAAGACCTACTTCAAGCTAGTGCGGAAGATGATGT
TAAAGCTATCAAGGATCTTTTAGATCAAACTAATAATCTCTTACATAAACTA
AAAATATTTCATATTAGTCAGTCAGAAGATAAGGCAAATATTTTAGACAAG
GATGAGCATTTTTATCTAGTATTTGAGGAGTGCTACTTTGAGCTAGCGAAT
ATAGTGCCTCTTTATAACAAAATTAGAAACTATATAACTCAAAAGCCATATA
GTGATGAGAAATTTAAGCTCAATTTTGAGAACTCGACTTTGGCTAATGGTT
GGGATAAAAATAAAGAGCCTGACAATACGGCAATTTTATTTATCAAAGATG
ATAAATATTATCTGGGTGTGATGAATAAGAAAAATAACAAAATATTTGATG
ATAAAGCTATCAAAGAAAATAAAGGCGAGGGTTATAAAAAAATTGTTTATA
AACTTTTACCTGGCGCAAATAAAATGTTACCTAAGGTTTTCTTTTCTGCTAA
ATCTATAAAATTTTATAATCCTAGTGAAGATATACTTAGAATAAGAAATCAT
TCCACACATACAAAAAATGGTAGTCCTCAAAAAGGATATGAAAAATTTGAG
TTTAATATTGAAGATTGCCGAAAATTTATAGATTTTTATAAACAGTCTATAA
GTAAGCATCCGGAGTGGAAAGATTTTGGATTTAGATTTTCTGATACTCAAA
GATATAATTCTATAGATGAATTTTATAGAGAAGTTGAAAATCAAGGCTACA
AACTAACTTTTGAAAATATATCAGAGAGCTATATTGATAGCGTAGTTAATCA
GGGTAAATTGTACCTATTCCAAATCTATAATAAAGATTTTTCAGCTTATAGC
AAAGGGCGACCAAATCTACATACTTTATATTGGAAAGCGCTGTTTGATGAG
AGAAATCTTCAAGATGTGGTTTATAAGCTAAATGGTGAGGCAGAGCTTTTT
TATCGTAAACAATCAATACCTAAAAAAATCACTCACCCAGCTAAAGAGGCA
ATAGCTAATAAAAACAAAGATAATCCTAAAAAAGAGAGTGTTTTTGAATAT
GATTTAATCAAAGATAAACGCTTTACTGAAGATAAGTTTTTCTTTCACTGTC
CTATTACAATCAATTTTAAATCTAGTGGAGCTAATAAGTTTAATGATGAAAT
CAATTTATTGCTAAAAGAAAAAGCAAATGATGTTCATATATTAAGTATAGAT
AGAGGTGAAAGACATTTAGCTTACTATACTTTGGTAGATGGTAAAGGCAAT
ATCATCAAACAAGATACTTTCAACATCATTGGTAATGATAGAATGAAAACAA
ACTACCATGATAAGCTTGCTGCAATAGAGAAAGATAGGGATTCAGCTAGGA
AAGACTGGAAAAAGATAAATAACATCAAAGAGATGAAAGAGGGCTATCTAT
CTCAGGTAGTTCATGAAATAGCTAAGCTAGTTATAGAGTATAATGCTATTG
TGGTTTTTGAGGATTTAAATTTTGGATTTAAAAGAGGGCGTTTCAAGGTAG
AGAAGCAGGTCTATCAAAAGTTAGAAAAAATGCTAATTGAGAAACTAAACT
ATCTAGTTTTCAAAGATAATGAGTTTGATAAAACTGGGGGAGTGCTTAGAG
CTTATCAGCTAACAGCACCTTTTGAGACTTTTAAAAAGATGGGTAAACAAA
CAGGTATTATCTACTATGTACCAGCTGGTTTTACTTCAAAAATTTGTCCTGT
AACTGGTTTTGTAAATCAGTTATATCCTAAGTATGAAAGTGTCAGCAAATCT
CAAGAGTTCTTTAGTAAGTTTGACAAGATTTGTTATAACCTTGATAAGGGCT
ATTTTGAGTTTAGTTTTGATTATAAAAACTTTGGTGACAAGGCTGCCAAAG
GCAAGTGGACTATAGCTAGCTTTGGGAGTAGATTGATTAACTTTAGAAATT
CAGATAAAAATCATAATTGGGATACTCGAGAAGTTTATCCAACTAAAGAGT
TGGAGAAATTGCTAAAAGATTATTCTATCGAATATGGGCATGGCGAATGTA
TCAAAGCAGCTATTTGCGGTGAGAGCGACAAAAAGTTTTTTGCTAAGCTAA
CTAGTGTCCTAAATACTATCTTACAAATGCGTAACTCAAAAACAGGTACTGA
GTTAGATTATCTAATTTCACCAGTAGCAGATGTAAATGGCAATTTCTTTGAT
TCGCGACAGGCGCCAAAAAATATGCCTCAAGATGCTGATGCCAATGGTGCT
TATCATATTGGGCTAAAAGGTCTGATGCTACTAGGTAGGATCAAAAATAAT
CAAGAGGGCAAAAAACTCAATTTGGTTATCAAAAATGAAGAGTATTTTGAG
TTCGTGCAGAATAGGAATAACCAAGCGGCCGCACTCGAGAAAAGGCCGGCGG
KFIKEASDHKLKISGYNELIKDIRIRAKDELGVDGKATFNRLLALYHKDNRDVFEAET
EEVVELYDTVFSKGSEFELRRQACGRMSIYQEFVNKYSLSKTLRFELIPQGKTLE
NIKARGLILDDEKRAKDYKKAKQIIDKYHQFFIEEILSSVCISEDLLQNYSDVYF
KLKICSDDDNLQKDEKSAKDTIKKQISEYIKDSEKEKNLENQNLIDAKKGQESDL
ILWLKQSKDNGIELFKANSDITDIDEALEIIKSFKGWTTYFKGEHENRKNVYSSN
DIPTSHYRIVDDNLPKFLENKAKYESLKDKAPEAINYEQIKKDLAEELTEDIDYK
TSEVNQRVESLDEVFEIANENNYLNQSGITKENTIIGGKEVNGENTKRKGINEYI
NLYSQQINDKTIKKYKMSVLEKQILSDTESKSEVIDKLEDDSDVVTTMQSFYEQ
IAAFKTVEEKSIKETLSLLFDDLKAQKLDLSKIYEKNDKSLTDISQQVFDDYSVI
GTAVLEYITQQIAPKNLDNPSKKEQELIAKKTEKAKYLSLETIKLALEEENKHR
DIDKQCRFEEILANFAAIPMIFDEIAQNKDNLAQISIKYQNQGKKDLLQASAEDD
VKAIKDLLDQTNNLLHKLKIFHISQSEDKANILDKDEHFYLVFEECYFELANIVP
LYNKIRNYITQKPYSDEKFKLNFENSTLANGWDKNKEPDNTAILFIKDDKYYLG
VMNKKNNKIFDDKAIKENKGEGYKKIVYKLLPGANKMLPKVFFSAKSIKEYNP
SEDILRIRNHSTHTKNGSPQKGYEKFEENIEDCRKFIDEYKQSISKHPEWKDEGF
RESDTQRYNSIDEFYREVENQGYKLTFENISESYIDSVVNQGKLYLFQIYNKDFS
AYSKGRPNLIITLYWKALFDERNLQDVVYKLNGEAELFYRKQSIPKKITHPAKE
AIANKNKDNPKKESVFEYDLIKDKRFTEDKEFFHCPITINEKSSGANKENDEINL
LLKEKANDVHILSIDRGERHLAYYTLVDGKGNIIKQDTENIIGNDRMKTNYHD
KLAAIEKDRDSARKDWKKINNIKEMKEGYLSQVVHEIAKLVIEYNAIVVFEDLN
FGEKRGREKVEKQVYQKLEKMLIEKLNYLVEKDNEFDKTGGVLRAYQLTAPF
ETFKKNIGKQTGIIYYVPAGFTSKICPVTGEVNQLYPKYESVSKSQEFFSKEDKI
CYNEDKGYFEFSFDYKNEGDKAAKGKWTIASEGSRLINFRNSDKNHNWDTREV
YPTKELEKELKDYSIEYGHGECIKAAICGESDKKFFAKETSVENTILQMRNSKT
GTELDYLISPVADVNGNFEDSRQAPKNMPQDADANGAYHIGLKGEMLLGRIKN
NQEGKKLNLVIKNEEYFEFVQNRNNQAAALEKRPAATKKAGQAKKKKSTPPPPP
This example describes analysis of SITE-Seq target sites for CCR5 and DHCR7. Whole genome resequencing analysis was performed. Sample included: total 7 (control+6 experimental samples). Total reads were 4,577,161,000, approximately 90 Gb per sample. Mean coverage was 26.78-32.22×. Read length was 300 bp. Control info was HEK293 (human embryonic kidney 293 lineage). Sample information is shown in the table below.
Below are tables showing on/off target region INDEL (DHCR7). These tables depict the results of whole genome sequencing between Cas9 and Cas9-RecJ. Cas9 and Cas9-RecJ showed similar offtarget efficiencies. (A) Summary of on-target results for DHCR7 are shown in the below table. The number of on target deletions in DHCR7 were 5. Deletions varied in length from 2 to 24.
Summary of off-target results for DHCR7 are shown in the below table. The samples were harvested at 24 h and 48 h after lipofection. The number of off target deletions in DHCR7 was 8. The deletions were largely two bases in length but ranged from 2 bases to 13.
Shown below is a table of on-target results after whole genome sequencing. Two genes, CCR5 and DHCR7, were tested. Each cell line was harvested 24 h and 48 h after lipofection.
Amplicon Setup. Working on ice, primers were added using a multichannel pipette: 4 μl from VERTCIAL i5(S5XX) primer strip was added to the COLUMNS of plate. 4 μl from HORIZONTAL i7(N7XX) primer strip was added to the ROWS of plate. Multichannel from polymerase 8-well strip 10 μl of polymerase into each well. Multichannel from DNA plate, 2 ul of 0.5 ng/μl DNA into corresponding wells. Seal plate, vortex, and spin in a plate centrifuge (2 mins at 2000 g). Proceed with PCR cycling conditions as follows. A qPCR (standard PCR can also be used) machine was used with KAPA HiFi mix for PCR as it contains SYBR green and is therefore possible to monitor how each sample is amplifying in real time. Cycling conditions are shown in the table below.
Clean second round PCR products as follows. 30 μl of H2O was added to each well of the PCR plate to bring the total volume per well to 50 μl. 50 μl of AmpureXP beads was added to each well of a 96-well round bottom plate. 50 μl of PCR product was transferred to the 96-well plate containing 50 μl AmpureXP mix and pipette up and down 10× to mix. Samples were incubated at least 10 mins on bench. Plate were placed on 96-well plate magnet for 5 mins (make sure liquid appears clear). Supernatant was discarded by pipette/aspirate. Samples were washed by adding 190 μl of 70-80%. Ethanol to each sample and wait 30 seconds. Ethanol was discarded by pipette/aspirate. Prior two steps were repeated for a total of two washes. Plates were removed from magnet and allow to air dry for 2-3 mins—make sure you cannot detect any ethanol. Plates were taken off the magnet and resuspend the beads in 22 μl of H2O, pipetting up and down 10× to mix thoroughly. Samples were incubated for at least 10 mins on bench. Plate was placed back on the magnet 5 mins (make sure liquid appears clear). 20 μl of the supernatant was transferred to a new 96-well PCR plate.
PCR products were pooled and the library was quantified as follows. 10 μl of each second round PCR product was transferred from plate into a single microcentrifuge tube. Concentration of DNA was determined using the Qubit. DNA concentration was adjusted to 2 nM. MiSeq protocols were followed for sequencing.
The table below shows off-target effects by amplicon deep sequencing. The results of amplicon deep sequencing between Cas9 and Cas9-RecJ. Cas9-RecJ had lower off targeting efficiency for three regions, KCNJ6, CNTPNA2, and Ch.5 except ADCY5. The samples were harvested at 48 h after electroporation.
Based on whole genome sequencing, there were no significant values of off-target effect detected between Cas9 and Cas9-RecJ treatment. Cas9-RecJ had lower off-targeting efficiency for three regions, KCNJ6, CNTPNA2, and Ch.5 except ADCY5 in amplicon deep sequencing.
This example describes use of the fusion constructs disclosed herein in plants.
Plant growth condition and protoplast transfection. All plants were grown under 150 E m−2 s−1 LED light under long-day (14-h light/10-h dark photoperiod) condition at 25° C. Rice seeds were sterilized in 20% hypochlorite solution for 40 min, and then placed on ½ MS media. The one-week-old leaves were used in this study. Tobacco (Nicotiana benthamiana) seeds were sterilized in a 20% hypochlorite solution for 1 min, washed three times in distilled water, and sown on 0.5× Gamborg B5 solid medium supplemented with 2% sucrose. The 4-week-old leaves grown in B5 media were digested with enzymes (1.5% cellulose R10, 0.3% macerozyme R10, 0.5 M Mannitol, 8 mM CaCl2, 5 mM MES [pH 5.7], 0.1% BSA) for 4 h at 25° C. in darkness. The mixture was filtered before protoplasts were collected by centrifugation at 100 g in a round-bottomed tube for 6 min. Re-suspended protoplasts were washed with W5 (154 mM NaCl, 125 mM CaCl2.2H2O, 5 mM KCl, 2 mM MES [pH5.7]) solution and pelleted by centrifugation at 100 g for 6 min. Finally, protoplasts were re-suspended in MMG (0.4 M mannitol, 15 mM MgCl2, 4 mM MES [pH 5.7]) solution and counted under the microscope using a hemocytometer. Protoplasts were diluted to a density of 1×106 protoplasts/ml of MMG solution and stabilized at least for 30 min at 4° C. before PEG-mediated transfection.
2×105 protoplast cells were transfected with Cas9 protein (10 μg) pre-mixed with in vitro-transcribed sgRNA (20 μg). Prior to transfection, Cas9 protein was mixed with sgRNA in 1×NEB buffer 3 and incubated for 10 min at room temperature. A mixture of protoplasts re-suspended in 200 μl MMG solution was gently mixed with 10-20 μl of RNP complex and 210-220 μl of freshly prepared PEG (0.2 M mannitol, 40% W/V PEG-4000, 100 mM CaCl2) solution and then incubate at 25° C. for 15 min. After a 15 min incubation at room temperature, transformation was stopped by 840-880 μl adding W5 solution. Protoplasts were then collected by centrifuging for 2 min at 100 g at room temperature and washed one more time with 1 ml of wash buffer by centrifuging for another 2 min at 100 g. The density of protoplasts was adjusted to 1×105/ml, and they were cultured in modified PIM (B5 medium 1.58 g, sucrose 103 g, 2,4-D 0.2 mg, BAP 0.3 mg, MES 0.1 g, CaCl2.2H2O 375 mg, NaFe-EDTA 18.35 mg and Sodium succinate 270 mg) medium.
Amplicon deep sequencing was carried out as described in EXAMPLE 24. Used primer sequences were
TTTAGGCT-3′,
The table below shows amount of gRNA and protein used in the generation of each RNP complex.
Results showed that Cas9-RecJ showed about 5%-40% higher genome editing efficiencies than Cas9 protein in rice and N. benthamiana.
This example describes evaluation of zinc sulfate treatment.
Cell culture. HEK 293 cells were maintained in DMEM media with 10% Fetal bovine serum FBS and P/S, at 37° C. in CO2 incubator. 150,000 cells were transferred to a 24 well plate in 50 ml of the growth medium a day before transfection.
Transfection. For Cas9 variants transfection to the cells, purified each Cas9 variant protein was added to up to 25 ml of Opti-MEM serum reduced medium in a micro tube, followed by addition of 120 ng guide RNA. The molar ratio of the guide RNA to Cas9 protein was kept nearly at 1.2:1 ratio(1). The mixture, then, mixed well by gentle tapping and incubated for 10 min at RT. In a separate tube. 2 ml of Lipofectamin 3000 transfection reagent was added to 25 ml of Opti-MEM and 25 ml of the diluted transfection reagent was added to the guide RNA and Cas9 protein mixture, followed by incubation for 15 min at RT and 50 ml mixture was added to the cells.
Genomic DNA extraction. Genomic DNA extraction was performed using PureLink Genomic DNA kits following the manufacture's instruction. Briefly cells were washed with PBS once and treated with T.E., followed by incubation at 37, for 5 min. 1.2 ml of growth media were added to cells to harvest cell and then, spin downed at RT, 250×g, for 5 min.
Amplification of genomic loci of human DHCR7. For amplification of genomic loci of human DHCR7, two different PCR primer pairs were used. Forward primer 1: 5′-CAGTAGAGCAGGCATGTTGAGT-3′ (SEQ ID NO: 101); Reverse primer 1: 5′-GTGAAGGTGTATCAAACGCTGA-3′ (SEQ ID NO: 102), which those pair results in two fragments of cut DNA bands whose sizes are 427 and 205, respectively, after T7E1 assay, while only single cut DNA fragment is produced when using following alternative primer pair:
T7E1 assay. Genomic DNA was amplified using specific primers and cleaned up using Wizard® SV gel and PCR clean-Up system. 200 ng PCR cleaned-up amplified DNA was added in a PCR-tube, followed by addition of 1 ml of NEB buffer 2 with up to 9 ml of distilled water (D/W). The mixture was then re-annealed in a PCR machine using following condition: 98° C. for 5 min for denaturation; cooling down to 85° C. at −2° C./sec, in turn, to 25° C. at −0.1/sec and kept at 4° C., in order to prevent denaturation of heteroduplex formation of the amplified DNA. 1 ml of T7E1 endonuclease was added to the mixture and incubated at 37° C. for 60 min.
Image Analysis. For analysis of gene modification, 2% gel was used image was obtained with and Alphaimager 2200 image analysis software was used for analysis. % indel was computed with following equation: 1−((1-fraction cleaved) ½)(2).
This example demonstrates an evaluation of SSB-SpyCas9 and DSB-SpyCas9.
SSB-SpyCas9 method (in vitro). Single stranded binding protein (SSB) fused to SpyCas9 was heterogeneously expressed in E. coli. In order to know its binding affinity, purified SSB-SpyCas9 protein was incubated with ssODNs, which were synthesized in commercial custom DNA oligonucleotide synthesis company. The used DNA oligos, 30mer is donor_NcoI_F1_5′-CAGGGAGGTGGACTGGTTTTCCATGGCGAG-3′ (SEQ ID NO: 105) and 130mer is donor_NcoI_F3_5′-CTCTTAGGGTCCTGGTGGGGCCCAGGGCAGATGGGCCCCAGTGTGACTGCCTGCAT CCGTCCTCGCAGGGAGGTGGACTGGTTTTCCATGGCGAGCGTCATCTTCCTACTGCT GTTCGCCCCCTTCATCG-3′ (SEQ ID NO: 106). SSB-SpyCas9 protein amount was used by increasing gradually from 1 μg to 4 μg with 2.5 μg of ssODNs, which used two different sizes, 30 nt and 130 nt, respectively. For 10 min incubation, and then the reaction mixtures were subjected to electrophoresis.
DSB-SpyCas9 method (in vitro). Double stranded binding protein (DSB) fused to SpyCas9 was heterogeneously expressed in E. coli. In order to know its binding affinity, purified DSB-SpyCas9 protein was incubated with dsDNA, which were synthesized in commercial custom DNA oligonucleotide synthesis company. The used DNA oligos, 253mer is 5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGGTATTTCTGTTCAGATCACTAA ACTCAAGAATCAGCAATTCTCTGAGGCTTTCTTTTAAATATACATAAGGAACTTTCG GAGTGAAGGGAGAGTTTGTCAATAACTTGATGCATGTGAAGGGGAGATAAAAAGG TTGCTATTTTTCATCAACATATTTTGATTTGGCTTTCTATAATTGATGGGCCTGTCTC TTATACACATCTCCGAGCCCACGAGAC-3′ (SEQ ID NO: 107). DSB-SpyCas9 protein amount was used by decreasing gradually from 7 μg to 7 ng with 50 ng of dsDNA. For 30 min incubation, and then the reaction mixtures were subjected to electrophoresis.
In vitro transfection and deep sequencing analysis of on-target sites was performed. For cell culture, HEK293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, penicillin, and streptomycin. For cell cycle synchronization, for improving efficiency of knock-in, HEK293T cells were seeded at 3×106 cell density in 10-cm culture dish. The cells were treated with nocodazole (200 ng/ml) for 16 hours before electroporation. dsDNA donors for knock-in (table) are listed below.
In vitro transfection and deep sequencing analysis of on-targets sites was performed.
RNP preparation and electroporation. Before transfection to the cells, purified each SpyCas9, DSB-SpyCasa9, and DSB-SpyCas9-RecJ protein (33 pmol) and sgRNA (66 pmol) were incubated at RT for 20 minutes for RNP complex. 2 pmol dsDNA was then added to RNP complex. Nucleofection of HEK293T cells was performed using Lonza. Each nucleofection reaction consisted of approximately 2×105 cells in 20 μl of nucleofection reagent and mixed with 10 μl of RNP:DNA.
Genomic DNA extraction. Genomic DNA extraction was performed using PureLink Genomic DNA kits following the manufacture's instruction.
Deep sequencing analysis of on-target sites. The genomic region flanking the target site for each gene was amplified by following PCR method. First, the genomic DNA from the edited and control samples was isolated and PCR amplified 35 cycles using Q5 High-fidelity DNA polymerase with Pt PCR primers to prevent capture donor DNA. Then, PCR products were further amplified using 2nd adapter primers. The resulting amplicons were QIAquick PCR Purification kit. These samples were subjected to eight cycles of PCR using KAPA HotStart DNA Polymerase for indexing, followed by AMPure bead purification. Purified DNA samples were quantified by Qubit 2.0 Fluorometer, size analyzed by BioAnalyzer, and pooled in an equimolar ratio. Sequencing libraries were sequenced with the Illumina MiniSeq. Data was analyzed using Cas-Analyzer program.
This example describes in vivo transfection and analysis of HDR by EcoRI restriction digestion. Cell culture. HEK293T cells are cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, penicillin, and streptomycin.
RNP preparation and electroporation. Before transfection to the cells, purified SpyCas9, SSB-SpyCas9, and SSB-SpyCas9-RecJ protein (33 pmol) and DHCR7 sgRNA (66 pmol) are incubated at RT for 20 minutes for RNP complex. 2 or 20 pmols of 56 mer ssODN (CCTCGCAGGGAGGTGGACTGGTTTTGAATTCCACTGGCGAGCGTCATCTTCCTACT (SEQ ID NO: 63)) are then added to RNP complex. Nucleofection of HEK293T cells is performed using Lonza. Each nucleofection reaction consists of approximately 2×105 cells in 20 μl of nucleofection reagent and is mixed with 10 μl of RNP:DNA.
Genomic DNA extraction. Genomic DNA extraction is performed using PureLink Genomic DNA kits following the manufacture's instruction.
PCR amplification of target region. A 1633 nt region of DHCR7 loci, containing the target site, is PCR amplified using the following primer set. Then, 2nd PCR is performed using 1st PCR product as a template. Primers are listed below. The resulting amplicons are purified using QIAquick PCR Purification kit. The PCR products are analyzed on 1% agarose gel.
Analysis of HDR by EcoRI restriction digestion. EcoRI directly cleaves PCR DNA containing the newly integrated EcoRI restriction sequence to detect successful HDR. The reaction contains 10 ug of PCR products and 10 units of EcoRI in CutSmart buffer. After 2 hours of enzyme digestion at 37° C., the product is resolved on 2% agarose gel. The percentage of HDR is calculated using ImageJ.
HDR is enhanced through the single stranded DNA binding (SSB) protein fusion to SpyCas9 at its N-terminus (SSB-SpyCas9). The SSB-SpyCas9 binds to the repair template ssODN. Ternary complex consisting of the ssODN, SSB-SpyCas9, and sgRNA may result in “Deliver to Repair” even with relatively tiny amount of the ssODN DNA. HDR occurs more efficiently than that of control group due to local availability of the ssODN, since SSB protein will bring ssODN at the place where double stand break occurs.
The present application is a 371 of International Application No. PCT/IB2018/001581, filed Dec. 21, 2018, which claims the benefit of priority to U.S. Provisional No. 62/609,727 filed Dec. 22, 2017, which is hereby incorporated by reference in its entirety, and U.S. Provisional No. 62/622,025 filed Jan. 25, 2018, which is hereby incorporated by reference in its entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/IB2018/001581 | 12/21/2018 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 62622025 | Jan 2018 | US | |
| 62609727 | Dec 2017 | US |
